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More than 1500 proteins have been identified as centrosome or cilia 
proteins, however it is still unknown how these proteins form networks to 
control functions such as centrosome orientation, maturation and 
ciliogenesis. TALPID3 is a centrosomal protein that plays a role in 
centrosome orientation and migration, ciliogenesis and Hedgehog pathway 
signal transduction. Although several proteins that interact with TALPID3 
have been identified, the TALPID3 protein interacting network has not been 
established. Loss of TALPID3 leads to a loss of ciliogenesis, as seen in the 
embryonic lethal talpid3 chicken. Unlike the talpid3 chicken however, human 
ciliopathy patients with mutations in KIAA0586 (human TALPID3 orthologue) 
have a range of defects that often do not result in lethality. 
Human KIAA0586 was modelled in the chicken, in order to understand the 
functional domains that are affected by mutations that are predicted to be 
hypomorphic. A construct containing human KIAA0586 was able to rescue 
Hedgehog-dependent expression patterns, when electroporated into the 
developing neural tube of talpid3 chicken embryos. An attempt to introduce 
a fluorescent tag at the endogenous TALPID3 locus to look at specific 
subcellular localisation, proved unsuccessful; however a super resolution 
imaging approach confirmed localisation of TALPID3 to the centrosome. 
Structured Illumination Microscopy showed that TALPID3 localises to the 
distal end of centrioles with more TALPID3 on one centriole than the other 
centriole, but no specific regions of localisation elsewhere in the cell. 
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A proteomic approach on isolated centrosomes was undertaken to 
investigate the TALPID3 protein network. Proteomic studies in the 
centrosome have previously been carried out in KE37 cells, however in order 
to establish alternative cell lines, specifically chicken Primordial Germ Cells 
(PGCs), as models for studying the centrosome and cilia, this study was 
completed in human Jurkat cells and chicken PGCs. PGCs can be derived 
from the talpid3 flock, therefore by including chicken PGCs the aim was to 
construct the centrosomal proteome of talpid3 vs wildtype centrosomes 
from talpid3 PGCs. Through this study, I have shown that Jurkat cells have a 
low frequency of ciliogenesis with modifications of the centrioles that 
correlate with their low ciliogenesis frequency; however PGCS are capable 
of forming cilia and have modifications of the centrioles that correlate with 
their ability to form cilia, highlighting PGCs as a suitable cell model for 
carrying out centrosome and cilia studies. A mass spectrometry screen on 
centrosomes isolated from Jurkat cells and PGCs failed to identify TALPID3; 
however, the screen identified CCDC77 and CCDC127 as novel centrosome 
proteins, which was confirmed by immunofluorescence. CRISPR/Cas9 
editing, demonstrated that mutations in CCDC127 resulted in a significant 
reduction of ciliogenesis and altered centrosome protein localisation 
patterns in RPE1 cells.  
Isolation of centrosomes from PGCs did not prove effective for constructing 
the proteome of talpid3, therefore an alternative approach was taken using 
protein extracted from whole cell lysate of talpid3 and wildtype PGCs. A 
quantitative proteomic study was undertaken in talpid3 PGCs with the aim 
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of understanding how protein networks are altered in talpid3. Following a 
Tandem Mass Tag (TMT) mass spectrometry approach, pathway analysis in 
Ingenuity Pathway Analysis software (IPA) identified down-regulation of 
protein pathways linked to regulation of the actin cytoskeleton and showed 
an overall change to protein pathways associated with cholesterol 
biosynthesis. Immunofluorescence in talpid3 embryo sections was used to 
examine changes to proteins involved in actin regulation, including F-actin, 
Profilin, Cofilin, Twinfilin and RhoC. 
The main findings of this thesis include evidence that talpid3 embryos can be 
used to model human ciliopathy mutations, demonstrate that PGCs are a 
primary cell model that can be used to study the centrosome and identify 
CCDC127 as a novel centrosome protein that is necessary for ciliogenesis in 
human RPE1 cells. Additionally, the findings show that protein pathways 
associated with the regulation of the actin cytoskeleton are downregulated 
in talpid3. Together the results produced in this thesis provide insight into 
the centrosome from the perspective of chicken PGCs as well as a better 






The drive to better understand human health and what causes disease is a 
major focus of research today. Diseases arise due to mutations in genes, 
often causing abnormalities during development of the embryo, prior to 
birth. Genes that are switched on are able to make protein, however 
mutations often switch the gene off resulting in a loss of protein. One such 
example of a group of diseases that occur during development is 
‘ciliopathies.’ Ciliopathies encompass a range of diseases that present with 
varying symptoms including but not limited to breathing abnormalities, liver 
disease, kidney disease, extra fingers, abnormal eye movement and 
intellectual disability. Ciliopathies are caused by mutations in genes that are 
necessary for forming cilia. Cilia are hair-like extensions that protrude from 
cells and use a group of proteins found in the centrosome, as an anchor, to 
project out of the cell. They are found on all cells in the body and are 
required for communication between cells during development and 
throughout adult life. TALPID3 is an example of a gene that when mutated 
fails to form the correct protein, thus disrupting the cilia and resulting in a 
ciliopathy.  
In order to study diseases, research is usually carried out on cell or animal 
models that mimic the disease or condition of interest. Where animal 
models are available, it is possible to generate cell lines from the animal to 
produce an accessible system in which to study the disease more easily. The 
TALPID3 gene was first discovered in a chicken flock when chicks failed to 
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hatch because of a mutation in TALPID3. Chickens are one of the animal 
models regularly used in research and because the talpid3 chicken is readily 
available, it is possible to generate cell lines from this chicken to provide 
talpid3 cell models. The objectives of this project were to identify and study 
proteins that are linked to ciliopathies, to better understand TALPID3 by 
studying the TALPID3 protein and to identify ways of modelling human 
diseases caused by mutations in TALPID3.  
In this study, I demonstrated that the talpid3 chicken is a tool that can be 
used to model the mutations in TALPID3 in human ciliopathy patients, 
providing a means to understand the disease and symptoms of the patients. 
By studying a group of proteins that are involved in the process of making 
cilia in cells, I identified a previously unknown protein, CCDC127 that when 
mutated leads to a loss of cilia in cells. In addition, I identified chicken 
Primordial Germ Cells (PGCs) as a cell line that have protein patterns that 
correlate with its ability to form cilia thus identifying a new cell model for 
studying ciliopathies. I generated PGCs from the talpid3 chicken flock to 
study the TALPID3 protein. This allowed me to identify groups of proteins 
that communicate with each other in the cell and cause some of the 
symptoms seen in the talpid3 chicken flock and patients with TALPID3 
ciliopathies. In summary, this study has demonstrated models for studying 
proteins that are necessary for cilia, with a focus on the TALPID3 protein and 
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Chapter 1. General Introduction 
 
1.1 Formation and function of the centrosome 
The centrosome is the main microtubule organising centre in the cell (Gould 
& Borisy, 1977; Joshi et al., 1992), consisting of two centrioles, the mother 
centriole and the daughter centriole, which are surrounded by the satellites 
within the pericentriolar material. The mother and daughter centriole are 
held together by filamentous interconnecting fibres between the proximal 
ends of each centriole (Bornens et al., 1987). As the centrosome orientates 
and migrates towards the cell surface, ciliary vesicles derived from the Golgi 
apparatus dock with the distal end of the mother centriole at the distal 
appendages, marking the  conversion to the basal body (Keeling et al., 2016; 
Schmidt et al., 2012; Sorokin, 1962). The basal body then docks at the plasma 
membrane, forming the transition zone at the base of the cilium (Figure 1.1) 









Figure 1.1 Schematic of the steps involved in basal body docking and ciliogenesis. The mother and daughter centriole are held together by 
filamentous interconnecting fibres between the proximal ends of each centriole and are surrounded by centriolar satellites in the pericentriolar 
material. Distal and subdistal appendages mark the distal end of the mother centriole. Ciliary vesicles derived from the Golgi apparatus accumulate 
at the distal end of the mother centriole and dock with the distal appendages. This marks the conversion of the mother centriole to the basal body 





The assembly of procentrioles is initiated at the G1-to-S transition of the cell 
cycle by PLK4 and Cep152 (Habedanck et al., 2005). Centrioles have a distinct 
barrel-shaped structure, composed of microtubules arranged in ninefold 
rotational symmetry. The ninefold arrangement of the microtubules is 
organised by the cartwheel, first observed using electron microscopy in 1960 
(Gibbons & Grimstone, 1960). This well-conserved mechanism appears at 
the early stages of centriole assembly (Hirono, 2014), and as the name 
suggests takes the form of a hub and spokes, the main component of which 
is the protein SAS-6 (Guichard et al., 2013; Winey & O’Toole, 2014).  PLK4 
and Cep152 are involved in recruitment of SAS-6 and STIL to the region of 
the mother centriole to organise the cartwheel formation (Tang et al., 2011). 
STIL interacts directly with CPAP (Kitagawa et al., 2011; Tang et al., 2011), a 
cell cycle regulated protein with similar protein levels as SAS-6 during the 
cell cycle (Tang et al., 2009). 
A single cartwheel is composed of a central ring (the hub), from which nine 
filaments arise (the spokes) that attach to the A-tubule of the triplet 
microtubule. The filaments connect to the A-tubule via a structure called the 
pinhead (Hirono, 2014). The triplet microtubules consist of the A tubule, B 
tubule and C tubule, of which the main component is tubulin (Li et al., 2012; 
Winey & O’Toole, 2014). There are also linkers found between consecutive 
A and C tubules in many organisms (Figure 1.2) (Winey & O’Toole, 2014). 
Typically multiple cartwheels are stacked on top of each other in the lumen 
of the centriole and occupy approximately 100 nm of the proximal end of 
the lumen (Hirono, 2014). This arrangement is well conserved but there are 
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variations; in humans the microtubules are arranged in triplets whereas 
Drosophila and C. elegans have doublet and singlet microtubules 
respectively (Winey & O’Toole, 2014). There are also differences in length of 
centrioles; typically centrioles are 400-450 nm in length and contain several 
layers of cartwheel stacks, however Trychonympha for example have a long 
centriole measuring about 4 μm and contains cartwheels filling 90% of the 
lumen (Gibbons & Grimstone, 1960; Hirono, 2014). Centriolar elongation 
requires a complex of proteins including CPAP, SPICE1 and Cep120 (Comartin 
et al., 2013b); Centrobin has also been implicated in centriolar elongation 
(Gudi et al., 2011). Additionally CP110 plays a role in regulation of centriole 
length by capping the distal end, with evidence to suggest that CPAP and 
CP110 play antagonistic roles in the extent of tubulin added during centriole 






Figure 1.2 Cartwheel structure of the centriole seen in a cross section. 
Many layers of these structures are stacked on top of one another inside the 
lumen of the centriole. Different proteins are responsible for controlling 
different aspects of centriole formation. 
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The centrosome and the cell cycle are closely linked; the duplication of 
centrosomes is coordinated with the cell cycle progression. At the G1-S 
phase transition during the cell cycle, the procentriole duplication cycle 
begins with the formation of a cartwheel at the proximal end of each 
centriole. These procentrioles then elongate until the end of G2 phase, when 
they have reached approximately the size of a mature centriole. During this 
time the centrioles remained linked together, however by the end of G2, the 
centrioles separated and the older centriole in each pair matures and 
develops distal and subdistal appendages. Prior to mitosis (M phase), the 
mother centriole in each pair is able to nucleate increased microtubules for 
spindle assembly, allowing the centrosomes to move to opposite sides of the 
cell as spindle poles. Following mitosis, the paired centrioles in each cell 
disengage, allowing the mother centriole to become a basal body and dock 
at the plasma membrane to form a primary cilium in G0 phase (Figure 1.3) 




Figure 1.3 Centrosome duplication and the cell cycle. Procentrioles form at 
the G1-S phase transition of the cell cycle. The procentrioles elongate 
through to the end of G2, when they mature and separate. During mitosis, 
centrioles form spindle poles at the opposite sides of the cell. Following 
mitosis, the paired centrioles disengage to allow formation of a primary 





Through the centrosomes role as the microtubule organising centre of the 
cell, it nucleates microtubules and controls their length and number; in 
doing so, the centrosome helps to regulate transport of complexes, position 
of cellular organelles, cell motility, cell shape, polarity and segregation of the 
chromosomes during cell division (Abal et al., 2002; Pitaval et al., 2017; 
Schatten, 2008). In addition, the centrosome orchestrates ciliogenesis when 
the cell enters the G0 phase of the cell cycle; the mother centriole matures 
to form the basal body which can orientate towards and dock with the cell 
membrane to form a cilium (Park et al., 2008; Sorokin, 1968). Maturation is 
marked in the mother centriole by distal and subdistal appendages that dock 
cytoplasmic microtubules and anchor the mother centriole to the cell 
membrane when it becomes a basal body during ciliogenesis (Figure 1.4) 
(Ishikawa et al., 2005; Tanos et al., 2013); this requires a series of proteins 
such as Cep164, ODF2, MACF1, Cep89, SCLT1, FBF1 and Cep128, which 
localise to the distal and subdistal appendages (Graser et al., 2007; May-
Simera et al., 2016; Mönnich et al., 2018; Tanos et al., 2013; Tateishi et al., 
2013).  
The role of CP110 is not only limited to controlling centriolar length but also 
plays a role in ciliogenesis, with evidence to suggest it can act as both a 
suppressor and promoter of ciliogenesis (Spektor et al., 2007; Tsang et al., 
2008; Yadav et al., 2016). Studies show that Cep97 recruits CP110 to the 
centrosome where it interacts with Cep290 to suppress ciliogenesis in cells 
(Spektor et al., 2007; Tsang et al., 2008). Cep290 also plays a key role at the 
transition zone, where it is required for microtubule and membrane linkers 
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and helps to regulate entry of proteins into the ciliary compartment (Anand 
& Khanna, 2012; Craige et al., 2010). The transition zone is located distal to 
the basal body at the base of the cilium and mediates linkage to the ciliary 
membrane, establishes a barrier to membrane diffusion and acts as a gate 
to maintain ciliary protein homeostasis (Czarnecki & Shah, 2012). This region 
at the base of the cilium is surrounded by the ciliary pocket, an invagination 
of the membrane, that acts as the site of exocytosis and endocytosis for 
vesicles transporting lipids and proteins from the trans-Golgi complex to the 
ciliary membrane (Figure 1.4) (Pedersen et al., 2016). 
Satellite proteins can also play a role in ciliogenesis, with PCM1, a key protein 
component of satellites, promoting ciliogenesis through interactions with 
specific groups of satellite associated proteins including Mib1, OFD1, 
Cep131, Cep72 and Cep290 (Wang et al., 2016). Satellites were first 
described as electron dense masses around the centrosome; they are now 
known to contain numerous proteins involved in centrosome maintenance 
and ciliogenesis and act as vehicles for protein trafficking towards the 
centrosome (Hori & Toda, 2017; Tollenaere et al., 2015). Proteins such as 
TALPID3 have a more complex role, interacting with a range of different 
proteins including CP110, MACF1, PCM1 and Cep120 (Kobayashi et al., 2014; 
May-Simera et al., 2016; Wu et al., 2014). These TALPID3-interacting 
proteins localise to different regions within the centrosome and are involved 
in regulation of different processes, leading to the question of how TALPID3, 
which has been shown to localise to the distal ends of centrioles and control 
orientation of the centriole prior to docking (Kobayashi et al., 2014; Stephen 
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et al., 2015), can interact with these proteins despite localising to different 
regions and being involved in different functions.  
Additionally there are groups of proteins required for the maintenance and 
assembly of cilia such as the Intraflagellar transport (IFT) proteins and the 
BBSome proteins that localise to the centriolar satellites and the membrane 
of the cilium (Nachury et al., 2007; Nakayama & Katoh, 2018; Pedersen et 
al., 2008). The IFT proteins mediate bidirectional trafficking of ciliary 
proteins along ciliary microtubules; this transport role is required for cilia 
assembly as well as cilia maintenance (Lechtreck, 2015; Nakayama & Katoh, 
2018). The BBSome is a complex of Bardet-Biedl Syndrome proteins that are 
thought to mediate membrane trafficking to the primary cilium through a 
link with Rab8, which targets vesicles to the cilium to promote ciliary 
elongation (Jin et al., 2010; Nachury et al., 2007). The BBSome moves in 
association with IFT trains and is involved in the assembly and stabilisation 
of IFT particles (Wei et al., 2012; Williams et al., 2014). Other ciliary 
components are more involved in the function of the cilium instead of the 
formation or maintenance of the cilia. For example the GTPase ADP 
ribosylation factor-like 13b (Arl13B) helps to regulate Hedgehog pathway 
signalling through regulation of Smoothened entry into the cilium and the 
distribution of Smoothened once in the cilium (Larkins et al., 2011). Although 
this only covers a small portion of proteins that make up the centrosome 
and cilia proteomes, it provides some insight into the nature of the dynamic 







Figure 1.4 Centrosome and cilia structure and protein localisation. Prior to ciliogenesis the centrosome is composed of a mother and daughter 
centriole that migrate towards and orientate at the plasma membrane. The mature mother centriole can be distinguished from the daughter 
centriole by the presence of distal and subdistal appendages. The distal appendages act as the site for vesicle docking. The mother centriole becomes 
the basal body as it docks to the plasma membrane via the distal and subdistal appendages. The region distal to the basal body at the base of the 
cilium is known as the transition zone. This region at the base of the cilium is surrounded by the ciliary pocket, which acts as the site for delivery 
and retrieval of vesicles. The centrioles are surrounded by the pericentriolar material, which contains the satellites. A complex network of proteins 
is required for correct formation and orientation of the mother and daughter centrioles prior to ciliogenesis. Some of the proteins localise to multiple 





There are over 1500 proteins known to be associated with the centrosome-
cilium interface (Gupta et al., 2015). This benchmark dataset of proteins was 
collated from CentrosomeDB (Alves-Cruzeiro et al., 2013; Nogales-Cadenas 
et al., 2009)  and Syscilia (Dam et al., 2013) and named the centrosome and 
cilium database (CCDB) (Gupta et al., 2015). Despite having identified the 
main groups of proteins that are required for the formation of centrosomes 
and how they interact, it is still not fully understood how the remaining 
proteins interact to form networks. A review in 2012 applied Gene Ontology 
(GO) cellular component cluster analysis to 599 human centrosome 
proteins, which grouped the proteins into 9 main clusters, which were then 
further subdivided into 43 categories; by showing the many different 
subgroups that centrosome proteins can be divided into based on where 
they localise and what processes they control, the review demonstrates the 
complexity of the protein networks in the centrosome (Habermann & Lange, 
2012).  
Following docking of the basal body at the cell membrane, the formation of 
a cilium (ciliogenesis) occurs. The cilia that form can be grouped into two 
categories: primary cilia and motile cilia. Primary cilia are non-motile 
organelles that can be found on the surface of almost all cells and act as a 
major site of signal transduction within the cell for key pathways including 
Hedgehog pathway signal transduction, Wnt signalling, Notch signalling, 
Hippo signalling, PDGFR signalling, mTOR signalling and GPCR signalling 
(Goetz et al., 2009; Huangfu et al., 2003; May-Simera & Kelley, 2012; Oh & 
Katsanis, 2013; Wheway et al., 2018). Motile cilia are usually found on 
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tissues that have the ability to produce multiple cilia, such as endothelial 
linings, enabling the cilia to beat in a synchronised manner to aid movement 
of particles over the surface of the tissue (Brooks & Wallingford, 2014; 
Ishikawa & Marshall, 2011; Sorokin, 1968). Motile cilia can also function 
independently as a single structure for example in sperm and the tail of 
Trypanosomes (Inaba & Mizuno, 2016; Ralston et al., 2009). The structure of 
primary and motile cilia differs based on their function; primary cilia are 
composed of nine doublet microtubules (Figure 1.5 A) that stem from the 
triplet microtubules within the basal body and continue the length of the 
cilium, whereas motile cilia contain nine peripheral doublet microtubules as 
well as an additional pair of central, singlet microtubules (9 + 2), radial 
spokes and outer and inner dynein arms (Figure 1.5 B) that allows them to 




Figure 1.5 Cross section of primary and motile cilia. (A) Cross section of a 
primary non-motile cilia with a 9 + 0 arrangement of microtubules. (B) Cross 
section of a motile cilia with a 9 + 2 arrangement of microtubules that 
enables the cilia to bend and beat. 
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1.2 Signalling at the cilium and ciliopathies 
The first evidence of the importance of cilia in the Hedgehog signalling 
transduction pathway came in a mouse mutagenesis screen that identified 
mice with phenotypes characteristic of Sonic hedgehog signalling defects, as 
having mutations that disrupt IFT proteins (Huangfu et al., 2003). The 
mechanism was not fully understood, however it was known that both the 
Hedgehog signalling pathway and ciliary function were important in a range 
of human diseases (Bale, 2002; Huangfu et al., 2003; Sloboda, 2002). The G-
protein coupled receptor Smoothened (SMO), which is essential for 
Hedgehog signalling was subsequently discovered to localise to the cilium in 
the presence of Sonic hedgehog ligand (Corbit et al., 2005), providing the 
link between cilia and Hedgehog signalling. These studies demonstrated that 
Sonic hedgehog (SHH) acting through the transmembrane receptor 
Patched1 (PTCH1) (Goodrich et al., 1996; Marigo et al., 1996) regulates SMO 
activity and translocation to the cilium. In the presence of ligand, SHH binds 
PTCH1 to remove it from the ciliary membrane. SMO is no longer inhibited 
by PTCH1 and can translocate to the cilium where full length Gli proteins can 
be processed to their activator forms (GliA). Where cells are not exposed to 
SHH ligand, PTCH1 remains localised to the ciliary membrane where it 
inhibits SMO, resulting in the processing and cleavage of Gli proteins to their 
repressor forms (GliR) (Figure 1.6). Exploration of the mechanism by which 
SMO, IFT and Hedgehog signalling are linked, demonstrated that IFT in the 
mouse is required for both Gli activator and repressor function and for the 
proteolytic processing of Gli3 (Liu et al., 2005; May et al., 2005). The Gli 
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proteins accumulate at the ciliary tip prior to modification and translocation 
(Haycraft et al., 2005), however whether IFT proteins control this through 
direct transport of the Gli proteins or whether they indirectly influence Gli 
proteins through their requirement during cilia assembly was not known. 
More recent studies have demonstrated that some IFT proteins, such as 
IFT25 and IFT27 are not required for the formation of the cilium, instead they 
are involved in Hedgehog signalling through their role in promoting Gli 




Figure 1.6 Schematic of Hedgehog signalling in the primary cilium. (A) In 
cells lacking Hedgehog ligand, PTCH1 localises to the ciliary membrane and 
inhibits SMO. Following transport of Gli proteins to the tip of the cilium, this 
results in full length Gli proteins being processed and cleaved to form the Gli 
repressor proteins (GliR). (B) In the presence of Hedgehog ligand, Shh binds 
to PTCH1 removing it from the ciliary membrane and allowing translocation 
of SMO to the ciliary membrane. Following transport of full length Gli 
proteins to the tip of the cilium by IFT transport, Gli is processed to its 




Hedgehog signalling is necessary for normal development of all organ 
systems in mammals and Hedgehog signalling requires cilia, thus 
demonstrating the importance of cilia in development (Bangs & Anderson, 
2017; Goetz et al., 2009). Genetic mutations that result in defective protein 
formation leading to abnormal cilia formation and function lead to a group 
of disorders known as ciliopathies (Reiter & Leroux, 2017). Many of the 
phenotypes associated with ciliopathies are characteristic of defective 
Hedgehog signal transduction, including a range of  abnormalities 
predominantly affecting the kidney, eye, liver, brain and skeletal 
organisation (Hildebrandt et al., 2011; Waters & Beales, 2011). Additionally, 
cilia malformations have been linked to diabetes, obesity, skeletal dysplasias 
and microcephaly to name a few (Chavali et al., 2014; Waters & Beales, 
2011).  
There is also evidence to suggest that large scale genomic changes and 
environmental factors can affect proteins involved in the centrosome and 
cilia during development to produce ciliopathy phenotypes. For example 
Trisomy 21, which is the most prevalent human chromosomal disorder, and 
Zika virus have both been linked to defects in centrosomes and cilia (Gabriel 
et al., 2017; Galati et al., 2018). Pericentrin, which localises to the 
centrosome and supports trafficking to and from the centrosome, is located 
on chromosome 21 (Doxsey et al., 1994; Galati et al., 2018; Jurczyk et al., 
2004). Individuals with Trisomy 21 have a triplication of chromosome 21, 
leading to an increased level of pericentrin. This increased level of 
pericentrin results in fewer and shorter cilia with decreased levels of Sonic 
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hedgehog signalling, demonstrating how genomic changes can alter gene 
dosage balance in the centrosome, causing ciliopathy phenotypes (Galati et 
al., 2018). Zika virus, which is associated with microcephaly in newborns, has 
recently been shown to cause premature differentiation of neural 
progenitors as a result of centrosome defects (Gabriel et al., 2017). Neural 
progenitors infected with Zika virus fail to recruit Microcephaly-linked 
proteins such as Cep153, PCNT and CPAP to the centrosome (Alcantara & 
O’Driscoll, 2014; Gabriel et al., 2016, 2017; Guernsey et al., 2010; Lancaster 
et al., 2013; Rauch et al., 2008). In addition, Zika virus infected cells have 
been shown to have decreased levels of the distal appendage protein 
Cep164 as well as mother centrioles that lack appendages (Gabriel et al., 
2017). These changes to centrosomes result in neural progenitor cells 
differentiating too early thus causing microcephaly (Alcantara & O’Driscoll, 
2014) and demonstrating how environmental cues can alter centrosome and 
cilia function.  
Microcephaly is not only caused by Zika virus but also caused by mutations 
in centrosome and cilia genes as well as centrosome amplification (Chavali 
et al., 2014; Malvezzi et al., 2018; Marthiens et al., 2013; Waters et al., 2015). 
Microcephaly is thought to arise from abnormal neurogenesis, resulting in a 
change to the number of neural progenitors, abnormal cell fate decisions 
and abnormal neuronal migration patterns (Chavali et al., 2014; Thornton & 
Woods, 2009). Mutations in Microcephaly-linked centrosome genes have 
been shown to impair centriole production, cause centriole amplification 
and impair centriole length. For example, cells with abnormal centrosome 
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numbers take longer to form a bipolar spindle, leading to mitotic delay; 
mitotic delay is the major phenotype seen following depletion of WDR62, 
ASPM and STIL.  This mitotic delay can eliminate the proliferative potential 
of progenitors thus leading to microcephaly (Novorol et al., 2013).  
Non-motile or sensory ciliary disorders are caused by defects in primary cilia 
and are characterised by a wide variety of phenotypes. The role of primary 
cilia in signalling pathways controls and maintains cell and tissue polarity, 
transduction of sensory stimuli and stem cell proliferation and maintenance; 
therefore, the phenotypes associated with defective primary cilia cover a 
wide range, including but not limited to cystic kidneys, neuronal 
developmental abnormalities, retina defects, liver fibrosis, pancreatic 
defects and skeletal abnormalities (Mitchison & Valente, 2017).  
There has been mixed evidence regarding a potential role for cilia in Wnt 
Signalling (May-Simera & Kelley, 2012). The Wnt signalling pathway 
regulates key aspects of cell fate determination, cell migration, cell polarity 
neural patterning and organogenesis during development. Wnt proteins 
bind the receptor Frizzled, stimulating signal transduction cascades including 
the canonical or Wnt/β -catenin dependent pathway and the non-canonical 
or β-catenin-independent pathway. The non-canonical pathway can be 
further divided into the Planar Cell Polarity pathway and the Wnt/Ca2+ 
pathway (Komiya & Habas, 2008). One of the first pathways to be associated 
with cilia dysfunction was the non-canonical Wnt planar cell polarity (PCP) 
pathway (Ross et al., 2005). The PCP pathway coordinates polarisation of 
cells within the plane of the epithelial cell layer and is also required during 
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organ morphogenesis for convergent extension (Komiya & Habas, 2008; 
Lapébie et al., 2011).  
Two Planar Cell Polarity components, Inversin and Dishevelled, were 
identified at the basal body (Otto et al., 2003; Park et al., 2008), and 
mutations in Inversin cause the ciliopathy Nephronophthisis (Otto et al., 
2003; Simons et al., 2005). In addition, three genes, DUBORAYA, OFD1 and 
SEAHORSE have been linked to ciliogenesis and the Planar Cell Polarity 
pathway in zebrafish; mutations in each of these genes results in a classical 
curved body and curly tail phenotype as well as other ciliopathy-like 
characteristics (Dale et al., 2009). A study found that IFT88, the gene 
mutated in cystic kidney disease in mice, is required for establishing 
epithelial planar cell polarity (Jones et al., 2008), linking ciliary genes to the 
PCP pathway. Additional findings showed that correct positioning of the 
basal bodies and formation of polarised cellular structures are disrupted 
when ciliary proteins are disrupted (Gerdes et al., 2007; Oishi et al., 2006; 
Park et al., 2008). Mice mutants for the core PCP component Fuz have neural 
tube defects, skeletal dysmorphologies and Hedgehog signalling defects that 
are caused by disrupted ciliogenesis (Gray et al., 2009; Tabler et al., 2013). 
These characteristics are similar to the phenotypes observed in many 
ciliopathy patients, demonstrating how defects in primary cilia can lead to 
ciliopathy phenotypes caused by disrupted PCP  (Waters & Beales, 2011).  
In addition to a role for cilia in the non-canonical Wnt PCP pathway, evidence 
suggests a role for cilia in the canonical Wnt/β -catenin dependent pathway; 
knockdown of several BBS genes and several other ciliary-associated genes 
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resulted in hyperactive canonical Wnt responses (Gerdes et al., 2007). In the 
canonical Wnt cascade, Wnt ligand binds the Frizzled receptors thereby 
stabilising β-catenin; in the absence of Wnt ligand, β-catenin is degraded by 
the APC degradation complex (Komiya & Habas, 2008; May-Simera & Kelley, 
2012). APC also plays a role in organisation of the cytoskeletal network (May-
Simera & Kelley, 2012) and APC has been shown to localise asymmetrically 
to the mother centriole supporting a role for APC in cilia formation and 
function (Jakobsen et al., 2011). A factor linking both canonical and non-
canonical Wnt signalling to the cilium is the Rho family GTPase, Cdc42. It is a 
key component in Wnt-dependent cytoskeletal rearrangements and a key 
component in cell polarity; additionally a complex consisting of 
Cdc42/Par6/aPKC localises to the cilium and is required for ciliogenesis in 
mammalian cells (Fan et al., 2004).  
In conclusion, greater than 20 studies have reported a relationship between 
the primary cilium and Wnt signalling, however not all studies are in 
agreement. For example, IFT88 zebrafish mutants that lack all cilia were 
shown to have normal canonical and non-canonical Wnt signalling (P. Huang 
& Schier, 2009). Additionally IFT88, IFT72 and KIF3A mutant mouse embryos 
all lack primary cilia and demonstrate normal activation of a transgenic 
canonical Wnt reporter (Ocbina et al., 2009). The result of conflicting 
evidence has led to the proposal of two theories; the first theory suggests 
that Wnt signalling is regulated by the basal body and not directly linked to 
ciliogenesis and the second theory suggests that only certain ciliary and 
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basal body proteins have roles in Wnt signalling and that those roles are 
independent of their function in the cilia (Oh & Katsanis, 2013). 
Defects in motile cilia can also result in ciliopathies, characterised by 
dysfunction of tissues and organs that rely on specialised ciliary and flagella 
machinery to generate fluid flow or movement within fluids, for example in 
the airways and the Fallopian tubes (Mitchison & Valente, 2017). Disruptions 
to ciliary motility almost exclusively results in primary ciliary dyskinesia 
(PCD), which results in respiratory distress, chronic sinopulmonary disease, 
infertility and can be accompanied by organ laterality defects (Praveen et al., 
2015; Reiter & Leroux, 2017). Mutations in more than 30 genes have been 
shown to cause primary ciliary dyskinesia, however this only accounts for 
65% of patients demonstrating the need for identifying further causes of the 
disease (Knowles et al., 2013; Praveen et al., 2015).  
There are now more than twenty disorders included in the ciliopathy 
spectrum; combined, ciliopathies affect nearly all major organs, including 
kidney, brain, limb, retina, liver, and bone (McIntyre et al., 2013; Novarino 
et al., 2011). Even within one disorder, the phenotypic range is huge and can 
be vastly different even among members of the same family meaning that 
clinical diagnosis can be difficult (Novarino et al., 2011). Joubert Syndrome 
is one such ciliopathy that results from defects in the primary cilium. It is 
classified by brain and spinal malformations and can be diagnosed by the 
Molar Tooth Sign (MTS) seen on an axial MRI brain scan. Abnormalities in 
the caudal midbrain, superior cerebellar peduncles and hypoplasia of the 
midline cerebellar vermis are responsible for the molar tooth sign (Maria et 
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al., 1999; Parisi, 2009). Intellectual impairment or developmental delay, 
hypotonia in infancy, abnormal eye movements and irregular breathing (M. 
A. Parisi, 2009) are all characteristics of Joubert Syndrome. The neural 
defects seen in Joubert Syndrome are likely to be caused by disruptions to 
signalling pathways that require cilia. The Sonic hedgehog pathway plays a 
role in cerebellar development, driving progenitor proliferation; in addition, 
Shh signalling plays a role in human stem cells and formation of adult neural 
stem cells (Spassky et al., 2008). Disruptions in cilia can lead to a decrease in 
canonical Wnt signalling and cell proliferation in the developing cerebellum, 
which causes cerebellar vermis hypoplasia and deep interpeduncular fossa 
that closely resembles the MTS seen in Joubert patients (Abdelhamed et al., 
2013). A subset of patients with Joubert Syndrome present with retinal 
defects, renal abnormalities and liver abnormalities (Romani et al., 2013). It 
is thought that cilia in the kidney are responsible for mechanosensory and 
chemosensory functions that transmit extracellular signals, such as urine 
flow into the cell, and maintain renal epithelial planar cell polarity and 
oriented cell division, resulting in healthy renal function. However, 
abnormalities in cilia disrupt these processes, leading to abnormal renal 
function and cystic kidneys (Huang & Lipschutz, 2014; Papakrivopoulou et 
al., 2014). In conclusion, multiple roles for cilia in signalling pathways as well 
as chemosensory and mechanosensory functions can lead to the 




The number of diseases that fall under the broader category of ciliopathies 
and the wide range of phenotypes associated with ciliopathies demonstrates 
the importance of centrosome and cilia function during development and 
throughout adult life. In particular, it highlights the need to identify the 
protein networks within the centrosome and determine how they function 
together to control centrosome formation, polarity, ciliogenesis and the 
signalling pathways associated with cilia. To date, there is no cure for 
ciliopathies, only treatment of the symptoms. Attempts have been made to 
treat ciliopathies using gene therapy (Chhin et al., 2009; Mcintyre et al., 
2012; Simons et al., 2011); however, for gene therapy to be effective in the 
future, a better understanding of exactly how the mutations are affecting 
multiple tissues, the degree of penetrance in different tissues and the 




The talpid3 chicken arose through a spontaneous recessive mutation 
discovered due to reduced hatchability (embryonic lethality) observed by 
Hunton in 1960. The talpid3 chicken mutant was first described by Ede and 
Kelly as having extensive abnormalities in the head, trunk and limbs (Ede & 
Kelly, 1964; Ede & Kelly, 1964). The talpid3 chicken produces an abnormal 
shortened TALPID3 protein (Davey et al., 2006) caused by an insertion 
mutation of a single Thymidine residue in the TALPID3 gene. The mutation 
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causes a stop codon nine residues after the thymidine insertion, stopping 
translation and resulting in the production of a protein that is only 366 amino 
acids in length (Davey et al., 2006). It is now known that TALPID3 is a 
centrosomal protein (Andersen et al., 2003; Yin et al., 2009) that plays a role 
in centrosome orientation and migration, ciliogenesis and Hedgehog 
pathway signal transduction (Stephen et al., 2013). Since the discovery of 
TALPID3, two knockout mouse models have been made and a knockout 
zebrafish model (Bangs et al., 2011; Ben et al., 2011; Wu et al., 2014). 
Additionally, a group of human ciliopathy patients have been identified as 
having mutations in KIAA0586 (human TALPID3 orthologue) (Figure 1.7) 
(Akawi et al., 2015; Alby et al., 2015; Bachmann-Gagescu et al., 2015; 





Figure 1.7 Schematic of chicken TALPID3 protein and human KIAA0586 protein demonstrating where the chicken, mouse, zebrafish and human 
mutations occur. The coiled-coil domains are marked in purple, with the conserved coiled-coil domain essential for function marked by a blue 
asterisk. The yellow region marks the predicted intrinsically disordered domain. The black line above the chicken protein schematic marks where 
the protein is truncated in the talpid3 chicken mutant. The red line above the chicken protein schematic marks the region deleted in the talpid3-/- 
mouse model. The blue line above the chicken protein schematic marks the region mutated in the TALPID3 knockdown zebrafish model. The lines 
below the human KIAA0586 protein mark all the known human patient mutations, demonstrating the wide range of mutations that are not limited 
to the conserved essential coiled-coil domain. Red lines indicate mutations that result in a premature stop codon, grey lines indicate a splice variant 




The chicken, zebrafish and mouse models all share a similar facial phenotype 
that results in hypoteleorism in the chicken, fused medial and lateral nasal 
processes in the mouse and mild cyclopia in the zebrafish. Additionally all 
three models have polydactyly, which presents in the zebrafish as 
symmetrical pectoral fins, as well as vasculature defects and skeletal defects 
(Bangs et al., 2011; Ben et al., 2011; Ede & Kelly, 1964; Davey et al., 2007; 
Davey et al., 2006; Mohammed, 1986). Other characteristics include 
abnormalities in the chicken liver and lungs, abnormal heart looping in the 
mouse not seen in the chicken and a cystic kidney phenotype in the zebrafish 
and chick (Bangs et al., 2011; Ben et al., 2011; Davey et al., 2014; Yin et al., 
2009).  
TALPID3 mutations in all the animal models (talpid3 chicken, talpid3-/- mouse 
and the TALPID3 knockout zebrafish) are lethal and causes a loss of both 
primary and motile cilia (Figure 1.8) (Bangs et al., 2011; Ben et al., 2011; 
Stephen et al., 2013; Yin et al., 2009). In talpid3 mutants, the basal bodies 
fail to orientate and migrate to the apical surface of the cell, resulting in a 
failure of the basal body to dock (Stephen et al., 2013, 2015; Yin et al., 2009), 
thus resulting in a loss of ciliogenesis. This loss of basal body migration and 
docking was also seen in the mouse mutant and the zebrafish mutant (Bangs 
et al., 2011; Naharros et al., 2018), confirming the shared role for TALPID3 
in all three models. The loss of ciliogenesis is responsible for Hedgehog 
signalling pathway defects, which leads to abnormal levels of Gli proteins 
causing many of the abnormalities associated with defective Hedgehog 
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signalling in the mutant TALPID3 models (Bangs et al., 2011; Ben et al., 2011; 




Figure 1.8 Talpid3 chicken mutant. Cartilage skeletons of E14 talpid3 mutant 
and wildtype sibling, showing skeletal defects including polysyndactyly in 
wings and legs of mutant. Image taken from Davey et al., 2018. (A-H) Anti-
gamma tubulin (red) to mark centrosomes and anti-acetylated tubulin 
(green) to mark cilia. Wildtype tissue sections contain cilia indicated by white 
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arrows. Talpid3 mutant tissue sections are lacking cilia as marked by white 
arrowheads. Taken from Yin et al., 2009. 
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In the developing limb bud of wildtype chick embryos, both Gli3 activator 
(Gli3A) and Gli3 repressor (Gli3R) proteins are expressed; Gli3R is present in 
a gradient along the anterior-posterior axis with higher levels of Gli3R in the 
anterior region of the limb bud. However, talpid3 mutant limb buds have a 
much higher level of Gli3A and fail to form the Gli3R gradient. 
Characterisation of dorsoventral patterning of the neural tube in talpid3 
demonstrated that there is a loss or reduction of ventral genes (loss of 
function phenotype) accompanied by a ventral expansion of the genes 
expressed in the dorsal neural tube (gain of function phenotype), which 
shows a loss of Hedgehog function and failure of Gli3A function. Despite the 
increased levels of Gli3A compared to Gli3R in the mutant, evidence in the 
neural tube shows that the Gli3A protein produced fails to function correctly 
in talpid3 (Davey et al., 2006). Rescue of the abnormal dorsoventral 
patterning of the neural tube can be achieved by electroporation of an 
activated Gli construct that is able constitutively translocate to the nucleus 
or by electroporation of a full length TALPID3 construct, demonstrating that 
this abnormal patterning in the talpid3 neural tube is caused by failure of 
correct Hedgehog signal transduction pathway (Davey et al., 2006; Yin et al., 
2009). Dorsoventral patterning of somites is also disrupted in talpid3, with 
an expansion and shift of cell types into more dorsal domains, which 
resembles a gain of function phenotype. This results in displacement of cells 
that mark boundaries between the myotome and dermomyotome during 
development (Davey et al., 2006). 
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Hedgehog signalling plays a key role in liver development by acting to control 
the balance between hepatoblast proliferation and differentiation into 
hepatocytes; additionally Sonic hedgehog plays a role in liver regeneration 
and repair, highlighting a need for cilia on liver cells (Hirose et al., 2009; 
Ochoa et al., 2010). However, cilia are not just required for hedgehog 
signalling in the liver, cilia on cholangiocytes, the epithelial cells lining the 
bile duct, are much longer and are required for mechanosensory, 
osmosensory and chemosensory functions (Masyuk et al., 2006). Loss of the 
long cilia on cholangiocytes leads to cystic and fibrotic liver disease 
(Strazzabosco & Somlo, 2011). In talpid3, the loss of short cilia in the liver 
suggests that hepatic abnormalities are due to aberrant Hedgehog 
signalling, however loss of long cilia on cholangiocytes could also contribute 
to liver fibrosis seen in talpid3 (Davey et al., 2014). 
Talpid3 mutants have severe abnormalities in lung development, which can 
be mimicked in the wildtype by introducing the Sonic Hedgehog inhibitor 
cyclopamine. This evidence, combined with the loss of primary cilia in the 
three main tissue types of the lung suggest that the disruption of lung 
morphogenesis and consequent defects in the epithelium and mesenchyme 
in talpid3 is a result of the loss of Hedgehog signalling (Davey et al., 2014). 
Defects, including haemorrhaging and oedema,  are also present in talpid3 
(Ede & Kelly, 1964; Davey et al., 2007; Mohammed, 1986). These defects 
have also been attributed to the aberrant Hedgehog signalling due to a loss 
of cilia. Similar to the loss of polarised gene expression in talpid3 limb buds 
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that leads to polydactyly, the antero-posterior vascular pattern is also lost in 
the talpid3 limb as a result of loss of Gli3R function (Davey et al., 2007). 
 The inability of centrosomes to orientate in talpid3 highlights a role for 
TALPID3 in polarity, independent of Hedgehog signalling (Stephen et al., 
2015). This role for TALPID3 is supported by the polycystic kidney phenotype 
that is frequently due to a loss of orientated cell division (Happé et al., 2011; 
Yin et al., 2009), cell migration defects that could be due to a loss of cell 
polarity (Bangs et al., 2011), as well as more recent work in the TALPID3 
mutant zebrafish model (Naharros et al., 2018). The skin and inner ear, two 
highly polarised tissues independent of Hedgehog signalling, are disrupted 
in talpid3. Talpid3 skin lacks characteristic rostral-caudal polarisation that is 
found in wildtype. Additionally, the hair cells of the inner ear in wildtype 
have a highly polarised structure that is determined by the non-canonical 
Wnt-PCP signalling pathway. Wildtype inner ear hair cells form an orientated 
actin-based stereocilia bundle, which forms a kinocilium and orientates in a 
specific direction; in contrast, inner ear hair cells in talpid3 lack a kinocilium 
and form stereocilia bundles that lack specific orientation demonstrating the 
disrupted polarity in talpid3 mutants (L. A. Stephen et al., 2015). An 
additional actin phenotype was reported in the talpid3 mutant, which 
showed a discontinuous band of F-actin at the apical edge of the developing 
neural tube as well as fewer stress fibres (and fewer focal adhesions) in 




The human KIAA0586 ciliopathy patients present with a range of  
characteristics that are similar to the chicken, mouse and zebrafish models, 
such as skeletal defects, brain defects and in a small number of cases 
polydactyly (Akawi et al., 2015; Alby et al., 2015; Bachmann-Gagescu et al., 
2015; Malicdan et al., 2015; Roosing et al., 2015; Stephen et al., 2015), 
supporting the conserved role for KIAA0586/TALPID3 during development. 
However, unlike the chicken, mouse and zebrafish models, only a small 
number of human patients with mutations in KIAA0586 have been reported 
to be lethal (Alby et al., 2015) instead presenting with a much less severe 
phenotype. The majority of the patients were diagnosed with Joubert 
Syndrome, which can be identified by the presence of the Molar Tooth Sign 
on an axial MRI brain scan (Maria et al., 1999; Parisi, 2009); the molar tooth 
sign is typically accompanied by intellectual impairment or developmental 
delay, hypotonia in infancy, abnormal eye movements and irregular 
breathing (Parisi, 2009). Ciliogenesis in KIAA0586 ciliopathy patients has not 
been explored widely, however in the three patients where ciliogenesis was 
examined, a significant reduction in ciliogenesis was observed but not a 
complete loss (Alby et al., 2015; Malicdan et al., 2015). 
In conclusion, the abnormalities seen in the talpid3 chicken, the talpid3-/- 
mouse and the TALPID3 knockdown zebrafish demonstrate the severe 
phenotype caused by a loss of TALPID3 protein during development. The 
similarities in the phenotype observed in all three mutant models 
demonstrates the conserved function of TALPID3 and its requirement during 
embryonic development. The human patients share many of the phenotypes 
34 
 
and demonstrate a reduction in ciliogenesis, thus supporting a conserved 
function of KIAA0586 in humans. However, the less severe phenotype 
associated with human KIAA0586 ciliopathy patients and the lack of 
complete loss of ciliogenesis in humans suggests a potential difference in the 




1.3.1 TALPID3 protein interacting network 
TALPID3 was first identified as a hypothetical centrosome protein in a 
proteomic study aimed at characterising the proteins in the centrosome 
(Andersen et al., 2003). A further proteomic study aimed at mapping the 
centrosome identified KIAA0586 with other known and novel centrosome 
proteins, all of which were grouped based on their localisation to 
substructures within the centrosome. This study placed TALPID3 in the 
centrosome (Jakobsen et al., 2011), confirming previous studies (Andersen 
et al., 2003; Yin et al., 2009), however it did not specify localisation to any 
substructures within the centrosome or its potential localisation elsewhere 
in the cell. Following a proteomic screen for members of the CP110-
containing complexes, immunoprecipitation showed that KIAA0586 binds to 
CP110 and more weakly interacts with Cep97, Cep290 and Kif24. 
Immunohistochemistry to confirm the proteomic results showed that 
KIAA0586 forms a ring-like structure around CP110 at the distal end of the 
centriole in human RPE1 cells (Kobayashi et al., 2014). Despite the 
interaction between TALPID3 and CP110, MEFs taken from CP110-/- mice 
showed no change to TALPID3 localisation, demonstrating that CP110 is not 
needed for recruitment of TALPID3 to the basal body (Yadav et al., 2016). 
The cell studies in RPE1 cells suggest that TALPID3 might interact with CP110 
to prevent CP110 from suppressing cilia formation, however the CP110-/- 
mouse demonstrates that CP110 also acts as a positive regulator of 
ciliogenesis (Yadav et al., 2016) suggesting a more complex role for the 
protein and a different role for the interaction of TALPID3.  
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Examination of KIAA0586 and Cep290 showed that ablation of either protein 
resulted in an accumulation of centriolar satellites in cells able to produce 
cilia. Additionally, the study found that KIAA0586 and Cep290 are needed to 
recruit Rab8a to the centrosome during the early stages of ciliogenesis, 
suggesting an interaction between KIAA0586 and Rab8A (Kobayashi et al., 
2014). Immunostaining for Cep290, in human fibroblasts lacking KIAA0586, 
showed that loss of KIAA0586 corresponded to an abnormal extended 
pattern of Cep290 (Alby et al., 2015), suggesting that Cep290 acts 
downstream of KIAA0586. Loss of KIAA0586 or Cep290 results in an 
accumulation of PCM1 granules around the centrosome leading to an 
accumulation of centriolar satellites that corresponds to defects in cilia 
formation (Kobayashi et al., 2014). This accumulation of satellites is 
consistent with accumulation of PCM1 seen in talpid3 cells (Stephen et al., 
2015).  PCM1 is required for restricting the E3 ligase, Mindbomb1 (Mib1), to 
the satellites. Loss of PCM1 results in translocation of Mindbomb1 to the 
centriole, where it interacts with and destabilises TALPID3 resulting in a loss 
of ciliogenesis (Wang et al., 2016). This suggests a regulatory pathway 
involving PCM1, Mib1 and TALPID3.  
Co-staining of embryonic fibroblasts, taken from a patient homozygous for 
c.1815G>A splice variant mutation in KIAA0586, showed that loss of 
KIAA0586 does not affect the localisation of the distal appendage protein 
Cep164  or  the subdistal/distal appendage protein ODF2 (Alby et al., 2015). 
Talpid3 mutants do not show a change in Cep164 localisation despite a loss 
of centriole orientation, however the CEP164 puncta are smaller than in 
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wildtype (Stephen et al., 2015). Loss of KIAA0586 does not lead to a loss of 
distal or subdistal appendages. Therefore, despite Cep164 being shown to 
localise in a ring around KIAA0586 at the distal end of the mother centriole 
(Kobayashi et al., 2014), these results demonstrate that Cep164 does not 
interact with KIAA0586.  
KIAA0586 has also been shown to interact with Cep120, a centrosome 
protein that is required for centriole duplication and elongation (Comartin 
et al., 2013a; Mahjoub et al., 2010; Wu et al., 2014). KIAA0586 regulates 
asymmetric localisation of Cep120 to the daughter centriole; specifically the 
region between amino acids 470-638 of KIAA0586 is essential for Cep120 to 
bind to KIAA0586 (Wu et al., 2014). Overexpression of Cep120 causes 
abnormal centriole elongation resulting in the production of extra-long 
centrioles (Comartin et al., 2013b; Lin et al., 2013). This, taken with the data 
showing KIAA0586 is needed for Cep120 to asymmetrically localise to the 
daughter centriole, suggests that KIAA0586 inhibits Cep120 through its 
interaction. Additionally TALPID3 has been shown to interact with 
Microtubule-Actin Cross Linking Factor 1 (MACF1), a ciliogenesis protein that 
is required in the early stages of ciliogenesis and required for maintenance 
of basal body positioning in differentiated tissue (May-Simera et al., 2016). 
Taken together, the protein interactions described above between 
KIAA0586/TALPID3 and other centrosome proteins suggest a complicated 
network in which KIAA0586 is essential for distinct roles and protein 







Figure 1.9 TALPID3 protein interactions at the centrosome. TALPID3 interacts with proteins in the centrosome that are involved in different 
processes and are known to localise to distinct regions. TALPID3 interacts with proteins found in the mother and daughter centrioles, proteins in 
the pericentriolar material and also MACF1, which is found at the appendages on the mother centriole. Each of these proteins is involved in slightly 
different functions within the centrosome and with the exception of CP110 and Cep290, are not known to interact with one another. There is no 
further evidence to confirm whether TALPID3 has a role in ciliogenesis after orientation and docking of the basal body at the cell membrane, however 
it is possible that TALPID3 localises to the transition zone during ciliogenesis. 
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1.3.2 What gaps still remain in our knowledge of 
TALPID3/KIAA0586? 
There are still questions surrounding the functional domains of 
TALPID3/KIAA0586, due to the inability to predict the protein structure of 
the predicted intrinsically disordered domain (Davey et al., 2006; Yin et al., 
2009). Evidence from complementation assays and localisation studies 
suggest that the TALPID3/KIAA0586 protein has additional functional 
domains at the C-terminal that rely on the essential coiled-coil domain for 
localisation to the centrosome (Davey lab, unpublished; Kobayashi et al., 
2014; Yin et al., 2009). The phenotypes associated with the lethal animal 
models compared to the varying non-lethal phenotypes associated with the 
human KIAA0586 ciliopathy patients suggest that the human patients may 
have an unidentified compensatory mechanism to provide some protein 
function (Akawi et al., 2015; Bachmann-Gagescu et al., 2015; Bangs et al., 
2011; Ben et al., 2011; Davey et al., 2006; Malicdan et al., 2015; Roosing et 
al., 2015; Stephen et al., 2015). The remaining unanswered questions 
highlight the need for an approach to model the human mutations using an 
assay that can provide insight into the functional domains within the protein. 
TALPID3/KIAA0586 has been confirmed as a protein that localises to the 
centrosome and that is required for correct centriole orientation prior to 
basal body docking at the cell membrane during ciliogenesis (Bangs et al., 
2011; Ben et al., 2011; Kobayashi et al., 2014; Stephen et al., 2015; Yin et al., 
2009). However, it is still unclear what centrosome proteins TALPID3 
interacts with or when and where in the centrosome it interacts with those 
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proteins, to control centriole orientation. A number of proteins including 
CP110, PCM1, Cep290, MACF1, Cep120 and Mib1 have been shown to 
interact with TALPID3 (Kobayashi et al., 2014; May-Simera et al., 2016; L. 
Wang et al., 2016; Wu et al., 2014), however these proteins are involved in 
different functions during centriole formation and ciliogenesis, highlighting 
the complexity of the role of TALPID3 in the centrosome. TALPID3 has also 
been shown to localise to the distal end of the centrioles (Kobayashi et al., 
2014; Wu et al., 2014), which leads to the question of how it interacts with 
proteins that localise elsewhere in the centrosome, such as PCM1, which 
localises to the pericentriolar material and how it can produce a satellite 
phenotype (Kobayashi et al., 2014; Stephen et al., 2015) from its position at 
the mother centriole. In addition to a complicated network of protein 
interactions in the centrosome, evidence from the actin phenotype seen in 
talpid3 mutant suggests that TALPID3 could play a role in the regulation of 
the actin cytoskeleton (Yin et al., 2009). This potential involvement in the 
regulation of actin suggests that TALPID3 may also have a functional role 
outside the centrosome. Therefore, it is likely that TALPID3 has a role in 
several different protein networks that control different functions, instead 
of multiple different proteins being involved in a novel ‘TALPID3 protein 
network,’ highlighting the need for further proteomic studies into the talpid3 
proteome. In addition, the dynamic localisation of TALPID3 during the cell 
cycle has remained unexplored; a tool to examine the endogenous 
localisation of TALPID3 during the cell cycle could provide some insight into 
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when and where in the centrosome TALPID3 has the opportunity to interact 
with other centrosome proteins. 
 
1.4 General thesis aims  
To date, the predicted intrinsically disordered domain in TALPID3 has led to 
failed attempts to determine the structure of the protein as well as 
hampering attempts to identify additional functional domains. Furthermore, 
the complicated nature of TALPID3 protein interactions in the centrosome 
has also prevented identification of the complete TALPID3 protein network.  
My thesis had three main aims. The first aim was to identify a method to 
model human KIAA0586 ciliopathy mutations that would allow identification 
of hypomorphic mutations and could provide insight into additional 
functional domains. The second aim was to identify a proteomic approach 
that was viable for studying the TALPID3 proteome in chicken Primordial 
Germ Cells, providing a proteomic method to study the talpid3 mutant 
proteome in a ciliated cell line for the first time. The third aim was to use the 
identified proteomic approach to uncover novel insights into the talpid3 




Chapter 2. Materials and Methods  
 
2.1 Nomenclature of KIAA0586/TALPID3  
In accordance with the Chicken Gene Nomenclature Committee (CGNC) 
TALPID3 and TALPID3 were used for designation of the chicken gene and 
protein, respectively. In accordance with the Human Gene Nomenclature 
Committee (HGNC), KIAA0586 and KIAA0586 were used for designation of 
the human gene and protein, respectively. Although the current gene 
symbol for the mouse gene is 2700049A03Rik and mouse protein is 
2700049A03RIK, I have used KIAA0586 and KIAA0586 as the gene and 
protein names respectively. Where I make a generic conclusion on the 
function of the orthologues of KIAA0586 I have used KIAA0586. As published, 
I have referred to the chicken model as talpid3 and the mouse model as 
talpid3-/- through-out this thesis. The nomenclature of human KIAA0586 
mutations described in this thesis refers to reference sequence 
NM_001244189.1 (corresponding protein: NP_001231118.1). 
 
2.2 Cell Culture  
Cell culture was completed in a sterile hood. All live cell experiments were 
completed under sterile conditions, with all equipment and materials 
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cleaned and sterilised with 70% ethanol prior to use. An Olympus CK2 
Inverted microscope was used for analysing all cells. 
 
2.2.1 Culturing cells 
Human RPE1 (retinal pigmented epithelial) cells were cultured in DMEM/F12 
media (Lonza BE04-687F/U1), supplemented with 10% fetal bovine serum 
(FBS) (PAA A15-151), 1% L-glutamine and 1% streptomycin/penicillin at 37°C, 
5% CO2 (carbon dioxide). Cells were passaged every 2-3 days. To passage 
cells, media was removed, cells were washed twice with 2-3 ml of pre-
warmed DPBS (Life Technologies 14190094) to remove residual media. Cells 
were treated with 1 ml of TrypLE (Life Technologies 12604013) at 37°C for 2-
5 minutes until dissociated. Following dissociation, 2-3 ml of DMEM/F12 
media was added to stop the dissociation reaction. Cells were then pelleted 
in a falcon tube at 180 x g for three minutes in a Sigma 3-16 centrifuge, 
supernatant was discarded and cells were resuspended in fresh media, pre-
warmed to 37°C.  
Human Jurkat cells were cultured in suspension in RPMI 1640 (Life 
Technologies 21875034), supplemented with 10% FBS at 37°C, 5% CO2. Cells 
were passaged every 2-3 days. To passage cells, media containing cells in 
suspension was transferred to a Falcon tube and pelleted at 180 x g for three 
minutes in a Sigma 3-16 centrifuge. The supernatant was discarded and the 
pellet was resuspended in fresh media, pre-warmed to 37°C. 
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Chicken Primordial Germ Cells (PGCs) were cultured in FAOT media in 
suspension at 37°C, 5% CO2. PGC media: Diluted DMEM was made up with 
76% DMEM (Life Technologies 21068-028), 22% tissue culture grade water, 
supplemented with 1% Sodium pyruvate and 1% MEM Vitamin Solution. The 
diluted DMEM was supplemented with B27 (50x), Glutamax (100x), NEAA 
(100x), Nucleosides (100x), Pyruvate (100x), B-mercaptoethanol, CaCl2, 
Ovalbumin (20%) and Na Heparin (50 mg/ml) to make B27 diluted DMEM. 
This was stored at 4°C and protected from the light. From the B27 diluted 
DMEM, FAOT media was made with h-Activin (25 μg/ml), h-FGF2 (25 μg/ml) 
and Ovotransferin (10 mg/ml). FAOT was also stored at 4°C and protected 
from the light. The PGCs were fed or passaged every 2-3 days. To feed cells, 
half of the media that cells were suspend in was removed and discarded and 
replaced with fresh media pre-warmed to room temperature. To passage, 
media containing cells in suspension was transferred to Eppendorf tubes and 
cells were pelleted at 1.7 rpm for four minutes in a miniSpin plus Eppendorf 
centrifuge, supernatant was discarded and cell pellet was resuspended in 
fresh media pre-warmed to room temperature.  
 
2.2.2 Freezing cells 
RPE1 cells at approximately 80% confluency were pelleted at 180 x g for 
three minutes in a Sigma 3-16 centrifuge. Supernatant was discarded and 
cells were resuspended in 2 ml culture media supplemented with an 
additional 60% FBS and 10% DMSO (Sigma D2650) and divided between two 
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cryogenic tubes. Cells were initially snap frozen at ˗80°C where they 
remained for 24 hours, following which they were transferred on dry ice to 
˗150°C for long-term storage. 
Jurkat cells at approximately 80% confluency were pelleted at 180 x g for 
three minutes in a Sigma 3-16 centrifuge. Supernatant was discarded and 
cells were resuspended in 2 ml culture media supplemented with 5% DMSO 
and divided between two cryogenic tubes. Cells were initially snap frozen at 
˗80°C where they remained for 24 hours, following which they were 
transferred on dry ice to ˗150°C for long-term storage. 
PGCs at approximately 80% confluency were pelleted at 1600 rpm for 4 
minutes in a miniSpin plus Eppendorf centrifuge. Cells were resuspended in 
250 μl of B27 stock solution media. 250 μl of freezing media (B27 stock 
solution media with 8% DMSO, 10% Biosera CS and 37.5 μl 20mM CaCl2) was 
added and mixed by gently pipetting up and down. The cells were divided 
between two cryovial tubes, labelled and frozen at ˗80°C. 24 hours later, the 
cells were transferred on dry ice to ˗150°C for long-term storage.  
 
2.2.3 Thawing cryopreserved cells 
Cells were removed from ˗150°C storage and transferred on dry ice to cell 
culture lab. RPE1 cells and Jurkat cells were thawed at 37°C in a water bath 
and PGCs were thawed gradually at room temperature. 1 ml of pre-warmed 
cell-appropriate media was added, cells were pelleted and supernatant 
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removed. Cells were then resuspended and seeded at an appropriate 
density.   
2.2.4 Deriving talpid3 flock primordial germ cell lines 
Eggs from the talpid3 flock were incubated for 50-60 hours, until the 
embryos were Hamburger Hamilton stage 15-16. Eggs were windowed and 
the membrane was removed. A needle was inserted into the dorsal aorta 
and approximately 1 μl of blood was removed by mouth pipetting, typically 
containing approximately 50 cells. Needles were pulled on a Moving-Coil 
Microelectrode Puller Model 753 (Campden Instruments Limited) using the 
following settings: pre-pull heating time 57, initial pull force 159, main pull 
force 286, main pull delay 49, heater control 139. Blood was transferred to 
a single well in a sterile 48-well plate containing 300 μl of FAOT media. 90 μl 
of FAOT media was removed and replaced with 100 μl of fresh FAOT media 
every 2-3 days for 10-14 days. After 10-14 days, cultures were pelleted, 
resuspended in 500 μl FAOT and transferred to a single well in a 24-well 
plate. The cell lines were cultured and expanded as described previously 
(section 2.2.1).  
 
2.2.5 Cell transfections 
For RPE1 cell transfections: 1.5 μg DNA was mixed with 100 μl Opti-MEM I 
reduced serum media (Gibco, cat no. 31985-0620) and incubated at room 
temperature for 5 minutes. 2 μl of Lipofectamine2000 (Invitrogen cat no. 
11668027) was added to 100 μl of Opti-MEM I per transfection and 
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incubated at room temperature for 5 minutes. DNA and Lipofectamine2000 
mixes were added together and incubated at room temperature for 20 
minutes. RPE1 cells were grown in a 6-well plate, to 70% confluence. Media 
on cells was replaced with 3 ml Opti-MEM I and the DNA/Lipofectamine mix 
was added to the cells. Cells were incubated in transfection mix for 24 hours 
at 37°C, 5% CO2. After incubation, Opti-MEM I was removed and replaced 
with DMEM/F12 media for several hours to allow recovery of cells. After 2-
3 hours, puromycin was added at a concentration of 5 μg/μl to select for 
positively transfected cells. After 48 hours, the media containing puromycin 
was removed and replaced with fresh DMEM/F12 media.   
For chicken PGC transfections: 200,000 cells were used per transfection. 2 
μg of DNA was added to 150 μl of Opti-MEM I serum media (Gibco, cat no. 
31985-0620) in a screw top 1.5 ml Eppendorf tube. 2 μl of 
Lipofectamine2000 (Invitrogen cat no. 11668027) was added to 148 μl of 
Opti-MEM I in a separate screw top 1.5 ml Eppendorf tube. Both tubes were 
incubated at room temperature for approximately 20 minutes. Tubes were 
combined (transfection mix) and flicked 5 times to mix, then incubated at 
room temperature for 25 minutes to allow complexes to form. Cells were 
pelleted at 1600 rpm for 4 minutes and media removed. Cells were 
resuspended in 750 μl of Opti-MEM, to wash and then re-pelleted at 1600 
rpm for 4 minutes. All media was removed and cells were resuspended in 50 
μl of Opti-MEM per transfection. 50 μl of cells in suspension was added to 
300 μl of transfection mix by gently pipetting up and down 5 times. Cells 
were incubated upright at 37°C, 5% CO2 for approximately 6 hours, with cap 
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loosened to allow CO2 and oxygen to enter the Eppendorf tube. Following 
approximately 6 hours of incubation, cells were pelleted at 2200 rpm for 10 
minutes, transfection solution was discarded and cells were resuspended in 
FAOT media and transferred to a fresh well in a 24-well plate. 24 hours later, 
2.0 μl of 0.1 mg/ml of Puromycin was added to transfected cells and 
incubated for 48 hours to select for positively transfected cells. After 48 
hours, cells were pelleted at 1600 rpm for 4 minutes, washed with B27 stock 
media and re-pelleted at 1600 rpm for 4 minutes. Cells were then resuspend 
in fresh FAOT media. 
 
2.3 Protein 
2.3.1 Protein extraction from cells  
RPE1 cells, Jurkat cells or chicken PGCs were expanded in culture. Cells were 
pelleted at 180 x g in a Sigma 3-16 centrifuge. Cells were resuspended in 1 
ml of ice cold DPBS to wash, then re-pelleted at 4000 rpm, 4°C for 3 minutes. 
DPBS was removed and pellet resuspended in 50-150 μl of SDT label free 
lysis buffer: 100mM Tris-HCl (pH7.6), 4% (w/v) sodium dodecyl sulfate and 
1% HALT protease inhibitors (100X). A mini homogeniser was used to 
resuspend pellet, following which sample was incubated on ice for 30 
minutes. Sample was then centrifuged at 20,000 x g, 4°C for 20 minutes. 
Supernatant, containing protein, was removed, transferred to a fresh, 




2.3.2 Centrosome Isolation  
Cells in suspension were grown up to a density of approximately 2 x 106 
cells/ml in T-160 flasks. Total number of cells for carrying out centrosome 
isolation was approximately 1 x 109. Cells were treated with 60 ng/ml 
nocodazol (stock solution: 5 mg in 10 ml DMSO, stored at ˗20°C) and 1 μg/ml 
cytochalasin D (stock solution: 2 mg in 1 ml DMSO stored at ̠ 20°C) for 1 hour 
at 37°C, to prevent association of microtubules with the centrosome during 
isolation. Cells were transferred to 50 ml falcon tubes and pelleted at 2500 
rpm, 10 minute, 4°C. Cell pellet was washed with half the initial suspension 
volume of 1 X TBS (Tris-buffered saline: 10 mM Tris.HCl, pH 7.4 / 150 mM 
NaCl, stored at 4°C) (25 ml per 50 ml tube), then washed again with half the 
previous volume of TBS 0.1-8% sucrose buffer (100 ml TBS + 80 g sucrose 
made up to 1 Litre with distilled water, made fresh) (12.5 ml per 50 ml tube). 
Cells were re-pelleted between each wash at 2500 rpm, 5 minutes, 4°C. Cells 
were resuspended in 20 ml TBS 0.1-8% sucrose buffer per tube. Lysis buffer 
(1 mM Hepes pH 7.2, 0.5% NP-40, 0.5 mM MgCl2, 0.1% β-mercaptoethanol, 
1 mM PMSF + 1 μg/ml leupeptidin, peptstatin A and aprotinin, made fresh) 
was added and then incubated on ice for 5 minutes. Nuclei/chromatin was 
pelleted at 4000 rpm for 10 minutes at 4°C. Lysate was filtered through one 
layer of medical gauze to remove chromatin and nuclei. 10 mM Hepes was 
added to lysate to digest the remaining chromatin and 10 μg/ml DNAse I was 
added to lysate and incubated for 30 minutes at 4°C. Lysate was transferred 
to centrifuge tubes and 5 ml 50% sucrose solution was gently pipetted to the 
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bottom of the tube. Centrosomes were deposited onto the 50% sucrose 
cushion, by spinning at 11000 rpm for 20 minutes at 4°C in a TH13 rotor. 50% 
sucrose cushions and centrosomes were removed, pooled and mixed. 
Centrosomes in sucrose solution were gently pipetted into a new centrifuge 
tube on top of a discontinuous sucrose gradient: 5 ml 70% sucrose, 3 ml 50% 
sucrose, 3 ml 40% sucrose. All sucrose solutions were made weight/weight 
sucrose to gradient buffer (10 mM K.Pipes pH 7.2, 0.1% Triton X-100, 0.1% 
β-mercaptoethanol). The sucrose gradient was centrifuged at 25000 rpm for 
75 minutes at 4°C in a SW28 rotor, in a Beckman Coulter Optima L-100K 
UltraCentrifuge, to collect the centrosomes at the bottom of the centrifuge 
tube. Elution was performed at room temperature by making a hole in the 
bottom of the centrifuge tube using a 20G needle. Twenty 0.5 ml fractions 
were collected and snap frozen in liquid nitrogen, labelled and stored at 
˗80°C. 
 
2.3.3 Protein extraction from centrosomes 
Centrosomes from fractions 6-10, determined based on previous protocol 
(Andersen et al., 2003), were spun out of sucrose solution at 100,000 x g in 
a SW28 rotor on a Beckman Coulter Optima L-100K Ultracentrifuge. 
Supernatant was poured off; the remaining sucrose solution was removed 
by pipette taking care not to disturb the protein pellet. Pellet was 
transferred to a 1.5 ml Eppendorf and any protein pellet left behind was 
scraped off and transferred to 1.5 ml Eppendorf to ensure no loss of protein. 
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Protein was pelleted at 20,000 x g, 4°C for 20 minutes. Excess supernatant 
was removed. Pellet was resuspended in 50 μl of SDT label free lysis buffer: 
100 mM Tris-HCl (pH7.6), 4% (W/V) sodium dodecyl sulfate and 1% HALT 
protease inhibitor cocktail (100X).  To resuspend completely, sample was 
pipetted up and down. A mini homogeniser was used when the pellet was 
big or difficult to resuspend by pipetting. Protein sample was incubated on 
ice for 20 minutes, then centrifuged at 20,000 x g, 4°C for 20 minutes. 
Supernatant, containing centrosome proteins, was transferred to a new 1.5 
ml Eppendorf tube. Pellet was kept as a negative control and both were 
stored at ˗80°C. 
 
2.3.4 BCA Assay 
Concentration of protein samples was calculated using a Thermo Scientific 
Pierce microBCA Protein Assay kit (23235), following user manual 
instructions in the kit. Working solution was made up using 50% reagent A, 
48% reagent B and 2% reagent C. BSA protein contained in kit was vortexed 
and used for making protein standards as follows: blank, 2 μg/μl, 4 μg/μl, 6 
μg/μl, 8 μg/μl, 10 μg/μl and 20 μg/μl. All protein samples to be quantified 
were vortexed and diluted in working solution, adding 1 μl of each protein 
sample to 1 ml of working solution. All protein standards and protein 
samples were done in duplicate. Protein standards and samples were mixed 
by hand, incubated at 60°C for 60 minutes and decanted into cuvettes  
(Fisher Scientific, Cuvette semi-micro disposable 10 mm light path 
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11547692). Samples were read on a spectrophotometer at 562 nm to 
determine optical density. The standards were used to calculate a standard 
curve and concentration of the protein sample was calculated based on the 
standard curve. 
 
2.3.5 Western Blot 
5 -20 μg of protein, in a volume of 10 μl, was loaded onto a gel. 5 μl of sample 
buffer (loading dye) was added to each sample and vortexed. Samples were 
incubated at 98°C for two minutes to linearise protein. 20 X MES or 20 X 
MOPS running buffer was diluted to a working concentration of 1 X. 
Packaging, including white strip and comb of a 12-well or 15-well NuPAGE 
Novex 4-12% Bis-Tris Protein Gel, 1.0 mm was removed. Where large 
molecular weight proteins were being analysed, a NuPAGE 3-8% Tris-Acetate 
Protein Gel, 1.0 mm, 15-well gel was used and run in 1 X NuPAGE Tris-
Acetate SDS Running Buffer. The wells in the gel were washed with 1 X 
running buffer by pipetting buffer into wells. Gel was loaded into tank, along 
with a buffer dam if only one gel was being run in the tank. The middle 
section of the gel tank was filled with 1 X running buffer; following 
confirmation that the running buffer did not leak into the sides of the gel 
tank, sides of tank were filled with running buffer. 2 μl of MagicMark protein 
ladder (LC5602) was loaded followed by 10 μl of each sample to appropriate 
wells. Gel was run at 80 V for 5 minutes to check running evenly, following 
which gel was run at 180 V for 55 minutes. Protein was transferred from gel 
54 
 
to a PVDF membrane using an iBlot1. Anode Stack (bottom) was placed in 
the iBlot device and a small volume of running buffer was placed on bottom 
stack to prevent drying out. The gel was removed from the encasement and 
placed on the PVDF membrane of the anode stack. Filter paper, soaked in 
deionised water, was placed on top of the gel, followed by the Cathode Stack 
(top) with copper electrode side facing up. Air bubbles were removed using 
Blotting Roller and the sponge was placed on the inner side of the lid, with 
the metal contact at the top right. The iBlot was run on the P3 programme 
for 7 minutes. PVDF membrane was removed for staining and other 
components of the stack were discarded.  
PVDF membrane was carefully rolled with no overlap and placed in a 50 ml 
falcon tube. A brief wash with PBS was carried out. PBS was replaced with 5 
ml of Odyssey Blocking buffer (PBS), and incubated on a roller at room 
temperature for 30 minutes. Blocking buffer was discarded and replaced 
with 5 ml of appropriate primary antibody diluted in Odyssey Blocking buffer 
(see Table 2.1 for dilutions) with 0.1% tween20, which was left rolling at 4°C 
overnight. Primary antibody was washed off with 6 x 5 minute washes in 
PBS, rolling at room temperature. Secondary antibody diluted (1:5000) in 5 
ml of Odyssey Blocking buffer, 0.1% tween20, was added and incubated on 
a roller at room temperature for 90 minutes. The tube was covered in foil to 
protect from the light. Secondary antibody was washed off with 6 x 5 minute 
washes in PBS, rolling at room temperature. Membrane was stored in PBS, 
at 4°C, protected from the light until imaging. Image of membrane was 
obtained on the LI-COR Odyssey Imaging System. 
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Where two antibodies were used on the same membrane simultaneously, 
measures were taken to ensure the antibodies had different host species or 
antibodies produced a single specific band that was distinct in size with no 
non-specific bands, to prevent ambiguous results.  
 
2.3.6 Immunofluorescence on cells 
Adherent cells were seeded on coverslips. Where ciliogenesis was being 
examined, cells were cultured in serum-free media for 24 hours, following 
seeding on coverslips, to induce ciliogenesis.  
Suspension cells were grown to appropriate confluence, pelleted, 
resuspended in 200 μl of cell-appropriate media and spread across poly-L-
lysine slides; the slides were incubated at 4°C for 10 minutes to ensure cells 
adhered to slide. Where ciliogenesis was being examined, cells were serum-
starved for 24 hours to induce ciliogenesis, prior to being pelleted and 
adhered to poly-L-lysine slides.  
All cells on coverslips and slides were washed gently with PBS to remove 
media. Cells were fixed in ice cold methanol for 10 minutes at 4°C, washed 
3 times with ice cold PBS and incubated with 100 μl blocking buffer (5% goat 
serum, 0.1% triton X-100 in PBS) at room temperature for 90 minutes. Non-
adherent cells on slides were covered with Parafilm to prevent drying out. 
Following blocking, primary antibodies were diluted appropriately (Table 
2.1) in blocking buffer, pipetted onto cells and incubated overnight at 4°C. 
Non-adherent cells on slides were covered with Parafilm to prevent drying 
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out. Primary antibody was removed and cells washed for 1 hour in PBS, 
rocking at room temperature. Secondary antibodies were diluted 
appropriately (Table 2.1) in blocking buffer, pipetted on cells and incubated 
at room temperature for 1 hour in the dark to protect from light. Non-
adherent cells on slides were covered with Parafilm to prevent drying out. 
Secondary antibody was removed and cells washed with PBS for 2 hours, 
rocking at room temperature. Dapi was diluted 1:35 in PBS, pipetted on the 
cells and incubated at room temperature for 10 minutes in the dark. Cells 
were washed in PBS for 10-20 minutes, rocking at room temperature. Excess 
PBS was removed and slides were mounted on glass cover slips with 2-3 
drops of ProLong Gold Antifade Reagent (P10144). Excess PBS was removed 
from cover slips containing adherent cells and placed on glass slides with 1 
drop of ProLong Gold Antifade Reagent (P10144). All mounted slides were 
retained in the dark at room temperature to cure, prior to imaging. 
 
2.3.7 Cryosectioning and Immunofluorescence on tissue 
sections 
Following fixation, tissue was washed twice in PBS before being washed in 
gelatine (7% 300 Bloom Gelatine/10% Sucrose) at 37°C. The tissue was then 
embedded in a block of gelatine with the correct orientation for sectioning. 
A drop of OCT was added to a square piece of corkboard and the block of 
gelatine containing the fixed tissue placed in the OCT. The sample was snap 
frozen in isopentane pre-chilled to ̠ 80°C, wrapped in foil, labelled and stored 
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at ˗80°C until sectioning.  For sectioning, the blocks were transferred to a 
Cryostat on dry ice, sectioned at 10 μM and sections were spread evenly 
across poly-L-lysine slides for immunofluorescence staining. Slides 
containing tissue sections were allowed to dry at room temperature for 
approximately 30 minutes, washed in PBS at 37°C to remove gelatine and 
then blocked (5% goat serum, 0.1% triton X-100 in PBS) for approximately 2-
3 hours at room temperature, while covered in Parafilm to prevent drying 
out of tissue. Primary antibodies were diluted appropriately (Table 2.1) in 
blocking buffer, pipetted onto tissue sections, covered in Parafilm and 
incubated overnight at 4°C. Primary antibody was removed and cells washed 
for approximately 90 minutes in PBS while rocking at room temperature. 
Secondary antibodies were diluted appropriately (Table 2.1) in blocking 
buffer, pipetted on cells, covered in Parafilm and incubated at 37°C for 1 
hour in the dark to protect from light. Where F-actin was also analysed, 
Phalloidin (A12381) was diluted 5 μl in 200 μl of blocking buffer and 
incubated on tissue sections for 30 minutes at room temperature in the 
dark. Phalloidin was washed off with PBS for approximately 1 hour, rocking 
at room temperature. Dapi was diluted 1:5000 in PBS and incubated on 
tissue sections at room temperature for 10 minutes in the dark. Dapi was 
washed off in PBS for approximately 30 minutes, rocking at room 
temperature. Excess PBS was removed and slides were mounted on glass 
cover slips with 2-3 drops of ProLong Gold Antifade Reagent (P10144).  
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Table 2.1 Antibodies used in this thesis. IF indicates application in 
immunofluorescence and WB indicates application in Western Blot. 
Antibody Source Species Dilution 
(Application) 
Gamma Tubulin  Sigma (T5326) Mouse 1:1000 (IF) 
1:2500 (WB) 




Sigma (T7451) Mouse 1:1000 (IF) 
Acetylated 
Tubulin 
Sigma (T3526) Rabbit 1:1000 (IF) 
KIAA0586 Sigma (HPA050249) Rabbit 1:100 (IF) 
ARMC3 Sigma (HPA037824) Rabbit 1:100 (IF) 
MYCBPAP Sigma (HPA023257) Rabbit 1:100 (IF) 
RIBC2 Sigma (HPA003210) Rabbit 1:100 (IF) 
VWA3A Sigma (HPA041696) Rabbit 1:100 (IF) 
MACF1 Santa Cruz (sc-377534) Rabbit 1:500 (IF) 
1:200 (WB) 
CCDC77 Sigma (HPA038854) Rabbit 1:100 (IF) 
1:625 (WB) 
CCDC127 Sigma (HPA045052) Rabbit 1:100 (IF) 
1:1250 (WB) 




Rabbit 1:500 (IF) 
1:500 (WB) 
PCM1 Abcam (ab72443) Rabbit 1:500 (IF) 
Pericentrin Abcam (ab4448) Rabbit 1:500 (IF) 
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Antibody Source Species Dilution 
(Application) 
Arl13b Abcam (ab83879) Rabbit 1:500 (IF) 
Cep164 ProteinTech (22227-1) Rabbit 1:500 (IF) 
1:200 (WB) 
GAPDH1 Millipore (CS207795) Mouse 1:2500 (WB) 
Pax6 DSHB Mouse 1:5 (IF) 
Pax7 DSHB Mouse 1:5 (IF) 
Islet1 DSHB Mouse 1:2 (IF) 
Nkx2.2 DSHB Mouse 1:2 (IF) 
Nkx6.1 DSHB Mouse 1:100 (IF) 
Testin Sigma (HPA015269) Rabbit 1:300 (WB) 
E-Cadherin BD Biosciences 
(610181) 
Mouse 1:2500 (WB) 
Gamma Actin MCA5776GA Mouse 1:500 (WB) 
RHOC Abcam (ab180785) Rabbit 1:500 (WB) 
1:100 (IF) 
RHOC Santa Cruz (sc-393090) Mouse 1:100 (WB) 
Twinfilin Sigma (HPA018116) Rabbit 1:350 (IF) 
1:250 (WB) 
Cofilin Santa Cruz (sc-33779) Rabbit 1:100 (IF) 
1:200 (WB) 
Profilin Abcam (ab180830) Rabbit 1:100 (IF) 
1:1000 (WB) 
LaminA Abcam (ab26300) Rabbit 1:1000 (WB) 
LaminB1 Abcam (ab16048) Rabbit 1:1000 (WB) 
SMCHD1 Sigma (HPA039441) Rabbit 1:250 (WB) 
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Antibody Source Species Dilution 
(Application) 
Fibronectin BD Biosciences 
(610078) 
Mouse 1:200 (WB) 
MYL3 Santa Cruz (sc-100550) Mouse 1:200 (WB) 
NDUFB7 Santa Cruz (sc-365552) Mouse  1:100 (WB) 
IDI1 Santa Cruz (sc-100550) Mouse 1:200 (WB) 
Neuropilin Santa Cruz (sc-5307) Mouse 1:200 (WB) 
WDR1 Santa Cruz (sc-393154) Mouse 1:100 (WB) 
NHERF-1 Santa Cruz (sc-271552) Mouse 1:100 (WB) 
Homer Santa Cruz (sc-17842) Mouse 1:500 (WB) 
Anti-Rabbit IgG 
Alexa Fluor 594 
Invitrogen (A21207) Donkey  1:500 (IF) 
Anti-Mouse IgG 
Alexa Fluor 594 
Invitrogen (A21203) Donkey 1:500 (IF) 
Anti-Mouse IgG 
Alexa Fluor 488 
Invitrogen (A11017) Goat 1:500 (IF) 
Anti-Rabbit IRDye 
689RD 
Odyssey (926-68071) Goat 1:5000 (WB) 
Anti-Mouse 
IRDye 800CW 





2.4 Mass Spectrometry based proteomics 
2.4.1 Label free proteomics applied to protein extracted from 
isolated centrosomes 
Protein samples were extracted in SDT lysis buffer containing 100 mM Tris-
HCl (pH7.6), 4% (W/V) sodium dodecyl sulfate (VWR) and 1% HALT protease 
inhibitor cocktail (100X) (see section 2.3.3). Protein concentration was 
determined using a micro BCA assay (see section 2.3.4).  
The following mass spectrometry experiments were performed by 
FingerPrints proteomic facility at the University of Dundee.  
Aliquots of protein preparations were processed through FASP (filter-aided 
sample preparation) involving buffer exchange to 8 M urea and alkylation 
with 50 mM iodoacetamide prior to a double digestion with trypsin (Roche, 
sequencing grade); lysates were exchanged by urea on a standard filtration 
unit, to allow detergent removal, buffer exchange, chemical modification 
and protein digestion. The filter membrane used retains high-molecular-
weight substances (protein and DNA), to allow low-molecular-weight 
substances (impurities and digested peptides) to be excluded. Protein 
preparations underwent a double digestion with trypsin (Roche, sequencing 
grade), initially for four hours at 30°C and then overnight at 30°C.  
Resulting peptides were desalted then separated using an Ultimate 3000 
RSLCnano system (Thermo Scientific, running dual column setup) coupled to 
a LTQ OrbiTrap Velos Pro (Thermo Scientific). Peptides were initially trapped 
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on an Acclaim PepMap 100 C18 trap column (100 µM inner diameter x 2 cm 
length) with 0.1% formic acid (Buffer C). After 3 minutes of trap enrichment 
peptides were eluted onto an Acclaim PepMap RSLC C18 column (75 µM x 
50 cm) with a linear gradient of 2-4% Solvent B (80% acetonitrile in 0.08% 
formic acid) over 150 minutes with a constant flow of 0.3 µl/min. The HPLC 
system was coupled to a linear ion trap Orbitrap hybrid mass spectrometer 
(LTQ-OrbiTrap Velos Pro, Thermo Scientific) via a transfer line (20 µM x 50 
cm) attached to an Easy Spray emitter (7 µM ID) (Thermo Scientific) to the 
mass spectrometer via an Easy-Spray source with temperature set at 50°C 
and a source voltage of 1.9 kV. Full-scan mass spectrometry survey spectra 
(m/z 335-1800) in profile mode were acquired in the Orbitrap with a 
resolution of 60 000 after accumulation of 1 000 000 ions. The 15 most 
intense peptide ions from the preview scan in the Orbitrap were fragmented 
by collision-induced dissociation (normalised collision energy, 35%; 
activation Q, 0.250; activation time, 10.000 ms) in the LTQ after the 
accumulation of 5000 ions. Dynamic exclusion parameters were set as 
follows: repeat count, 1; repeat duration, 30 seconds; exclusion list, 500; 
exclusion duration, 45 seconds; exclusion mass width, ± 10 ppm (relative to 
reference mass). Maximal filling times were 500 mseconds for the full scans 
and 100 mseconds for the MS/MS scans. Parameters for the MS/MS scan 
included: minimum signal required, 50005; isolation width, 2.00; default 
charge state, 2. OrbiTrap Velos .RAW data files were extracted and 
converted to mascot generic files (.mgf) using the Spectrum Selector and 
Spectrum Exporter nodes within Proteome Discoverer (Thermo Scientific, 
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v1.4.1.14). Extracted data was then searched against the Chicken UniProt 
database using the Mascot Search Engine (Mascot Daemon Version 2.3.2). 
The parameters used to search in the Mascot Search Engine included: type 
of search, MS/MS ion search; enzyme, Trypsin/P; fixed modifications, 
Carbamidomethyl (C); variable modifications, acetyl (N-term), Dioxidation 
(M), Gln->pyro-Glu (N-term Q) and Oxidation (M), Deamidated (MQ); mass 
values, monoisotopic; protein mass, unrestricted; peptide mass tolerance 
plus/minus 10 ppm (# 13C = 2); fragment mass tolerace, plus/minus 0.6 Da; 
maximum missed cleavages, 2; instrument type, ESI-TRAP. 
  
2.4.2 Analysis of Jurkat centrosome protein datasets following 
mass spectrometry  
The first sample (Jurkat sample 1) consisted of protein from two 
independent centrosome isolation samples pooled. The second Jurkat 
sample (Jurkat sample 2) consisted of protein from three independent 
centrosome isolation samples pooled. Mass spectrometry on the first 
sample identified 1226 proteins, of which 612 were associated with two or 
more unique peptides and were included in further analysis. Mass 
spectrometry on the second sample identified 1304 proteins of which 575 
were associated with two or more unique peptides and were included in 
further analysis. I combined proteins with two or more unique peptides from 
Jurkat sample 1 and Jurkat sample 2 and removed duplicates so they were 
only represented once, resulting in 1131 individual proteins identified by 
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accession number. Further comparisons and analysis were completed using 
the gene name associated with each protein, consequently the combined 
total of Jurkat proteins for further analysis was 816 proteins, as 315 
accession numbers had no gene name associated with them. 
 
2.4.3 Analysis of primordial germ cell centrosome protein 
dataset following mass spectrometry  
Mass spectrometry identified 796 proteins, of which 791 proteins were 
associated with two or more unique peptides and also had gene names or 
identifiers associated with them. These 791 proteins were included in 
further analysis. 
  
2.4.4 Tandem Mass Tag Proteomics applied to protein from 
talpid3 and wildtype PGCs 
Protein samples were extracted in SDT lysis buffer containing 100 mM Tris-
HCl (pH7.6), 4% (W/V) sodium dodecyl sulfate (VWR) and 1% HALT protease 
inhibitor cocktail (100X) (see section 2.3.1). Protein concentration was 
determined using a micro BCA assay (see section 2.3.4).  
The following mass spectrometry experiments were performed by 
FingerPrints proteomic facility at the University of Dundee.  
Samples underwent FASP (filter-aided sample preparation) processing. Each 
sample was reduced with 100 mM DTT and samples were then processed 
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using the FASP protocol (Wisniewski et al., 2009) with some modifications. 
Following removal of SDS with 8 M urea, filters were washed 3 times with 
100 mM Tris-HCL pH 8 and then washed another 3 times with 100 mM 
triethyl ammonium bicarbonate (TEAB). Proteins on the filters were then 
digested twice at 30°C with trypsin (2 x 6.25 µg), first overnight and then for 
another 6 hours in a final volume of 200 µl.   
Samples then underwent TMT (tandem mass tag) labelling and fractionation. 
Desalted tryptic peptides (100 µg per sample) were dissolved in 100 µl of 
100 mM TEAB. The 10 different TMT labels were dissolved in 41 µL of 
anhydrous acetonitrile, and each label was added to a different sample. The 
mixture was incubated for 1 hour at room temperature and the labelling 
reaction was stopped by adding 8 µL of 5% hydroxylamine. 
Following labelling with TMT, samples were mixed, desalted and then dried 
in a speed-Vac at 30°C. Samples were dissolved in 200 μL ammonium 
formate (10 mM, pH 10) and peptides were fractionated using RP-High pH 
HPLC. A C18 Column from Waters (XBridge peptide BEH, 130Å, 3.5 µm 2.1 X 
150 mm, Ireland) with a guard column (XBridge, C18, 3.5 µm, 2.1X10mm, 
Waters) were used  on an Ultimate 3000 HPLC (Thermo-Scientific). Buffers A 
and B used for fractionation consist of 10 mM ammonium formate in milliQ 
water and 10 mM ammonium formate with 90% acetonitrile respectively; 
both buffers were adjusted to pH 10 with ammonia. Fractions were collected 
using a WPS-3000FC auto-sampler (Thermo-Scientific) at 1 minute intervals. 
Column and guard column were equilibrated with 2% buffer B for 20 minutes 
at a constant flow rate of 0.2 ml/min. Samples (175 µl) were loaded onto the 
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column at 0.2 ml/min, and the separation gradient started 1 minute after 
the sample was loaded onto the column. Peptides were eluted from the 
column with a gradient of 2% buffer B to 5% buffer B in 6 minutes then from 
5% buffer B to 60% buffer B in 50 minutes. The column was washed for 16 
minutes at 100% buffer B and equilibrated at 2% buffer B for 20 minutes as 
mentioned above. The fraction collection started 1 minute after injection 
and stopped after 80 minutes (total of 80 fractions, 200 µl each). The total 
number of fractions concatenated was set to 20 and the content of the 
fractions was dried and suspended in 50 µl 1% formic acid prior to analysis 
with LC-MS. 
Following fractionation, samples were analysed by LC-MS analysis. Analysis 
of peptides was performed on a Q-exactive-HF (Thermo Scientific) mass 
spectrometer coupled with a Dionex Ultimate 3000 RS (Thermo Scientific). 
LC buffers were the following:  buffer A (2% acetonitrile and 0.1% formic acid 
in Milli-Q water (v/v)) and buffer B (80% acetonitrile and 0.08% formic acid 
in Milli-Q water (v/v)). Aliquots of 15 μL of each sample were loaded at 5 
μL/min onto a trap column (100 μm × 2 cm, PepMap nanoViper C18 column, 
5 μm, 100 Å, Thermo Scientific) equilibrated in 98% buffer A. The trap 
column was washed for 6 minutes at the same flow rate and then the trap 
column was switched in-line with a Thermo Scientific, resolving C18 column 
(75 μm × 50 cm, PepMap RSLC C18 column, 2 μm, 100 Å). The peptides were 
eluted from the column at a constant flow rate of 300 nl/min with a linear 
gradient from 95% buffer A to 40% buffer B in 122 minutes, and then to 98% 
buffer B by 132 minutes. The column was then washed with 95% buffer B for 
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15 minutes and re-equilibrated in 98% buffer A for 32 minutes. Q-Exactive 
HF was used in data dependent mode. A scan cycle comprised MS1 scan 
(m/z range from 335-1800, with a maximum ion injection time of 50 ms, a 
resolution of 120000 and automatic gain control (AGC) value of 3x106) 
followed by 15 sequential dependant MS2 scans (with an isolation window 
set to 0.7 Da), resolution at 60000, maximum ion injection time at 200 ms 
and AGC 1x105. To ensure mass accuracy, the mass spectrometer was 
calibrated on the first day that the runs were performed.  
 
2.4.5 MaxQuant Analysis of TMT LC-MS Data 
Following LC-MS analysis, data was processed in MaxQuant (Version 
1.5.2.8). The parameters used to search in the MaxQuant search engine 
included: fixed modifications, Carbamidomethyl (C); decoy mode, revert; 
Special AAs, KR; Include contaminants, true; MS/MS tol. (FTMS), 10 ppm; 
Top MS/MS peaks per 100 Da. (FTMS), 12; MS/MS deisotoping (FTMS), true; 
MS/MS tol. (ITMS), 0.06 Da; Top MS/MS peaks per 100 Da. (ITMS), 8; MS/MS 
deisotoping (ITMS), false; MS/MS tol. (TOF), 40 ppm; Top MS/MS peaks per 
100 Da. (TOF), 10; MS/MS deisotoping (TOF), true; MS/MS tol. (Unknown), 
0.5 Da; Top MS/MS peaks per 100 Da. (Unknown), 8; MS/MS deisotoping 
(Unknown), false; PSM FDR, 0.01; Protein FDR, 0.01; Site FDR, 0.01; Use 
normalised ratios for occupancy, true; Minimum peptide length, 7; 
Minimum score for unmodified peptides, 0; minimum score for modified 
peptides, 40; minimum delta score for unmodified peptides, 0; minimum 
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delta score for modified peptides, 6; minimum unique peptides, 0; minimum 
razor peptides, 1; minimum peptides, 1; use only unmodified peptides, true; 
modifications include in protein quantification, Acetyl (Protein N-term), 
Oxidation (M); peptides used for protein quantification, razor; discard 
unmodified counterpart peptides, true; minimum ratio count, 2; re-quantify, 
false; use delta score, false; iBAQ, false; iBAQ log fit, false; match between 
runs, true; matching time window (minute), 0.7; alignment time window 
(minute), 20; find dependent peptides, false; labelled amino acid filtering, 
true; RT shift, false; advanced ratios, true; AIF correlation, 0.47; first pass AIF 
correlation, 0.8; AIF topx, 20; AIF min mass, 0; AIF SIL weight, 4; AIF ISO 
weight, 2; AIF iterative, true; AIF threshold FDR, 0.01. 
 
2.4.6 Analysis of TMT protein dataset following MaxQuant 
analysis 
Proteins were identified based on peptide identification in Uniprot and 
relative quantification was analysed in MaxQuant. Mass spectrometry 
identified 7052 proteins across the ten protein samples. Of the 7052 
proteins identified, 403 did not have quantitative values associated with 
them and were excluded from any further quantitative analysis. 44 proteins 
had zero unique peptides associated with them and were also excluded from 
any further analysis. One of the proteins with no quantitative values 
associated also had zero unique peptides. This left 6606 proteins with 
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quantitative values and one or more unique peptides associated with the 
protein that were taken forward for further analysis. 
 
2.4.7 Validation of TMT mass spectrometry dataset 
Many commercially available antibodies are not specific for chicken and do 
not recognise the chicken protein; therefore, all the antibodies were tested 
in controlled conditions on a western blot using chicken and human protein 
extracted from cells prior to use in validating the TMT mass spectrometry 
dataset. Twenty-four test western blots (Appendix 7) were completed prior 
to validating the chicken PGC mass spectrometry. Gamma (γ) tubulin, E-
cadherin, Testin and gamma (γ) actin were identified as proteins in all ten 
PGC protein samples following mass spectrometry that worked well in 
western blot and recognised the chicken protein. The gamma tubulin 
antibody was raised against amino acids 38-53 of human gamma tubulin 
protein. This region is not found in other members of the tubulin family and 
when aligned, human and chicken gamma tubulin protein have 99% 
sequence similarity, confirming specificity for gamma tubulin with this 
antibody. The E-cadherin antibody recognises the cytoplasmic domain 
regardless of phosphorylation and recognises amino acids 735-883 of the 
human E-cadherin protein. When aligned with the equivalent region of the 
chicken E-cadherin protein, human and chicken share 89% sequence 
similarity. E-cadherin has a predicted molecular weight of 120 kDa, although 
bands have been reported from 80-120 kDa for E-cadherin previously. The 
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testin antibody recognises a domain in the middle of the human Testin 
protein. When aligned, human and chicken Testin proteins share 89% 
sequence similarity. The gamma actin antibody recognises human gamma 
actin protein. When compared to chicken gamma actin, the human and 
chicken proteins share 99% sequence similarity.  
 
2.5 Molecular Biology  
2.5.1 Transformation of chemically competent cells 
XL-Gold competent cells were removed from ˗80°C and thawed on ice. 1 μl 
β-mercaptoethanol was added per 25 μl of XL-Gold competent cells being 
transformed and incubated on ice for 10 minutes. 2 μl of appropriate DNA 
was added to cells, mixed and incubated on ice for 30 minutes. Cells were 
heat shocked at 42°C for 30 seconds on a thermocycler and then incubated 
on ice immediately afterwards for 2 minutes to recover. 600 μl of pre-
warmed SOB media was added and incubated at 37°C, shaking for 1 hour. LB 
agar plates containing 100 μg/ml Ampicillin were incubated at 37°C to dry 
out for 1 hour. Following incubation, cells were centrifuged at 5 rpm for 1 
minute. 400 μl of SOB media was removed and remaining media was used 
to resuspend the pellet. Resuspended cells were spread across the pre-
warmed LB agar ampicillin plates. Plates were labelled and incubated 




2.5.2 Growth of colonies 
For Minipreps, single colonies were picked and grown overnight in 5 ml LB 
broth containing 100 μg/ml ampicillin at 37°C, shaking. For Maxipreps, single 
colonies were picked and grown during the day as a starter culture in 5 ml 
of LB broth containing 100 μg/ml ampicillin at 37°C, shaking. After 4-8 hours 
of incubation, the starter culture was poured into a conical flask containing 




Overnight 5 ml cultures were pelleted and used for Minipreps; The Qiagen 
QIAprep Spin Miniprep kit (27104) was used and the user manual was 
followed. Briefly, bacterial cultures were pelleted, resuspended, lysed under 
alkaline conditions, neutralised and then adjusted to high salt binding 
conditions to allow DNA binding to a silica membrane. Endonucleases and 
salts were removed through wash buffers and the DNA eluted in 30-50 μl 
water. DNA was nanodropped to determine concentration and then stored 
short term at 4°C and long term at ˗20°C. 
 
2.5.4 MaxiPrep 
Overnight 200 ml cultures were pelleted and used for Maxipreps; The 
Invitrogen PureLink HiPure Plasmid Filter MaxiPrep Kit (K210016) was used 
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and the user manual was followed. Briefly, overnight cultures were pelleted, 
resuspended in buffer, loaded onto a column, washed and eluted in 50-100 
μl of water. DNA was nanodropped and then stored at ˗20°C. 
 
2.5.5 Guides into px462 Vector 
Oligos (Table 2.2) were resuspended to a final concentration of 100 μM. 
Reaction was set up to phosphorylate and anneal oligos: 1 μl of sgRNA top 
(100 μM), 1 μl of sgRNA bottom (100 μM), 1 μl T4 ligation buffer 10X, 1 μl T4 
PNK, 6 μl ddH20 to make a final volume of 10 μl. Reaction was run on a 
thermocycler: 37°C for 30 minutes; 95°C for 5 minute; ramp down to 25°C at 
5°C minute-1. The phosphorylated and annealed oligos were diluted 1:200. 
sgRNA was cloned into a pSpCas9 vector by setting up a ligation reaction: 1 
μl (100 ng) px459 vector, 2 μl of diluted oligos, 2 μl Tango buffer 10X, 1 μl 
DTT (10 mM), 1 μl ATP (10 mM), 1 μl FastDigest BbsI, 0.5 μl T7 ligase, 11.5 μl 
ddH20 to make reaction up to 20 μl total. The reaction was incubated on a 
thermocycler for 1 hour. 6 cycles were completed: 37°C for 5 minutes, 21°C 
for 5 minutes. The ligation reaction was treated with Plasmid Safe to remove 
any residual linearised DNA: 11 μl ligation reaction, 1.5 μl PlasmidSafe buffer 
10X, 1.5 μl ATP (10 mM), 1 μl PlasmidSafe exonuclease to make a total 
volume of 15 μl. The reaction was incubated on a thermocycler: 37°C for 30 





Table 2.2 CRISPR guides used in this thesis 
Guide Name Gene  Oligo Sequence 




















Talpid 5’ guide3 
top 
TALPID3 caccgCTATGAAGCCTTCATGGAAG 
Talpid 5’ guide3 
bottom 
TALPID3 aaacCTTCCATGAAGGCTTCATAGc 
Talpid 5’ guide5 
top 
TALPID3 caccgGCACCAGCCAGGACTCGCTG 
Talpid 5’ guide5 
bottom 
TALPID3 aaacCAGCGAGTCCTGGCTGGTGCc 
Talpid 3’ guide2 
top 
TALPID3 caccGCCCGAGTTGTTCATGTGAGA 
Talpid 3’ guide2 
bottom 
TALPID3 aaacTCTCACATGAACAACTCGGGc 
Talpid 3’ guide3 
top 
TALPID3 caccGCCTTCTCACATGAACAACTC 





Guide Name Gene  Oligo Sequence 
Talpid 3’ guide4 
top 
TALPID3 caccGGCACAACTCGTGCATCTCCT 







Primers (Table 2.3) were designed in Primer3 or in the NEBuilder Assembly  
Tool for design of primers used in Gibson Assembly. PCR reactions were set 
up using Phusion or FastTaq DNA polymerase. The NEB Tm Calculator was 
used to determine annealing temperature for primers. A 3-step PCR reaction 
was used where the annealing temperatures were below 72°C and a 2-step 
reaction was used where annealing temperatures were 72°C or above. For 
every 1000 bp of intended amplicon, the extension time was increased by 1 
minute. 100 ng of DNA per reaction was used. Reactions with Phusion 
typically contained 4 μl of HF buffer, 0.4 μl of dNTP, 0.2 μl of 10 pMol primers 
and 0.2 μl of Phusion made up to a total volume of 20 μl. Reactions with 
FastTaq typically contained 1.5 μl Mg+ buffer, 0.3 μl dNTP, 0.3 μl 50 pMol 
primers and 0.1 μl FastTaq made up to a total volume of 15 μl. A typical PCR 
reaction would be carried out in the following format: 
    Denaturation  98°C  30 seconds 
    Denaturation  98°C  10 seconds 
       30-35 x   Annealing  54-72°C 30 seconds 
    Extension  72°C  1-2 minutes 





Table 2.3. Primers used in this thesis 







CCDC77 Fwd1 Seq ACCCATAATCCTTCCATGCCA Phusion 60°C 1 minute 35 
CCDC77 Rev1 Seq AGAGTCCCCGTACCTACAGT Phusion 60°C 1 minute 35 
CCDC77 Fwd2_3 Seq GAGAATCGCTTGAACCCAGA Phusion 64°C 1 minute 35 
CCDC77 Rev2_3 Seq ACCTTTCCAGTTCCTATGCTTAG Phusion 64°C 1 minute 35 
CCDC127 Fwd1_2 CCCGACATGTCTGCTGTTG FastTaq 56°C 1 minute 35 
CCDC127 Rev1_2 CTCCGACCCCATTCCCTG FastTaq 56°C 1 minute 35 
CCDC127 Fwd2_2 CCCGGCTCTGGTCTAGTTTT FastTaq 54°C 1 minute 32 
CCDC127 Rev2_2 CTGCTTCCATCACCACCATC FastTaq 54°C 1 minute 32 




Phusion 72°C 2 minutes 30 
5’ Talpid3 Right Arm 
Rev 
TATGGTCGACCTGCAGGCGGCCGCGAGAGAATGGATGCCCCACAGGC Phusion 72°C 2 minutes 30 
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5’ Talpid3 Left Arm 
Fwd 
TCCCGGCCGCCATGGCGGCCGCGGGTCTGAAGCACCACTCCCTCTG Phusion 72°C 2 minutes 30 
5’ Talpid3 Left Arm 
Rev 
CCTTGCTCACCATAGCGGAGAGGTTAGCAGCGG Phusion 72°C 2 minutes 30 
GFP Fwd TAACCTCTCCGCTATGGTGAGCAAGGGCGAGGA Phusion 72°C 2 minutes 30 
GFP Rev ACCTCCTCCACCTCCCTTGTACAGCTCGTCCATGCC Phusion 72°C 2 minutes 30 
3’ Talpid3 Right Arm 
Fwd 
TCCCGGCCGCCATGGCGGCCGCGGGTTTTTATTAACTTCAGCTCACC Phusion 65.5°C 1 minute 32 
3’ Talpid3 Right Arm 
Rev 
ACCTCCTCCACCTCCTCTTCTCACATGAACAACTC Phusion 65.5°C 1 minute 32 
3’ Talpid3 Left Arm 
Fwd 
GCTGTACAAGTAAAAGTCTGAAGAGATGCAAGAAG Phusion 65.5°C 1 minute 32 
3’ Talpid3 Left Arm 
Rev 
TATGGTCGACCTGCAGGCGGCCGCGCAACAATTCTGAATTTCTGAG Phusion 65.5°C 1 minute 32 
Venus Fwd TCATGTGAGAAGAGGAGGTGGAGGAGGTGGAATGGTGAGCAAGGG 
CGAG 
Phusion 65.5°C 1 minute 32 
Venus Rev TCTCTTCAGACTTTTACTTGTACAGCTCGTCCATG Phusion 65.5°C 1 minute 32 
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2.5.7 DNA Extraction for Sequencing 
Following PCR, amplicons were run on a 1% agarose gel, bands were viewed 
on a Kodak Gel Logic 200 Imaging System and isolated from the gel for 
purification using a scalpel. The DNA contained within the agarose slice was 
then purified using the PureLink Quick Gel Extraction Kit (K210012), 
following user manual instructions. Gel slices were weighed to determine 
volume of reagents to use and the extraction was carried out following the 
instructions in the user manual using a centrifuge. 5 μl of clean DNA 
combined with 1 μl of 6.4 pMol primer was added to a PCR tube and sent to 
Edinburgh Genomics for Sanger Sequencing using BigDye v3.1 Terminator 
Cycle Sequencing Kit (Thermofisher P/N AB0384/240; BS034042). 
 
2.5.8   DNA Extraction for Gibson Cloning 
Following PCR, amplicons were run on a 1% agarose gel, bands were viewed 
on a Kodak Gel Logic 200 Imaging System and isolated from the gel for 
purification using a scalpel. The amplicon contained within the agarose slice 
was then purified using a GeneJet PCR Purification Kit from Thermo Scientific 
(cat no. K0701), following the user manual. Briefly, binding buffer was added 
to the PCR reaction and transferred to a purification column. Column was 
washed and waste eluted by centrifugation. 20-50 μl of elution buffer was 
added to the column and purified DNA was eluted by centrifugation into a 




2.5.9 DPN1 Treatment 
Following PCR amplification of GFP and Venus, the amplicon was treated 
with DPN1 to digest any remaining plasmid. The reaction was set up with 20 
μl of Venus DNA, 5 μl of 10 X buffer, 1 μl of DPN1 and made up to a total 
reaction volume of 50 μl with water and incubated for 1 hour at 37°C. To 
inactivate DPN1, the reaction was purified using a purification column from 
the GeneJet PCR Purification kit from Thermo Scientific (cat no. K0701) 
following the user manual instructions.  
 
2.5.10 Preparation of pGEM-T Easy Vector for Gibson Cloning 
A pGEM-T Easy vector was used as the backbone for Gibson cloning. A 
digestion reaction was set up with 1 μl of pGEM-T Easy vector, 1 of μl EcoR1, 
2 μl of 10 X CutSmart buffer and made up to a total volume of 20 μl with 
water. The reaction was incubated at 37°C for 1 hour. Linearised pGEM-T 
easy vector was run on a 1% agarose gel and the resulting band was 
extracted using a scalpel. The band containing the linearised vector was 
purified using a PureLink Quick Gel Extraction Kit (K210012), following the 
user manual instructions.  
 
2.5.11 Gibson Cloning  
Gibson cloning was used to make the plasmid template that was used for 
homology directed repair during CRISPR/Cas9 gene editing experiments. The 
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Gibson Cloning used a 1-step reaction to incorporate multiple fragments 
together into a plasmid, by using overlapping ends to join the fragments 
together. Following amplification of fragments, PCR purification and 
preparation of the pGEM-T Easy vector, the cloning reaction was set up 
following the user manual instructions. A 1:1 ratio of fragments to vector 
was added to 10 μl of Gibson cloning master mix and made up to a total 
volume of 20 μl with water. The reaction was incubated on a thermocycler 
at 50°C for 1 hour. Briefly, during the Gibson Assembly reaction, exonuclease 
chews back the 5’ ends, the resulting single-stranded regions at the ends of 
adjacent fragments anneal, DNA polymerase incorporates nucleotides to fill 
the gaps and DNA ligase joins the adjacent DNA sections, thus removing any 
nicks in the DNA. The reaction was stored at 4°C until it was transformed 
(see section 2.5.1), colonies grown (see section 2.5.2) and a miniprep was 
completed (see section 2.5.3). To confirm correct assembly of fragments, a 
restriction digest was completed using EcoR1 for the plasmid designed to 
target the 5’ end of TALPID3 and BAMH1 combined with NOT1 for the 
plasmid designed to target the 3’ end of TALPID3. The restriction digests 
were run on a 1% agarose gel and examined for specific size of bands to 
confirm that all the fragments had annealed correctly. 
  
2.5.12 RNA probes for in situ hybridisation 
Chicken ESTs (Table 2.4) were ordered for genes of interest and DNA 
extracted. DNA was linearised by restriction digest using NotI enzyme at 
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37°C for two hours. Inactivation of enzyme was achieved by incubation at 
65°C for twenty minutes. Sodium acetate precipitation was used to 
concentrate linearised DNA. RNA probe was then synthesised in a 18.5 μl 
reaction of RNAse free water, 5x transcription buffer, 0.1 M DTT, DIG-RNA 
labelling mix 10X (cat no. 1277073910), RNAse inhibitor, RNA polymerase T3 
and the linearised plasmid. Reaction was incubated at 37°C for a minimum 
of 2 hours. Probe was purified using the Illustra ProbeQuant Kit (G50 
Column, 27-5335-01, GE Healthcare UK Lt.), following the user manual. The 
probe was then stored in Hybridisation buffer (50% formamide, 5X SSC, 2% 
Blocking Powder (Boehringer), 0.1% Trition X, 0.1% CHAPS, 20 μg/ml tRNA 
(Boehringer 109495), 5 mM EDTA, 50 μg/ml Heparin (Sigma H2144)) and 
stored at ˗20°C. 
 
Table 2.4 Chicken ESTs used to make RNA probes in this thesis 








2.6 Chicken Embryo Work 
2.6.1 Chicken models 
For all experiments involving talpid3 flock embryos, eggs were obtained from 
the talpid3 flock, which are maintained as described previously (Stephen et 
al., 2015). Embryos for RNA in situ hybridisation were obtaine↕d from Isa 
Brown hens, maintained at The Roslin Institute. Chicken embryos were 
sacrificed by a schedule one method that is not a regulated procedure under 
UK Home Office rules. 
 
2.6.2 Incubation and dissection of chicken embryos 
For embryo experiments, all eggs were incubated at 37°C until they had 
reached the desired stage based on Hamburger and Hamilton staging. 
Where manipulations were carried out, the egg was windowed, DMEM + 
antibiotics was introduced and the membrane was removed. Following the 
manipulation, eggs were re-sealed with sellotape and re-incubated until the 
stage required for analysis. To dissect embryos, membranes were disrupted 
and the embryo was transferred to ice cold PBS, where the embryonic 
membranes were removed before further dissection or fixation in 4% PFA (4 
g Para formaldehyde per 100 ml of DEPC PBS). All manipulations and 
dissections were carried out using a Leica MZ6 Microscope, using a Schott 




2.6.3 Dehydration of Embryos prior to RNA in situ hybridisation 
Following dissection and fixation in 4% PFA, embryos were washed twice 
with cold DEPC PBS (1 ml DEPC in 1 litre of PBS solution, autoclaved) for 10 
minutes, while shaking. Embryos were dehydrated through 25%, 50% and 
75% methanol/DEPC PBST (DEPC PBS + 1 ml Tween20) for ten minutes each, 
while shaking. Embryos were transferred to 100% methanol and then stored 
at ˗20°C until RNA in situ hybridisation. 
 
2.6.4 RNA in situ hybridisation 
Embryos, stored in 100% methanol at ˗20°C, were rehydrated through a 
methanol gradient until they were in 100% PBT. Embryos were treated with 
1:1000 (20 μg/ml) proteinase K (K-03115836001, Roche) diluted in PBS, on 
ice. Embryos were incubated for 1 minute per stage of their development. 
Embryos were washed in PBT and refixed in 4% PFA for 20 minutes on ice. 
Embryos were re-washed with PBT and then incubated overnight in pre-
warmed hybridisation buffer (50% formamide, 5 X SSC, 2% Blocking Powder 
(Boehringer), 0.1% Triton X-100, 0.1% CHAPS, 20 μg/ml tRNA (Boehringer 
109495), 5 mM EDTA, 50 μg/ml Heparin (Sigma H2144)) at 67.5°C with gentle 
agitation. Hybridisation buffer was replaced with the RNA probe (see 2.5.12) 
and incubated at 67.5°C for 2-3 days. Following incubation with probe, 
embryos were washed in a series of buffers at 70°C: 2 x 10 minutes buffer A 
(2 x saline sodium citrate buffer), 3 x 20 minutes buffer B (2 x saline sodium 
citrate, 0.1% CHAPS), 3 x 20 minutes buffer C (0.2 x saline sodium citrate, 
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0.1% CHAPS). Embryos were then washed twice in KTBT (50 mM Tris-HCL 
pH7.5, 150 mM NaCl, 10 mM KCl, 1% Triton X-100) for 10 minutes at room 
temperature, following which embryos were blocked in blocking buffer (20% 
heat inactivated fetal calf serum/KTBT) for 2-3 hours at room temperature. 
Blocking buffer was replaced with 1:1000 mouse Anti-DIG-AP Fab fragment 
(Anti-Digoxigenin-AP, Fab fragment cat no. 1093274) in blocking buffer, 
overnight at 4°C. The following day, embryos were washed 5 x for 1 hour in 
KTBT (50 mM Tris-HCL pH7.5, 150 mM NaCl, 10 mM KCl, 1% Triton X-100) at 
room temperature and left in KTBT overnight at 4°C. Embryos were 
transferred to Bijou vials and washed 2 x 5 minutes at room temperature 
with freshly made NTMT buffer (100 mM Tris-HCl pH9.5, 50 mM MgCl2, 100 
mM NaCl, 0.1% triton X-100). For the detection solution, 35 μl NBT (N-6876 
Sigma, stock solution 100 mg/ml 70% DMF (dimethylformamide), use 3.5 
μl/ml) and 35 μl BCIP (B-8503 Sigma,  stock solution 50 mg/ml DMF, use 3.5 
μl/ml) was added to 10 ml NTMT (100 mM Tris-HCl pH9.5, 50 mM MgCl, 100 
mM NaCl, 0.1% Triton X-100). Detection solution was added to embryos and 
refreshed as necessary. Embryos were checked every 10-15 minutes for 
expression. Once expression patterns could be clearly seen, the detection 
reaction was stopped by replacing the detection solution with 4% formal 
saline (10% formalin neutral buffered, in PBS). To deepen staining for 
imaging, embryos were incubated in NTET (1 ml of 5 M NaCl, 1 ml of 0.5 
EDTA pH8, 5 ml of 1 M Tris-HCl pH8, 0.5 ml of Tween20, 42.5 ml of dH20). 
Once embryo stain was appropriate level for imaging, NTET was removed 
and embryos were placed back into 4% formal saline. 
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Once images had been obtained of embryos following whole mount in situ 
hybridisation, embryos were embedded in gelatine (7% 300 Bloom 
Gelatine/10% Sucrose) and snap frozen in isopentane pre-chilled to ˗80°C 
prior to sectioning. Embryos were sectioned at 30 μm on the cryostat for 
analysis of tissue specific expression. 
 
2.6.5 Electroporation 
For transfection of constructs of interest in the chick, injection followed by 
electroporation in the neural tube of developing chick embryos was carried 
out. Following 48 hours of incubation to reach Hamburger-Hamilton stage 
10-12, eggs were windowed and the membrane was removed. The neural 
tube was injected with 1 μg/μl DNA + 0.02% FastGreen dye. DNA constructs 
included: empty-pCAGGS, pCAGGS-eGFP, pCAGGS-hsKIAA0586 (full length 
human KIAA0586), pCAGGS-hsKIAA0586c.1697A>T,p.D566V (human 
ciliopathy mutation in KIAA0586). All injected DNA was comprised of the 
construct of interest combined with pCAGGS-eGFP to allow visualisation of 
successful electroporations. Injections were carried out by mouth pipette, 
needles were pulled on a Moving-Coil Microelectrode Puller Model 753 
(Campden Instruments Limited) using the following settings: pre-pull 
heating time 57, initial pull force 159, main pull force 286, main pull delay 
49, heater control 139.  Electrodes were placed either side of the neural tube 
at the site of the injection and embryos were immediately electroporated at 
20-25 V five times with 100 ms intervals. 2-3 drops of DMEM + 1% 
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penicillin/streptomycin was added to the embryo and then covered with 
sellotape to prevent embryos from drying out. Embryos were re-incubated 
until Hamburger-Hamilton stage 20-24. Embryos were examined for green 
fluorescence in the neural tube on a Zeiss Axio Zoom.V16 microscope, to 
identify embryos that were successfully integrated the DNA following 
electroporation. If fluorescence was present, embryos were dissected in ice 
cold PBS and the section of neural tube containing fluorescence was 
dissected out and fixed in 4% PFA at room temperature for 1-2 hours prior 
to embedding in gelatine for sectioning on the cryostat.   
 
2.7 Microscopy 
2.7.1 Confocal Microscopy 
All confocal images were taken on an Inverted Zeiss LSM 710 Confocal 
microscope. Cells were imaged using a x63 oil lens. Tissue sections were 
imaged using a x10 lens, x20 lens, x40 oil lens or x63 oil lens. Image 
processing was completed in ZEN (black edition) software, Zen (blue edition) 
software or ImageJ software.  
 
2.7.2 Structured Illumination Microscopy (SIM) 
Super-resolution microscopy allows for the observation of fluorescent 
samples at resolutions beyond the diffraction of light limit. All super-
resolution images were acquired using structured illumination microscopy. 
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Briefly, Structured Illumination Microscopy (SIM) uses patterned 
illumination, usually stripes, to excite samples. Emitted fluorescence is 
recorded in a range of positions and orientations; the interaction between 
the excitation pattern and the sample produces Moiré patterns and allows 
capture of high frequency information at low spatial frequencies. In 3-D SIM, 
the illumination is modulated in three dimensions and reconstruction of the 
final super-resolved image requires a greater number of raw images 
collected at different orientations of the structured illumination. Samples 
were prepared on high precision cover-glass (Zeiss, Germany). 3D SIM 
images were acquired on a Nikon-Structured Illumination Microscope (Nikon 
Instruments, UK) using a 100x 1.49NA lens and refractive index matched 
immersion oil (Nikon Instruments). Samples were imaged using a Nikon Plan 
Apo TIRF objective (NA 1.49, oil immersion) and an Andor DU-897X-5254 
camera using 405, 488 and 561 nm laser lines. Z-step size for Z stacks was 
set to 0.120 um as required by manufacturer’s software. For each focal 
plane, 15 images (5 phases, 3 angles) were captured with the NIS-Elements 
software. SIM image processing, reconstruction and analysis were carried 
out using the N-SIM module of the NIS-Element Advanced Research 
software. Images were checked for artefacts using the SIMcheck software 
(http://www.micron.ox.ac.uk/software/SIMCheck.php). Images were 
reconstructed using NiS Elements software v4.6 (Nikon Instruments, Japan) 
from a z-stack comprising of no less than 1 μm of optical sections. In all SIM 
image reconstructions the Wiener and Apodization filter parameters were 
kept constant. Reconstructed images were exported as .nd2 files, converted 
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to LIM files using IMARIS file converter software and imported into IMARIS 
for segmentation, further processing and analysis. 
 
2.7.3 Single cell sorting for clonal cell lines 
Single cells were deposited into individual wells of 96 plates using an 
Automatic Cell Deposition Unit (ACDU) on a Becton Dickinson FACS Aria III 
high speed Fluorescence Activated Cell Sorter. The Single Cell digital purity 
filter was used to avoid introducing contaminating cells. Each cell was 
contained within a droplet of approximately 5 nl of sterile phosphate 
buffered saline (PBS) as it was sorted. 
 
2.8 Statistical, Software and Bioinformatics 
Analysis 
The value of significance is accepted as p <0.05 throughout all statistical 
tests. Data was collected in Excel and all statistical tests were carried out in 
Minitab. The test used for statistical analysis is specified in the captions of 
figures or main text of this thesis. Graphs were generated in R (R Core Team, 




2.8.1 FANTOM5 Zenbu Analysis 
Zenbu in FANTOM5 was used to predict transcriptional expression of 
KIAA0586 transcripts. KIAA0586 was searched in the FANTOM5 human 
promoterome view, transcripts were identified in the 
UCSC_RefSeq_hg19_20120101 tab and transcripts of interest were 
examined for evidence of promoter activity in different tissue and cell types 
in the FANTOM5 CAGE Phase1 CTSS human tracks pooled filtered with 3 or 
more tags per library.  
 
2.8.2 Alignment Analysis 
Sequence alignments were completed using Clustal Omega from EMBL-EBI 
(Clustalo, V1.2.4). Protein sequences for alignments were taken from NCBI, 
based on the following accession numbers: Nematostella vectensis, 
ACJ61010; Saccoglossus kowalevskii, XP_002735892.1; Danio rerio, 
NP_001245157; Gallus gallus, AAZ22766; Homo sapiens, NP_001231118; 
Mus musculus, NP_001156850. Sequence alignments were imported into 
Jalview (Version 2), where protein domains were annotated (Waterhouse et 
al., 2009). 
 
2.8.3 DAVID Analysis 
The Database for Annotation, Visualisation and Integrated Discovery 
(DAVID) provides a set of functional annotation tools aimed at 
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understanding the biological meaning behind a large dataset or list of genes. 
Lists of genes, extracted from proteomic datasets, were uploaded into 
DAVID and submitted for analysis using the official gene symbol. The species 
was selected to limit annotations of gene lists to the species of the 
proteomic dataset being analysed. For human Jurkat cells, homo sapiens was 
selected; for chicken PGCs, gallus gallus was selected. Functional annotation 
clustering was used to determine Gene Ontology (GO) terms associated with 
the datasets, clusters of genes and the enrichment scores of those clusters.  
 
2.8.4 Ingenuity Pathway Analysis 
To understand potential cellular pathways that may be modified as a result 
of protein changes in different conditions, the Ingenuity Pathway Analysis 
(IPA) application (Ingenuity Systems, Silicon Valley, CA) was used as 
previously described (Mcgorum et al., 2015). Pathway analysis has been 
demonstrated to highlight downstream molecular consequences relating to 
a specific underpinning difference in a system. The interaction data was 
limited as follows: direct and indirect interactions; experimentally observed 
data only; maximum 35 molecules per network. P-values were calculated in 
IPA using a right-tailed Fishers exact test, allowing the programme to 
determine how relevant the network is to the current analysis. Z-scores were 
generated in IPA and represent a statistical measure of the match between 
an expected relationship direction and the observed protein expression. 
Positive z-scores indicate activation (orange) and negative z-scores indicate 
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inhibition (blue). Where no activity pattern was observed, z-scores were 
unavailable (grey). 
 
2.8.5 Image Studio Lite Western Blot Band Analysis 
All fluorescent Western blot images were obtained on the LICOR imaging 
system using Image StudioLite Software. Size of bands was calculated 
through Image Studio Lite by marking the protein standard band sizes. 
Relative quantification of bands was also carried out in Image StudioLite 
giving a read-out of signal for each band, which allowed calculation of 
relative fold change between bands.  
 
2.8.6 ImageJ Cell Counter 
Images of cells stained for gamma tubulin and acetylated tubulin were 
obtained using the 40x oil lens on the Zeiss LSM 710 Confocal microscope. 
Images were converted to .jpeg files and imported into ImageJ. Images were 
converted to an RGB (Red Green Blue) stack to separate the channels into 
separate images, ensuring an unbiased count. The cell counter plugin was 
used, which allowed cilia to be counted in one channel and nuclei (to 
represent each cell stained) to be counted separately in another channel. 
Each count was recorded on the image and images saved. The results were 
recorded in a table and exported as an excel file. Following collection of 
numbers of ciliated cells, the data was normally distributed; therefore, an 
92 
 
unpaired two-tailed student t-test was carried out to determine statistical 
significance between individual mutated cell lines and unedited cell lines. 
 
2.8.7 Extraction of list of centrosome proteins from the 
Andersen (2003) dataset 
The list for the KE37 cells comprised of 552 proteins identified from 
centrosome preparations (Andersen et al., 2003); the proteins were 
identified using the International Protein Index (IPI), which has since closed. 
To allow a comparison of the KE37 cell proteins with the Jurkat protein 
identifications, the UniProtKB ID/AC was extracted, where it was included in 
the KE37 raw dataset. Where accession numbers that are no longer used 
were included, the UniProt Retrieve ID/Mapping feature was used to 
convert the IDs to UniProtKB ID/AC. Of the 552 proteins identified in the 
KE37 raw dataset, a list of 505 proteins was extracted that could be matched 
with known accession numbers. Of those 505, there were thirteen proteins 
in duplicate following the ID conversion. The final list of proteins taken from 




Chapter 3. Investigating the functional 
domains and localisation of KIAA0586 
 
3.1 Introduction 
The talpid3 chicken flock contains a mutation that results in a severe 
embryonic lethal phenotype (Davey et al., 2006), however human ciliopathy 
patients with mutations in KIAA0586 (human TALPID3 orthologue) result in 
a much wider range of ciliopathy phenotypes from relatively mild to more 
severe, with only some cases of early lethality (Akawi et al., 2015; Alby et al., 
2015; Bachmann-Gagescu et al., 2015; Malicdan et al., 2015; Roosing et al., 
2015; Stephen et al., 2015). The following chapter explores ways of 
modelling the human mutations in talpid3 embryos in order to understand 
the functional domains that are affected by mutations that are predicted to 
be hypomorphic. In addition, this chapter explores tools to study the 
subcellular localisation of TALPID3. 
 
3.1.1 Functional domains of TALPID3/KIAA0586 
Analysis of the TALPID3 protein in chicken, mouse and zebrafish has 
identified a conserved coiled-coil domain (Figure 3.1) that is essential for 
function (Figure 3.2) (Bangs et al., 2011; Ben et al., 2011; Yin et al., 2009). 
This region was deleted in mouse and zebrafish to produce the talpid3-/- 
mouse model and the TALPID3 knockout zebrafish model, confirming this 
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region as being essential for function (Bangs et al., 2011; Ben et al., 2011). 
The conserved coiled-coil domain is also found in the human KIAA0586 
protein, as well as the broader category of chordates. Conservation is 
determined based on the presence of a coiled-coil domain in a region of the 
protein sequence that aligns with and has greater than 60% similarity to that 
of the chicken, mouse, zebrafish and human KIAA0586 proteins. A study in 
human RPE1 cells demonstrated that amino acid residues 466-602 of human 
KIAA0586, which contains the conserved coiled-coil domain was able to 
localise to centrosomes in human RPE1 cells (Kobayashi et al., 2014), thus 
supporting the conserved function of this domain in human KIAA0586. There 
is additional evidence in RPE1 cells to suggest that a region at the N-terminal 
of human KIAA0586 also weakly localises to the centrosome (Kobayashi et 
al., 2014), suggesting that human KIAA0586 might require two distinct 
regions of KIAA0586 to localise to the centrosome (Figure 3.2) (Kobayashi et 
al., 2014). 
A second region towards the C-terminal of TALPID3 contains a predicted 
intrinsically disordered domain (Figure 3.2) (Davey et al., 2006; Yin et al., 
2009). Disordered domains can enable the protein to have multiple 
interactions with multiple different proteins, due to the increased levels of 
flexibility and lack of stable secondary and tertiary structure (Dunker et al., 
2002; Sormanni et al., 2015), thus supporting the suggestion that the 
disordered domain in TALPID3 most likely contains unidentified functional 
domains. This domain is not highly conserved at the amino acid level, 
however chicken, mouse, zebrafish and human KIAA0586 proteins have all 
95 
 
been shown to contain predicted intrinsically disordered domains at a 
similar C-terminal region of the protein (Figure 3.1). The presence of the 
predicted intrinsically disordered domain has prevented successful 
structural modelling of the TALPID3 protein. Evidence in human RPE1 cells 
suggests that there are no additional C-terminal domains in human 
KIAA0586 protein that are required for targeting the protein to the 
centrosome (Kobayashi et al., 2014), suggesting that the functional C-
terminal domains rely on the essential coiled-coil domain for targeting to the 








Figure 3.1 Alignment of the conserved sequence of TALPID3/KIAA0586 essential coiled-coil domain and the predicted intrinsically disordered 
domain. (A) The conserved coiled-coil domain that is essential for function is marked in blue. (B) The predicted intrinsically disordered domain that 
is predicted to contain functional domains highlighted in red. The first sequence, Nematostella vectensis (Starlet sea anemone), is conserved, 
containing both the coiled-coil domain and an intrinsically disordered domain. The second sequence, Saccoglossus kowalevskii (Acorn worm), is not 
conserved. It contains a coiled-coil domain in a similar region, but does not appear to share sequence similarity and does not contain an intrinsically 
disordered domain. The bottom four sequences are Danio rerio (zebrafish), Gallus gallus (chicken), Homo sapiens (human) and Mus musculus 







Figure 3.2 TALPID3/KIAA0586 functional domain studies. Schematic of TALPID3 chicken protein and human KIAA0586 protein, with the talpid3 
chicken mutation annotated. Black vertical lines along proteins indicate exon boundaries. Purple boxes mark coiled-coil domains and the yellow box 
marks the predicted intrinsically disordered domain. A blue asterisk marks the coiled-coil domain in the conserved region that is essential for 
function. Green lines represent functional regions of protein or regions that localise to the centrosome. Grey lines represent non-functional regions 
of protein or regions that do not localise to the centrosome. The complementation assay (Yin et al., 2009) demonstrating that the conserved coiled-
coil domain is essential but not sufficient for function is directly below the chicken protein. The second complementation assay (Davey lab, 
unpublished) tested regions of the C-terminal by deleting sections of the protein including regions that overlap with the predicted intrinsically 
disordered domain, demonstrating a region of function between amino acid residues 1275-1400. The Flag-tagged KIAA0586 deletion mutants tested 
in human RPE1 cells are presented under the human protein schematic (Kobayashi et al., 2014) and show a region at the N-terminal of KIAA0586 




3.1.2 Ciliopathies associated with KIAA0586 
Mutations in KIAA0586 have been shown to cause ciliopathies including 
Joubert syndrome, Short-Rib Polydactyly syndrome (SRPS) and Jeune 
syndrome (Akawi et al., 2015; Alby et al., 2015; Bachmann-Gagescu et al., 
2015; Fleming et al., 2017; Malicdan et al., 2015; Pauli et al., 2018; Roosing 
et al., 2015; Stephen et al., 2015; Vilboux et al., 2017). Joubert syndrome is 
classified by brain and spinal malformations and can be diagnosed by the 
Molar Tooth Sign. The Molar Tooth Sign is caused by a deep interpeduncular 
fossa, elongated, thick and mal-oriented superior cerebellar peduncles and 
absent or hypoplastic cerebellar vermis that give the appearance of a “molar 
tooth” at the junction of the midbrain and hindbrain on an axial MRI 
(Gleeson et al., 2004; Maria et al., 1999; Parisi, 2009). Common clinical 
characteristics also include hypotonia, abnormal eye movements and 
abnormal breathing patterns (Maria et al., 1999; Parisi, 2009; Parisi et al., 
2007). Short Rib Polydactyly syndrome and Jeune syndrome fall under the 
same group of skeletal dysplasias characterised by a constricted thoracic 
cage, short ribs and shortened tubular bones (Ho et al., 2000; Huber & 
Cormier-Daire, 2012). Additional features can include polydactyly, renal, 
liver and retinal involvement (Baujat et al., 2013; Huber & Cormier-Daire, 
2012). Transduction of the Hedgehog signalling pathway is important in 
skeletal development for patterning of the limb, intramembranous 
ossification in craniofacial bones and endochondral ossification in other 
parts of the skeleton, joint formation and maintenance and repair of bones 
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throughout life (Alman, 2015; Ehlen et al., 2006; Yang et al., 2015), hence 
the range of skeletal abnormalities associated with ciliopathies.  
The ciliopathy patients contain a range of mutations that affect different 
regions of the KIAA0586 protein and cause a wide range of phenotypes, 
which mostly follow a pattern of more severe phenotypes associated with 
mutations at the N-terminal region of the KIAA0586 protein, prior to the 
essential coiled-coil domain (Figure 3.3) (Akawi et al., 2015; Alby et al., 2015; 
Bachmann-Gagescu et al., 2015; Malicdan et al., 2015; Roosing et al., 2015; 
Stephen et al., 2015). Of the mutations identified, one particular mutation 
appears to arise more frequently. This mutation, c.428delG p.Arg143Lysfs*4 
(seen on Figure 3.3) is predicted to result in a premature stop codon, 
resulting in production of only 143 amino acids, and therefore, predicted to 
be incompatible with life; however, the evidence from patients suggests that 
the mutation is hypomorphic and that there is still some functional 
KIAA0586 protein being produced (Pauli et al., 2018). This common variant 
mutation is found at a Minor Allele Frequency of 0.003916 (378 out of 
96,534 alleles) in the ExAC database, which shows it is found in healthy 
individuals in the general population. With a Minor Allele Frequency of <0.05 
this is considered a rare common variant mutation. Most of the patients 
identified with KIAA0586 mutations contain compound heterozygous 
mutations, and the majority of published compound heterozygous cases 
(34/49) contain the common variant mutation, c.428delG (p.Arg143Lysfs*4), 
as one of the mutations, thus supporting the common variant mutation as 
having some functional protein (Akawi et al., 2015; Bachmann-Gagescu et 
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al., 2015; Malicdan et al., 2015; Roosing et al., 2015; Stephen et al., 2015). 
There are two reported cases where a patient is homozygous for the 
common variant mutation and presents with a Joubert syndrome phenotype 
(Bachmann-Gagescu et al., 2015; Roosing et al., 2015) and one healthy 
individual homozygous for this mutation (Pauli et al., 2018). In one 
homozygous case the patient presents with a Molar Tooth Sign, abnormal 
eye movements and brainstem heterotopia; however, this patient also has 
a rare deleterious variant in another known Joubert syndrome gene, which 
could be contributing to the phenotype (Bachmann-Gagescu et al., 2015). In 
the second homozygous case, the patient presents with a Molar Tooth Sign 
and no additional phenotypic details available; there are no additional 
known Joubert syndrome gene mutations identified in the patient 
suggesting that the common variant mutation could be responsible for the 
Molar Tooth Sign (Roosing et al., 2015). Taken together, the relatively mild 
ciliopathy phenotypes of patients with the common variant mutation and 
the viability of patients who are homozygous for the common variant 





Figure 3.3 Human ciliopathy patient mutations mapped on a schematic of the human KIAA0586 protein. Black vertical lines along the protein 
indicate exon boundaries. Purple boxes mark coiled-coil domains in the protein, the blue asterisk indicates the conserved coiled-coil domain that is 
essential for function and the yellow box indicates the predicted intrinsically disordered domain. Red horizontal lines indicate mutations that cause 
premature stop codons. Grey horizontal lines indicate splice variant mutations and green horizontal lines indicate single heterozygous deleterious 
mutations. The pink asterisk indicates the common variant mutation. The blue horizontal line indicates a predicted potential alternative start codon 





The severity of the phenotype seen in patients is largely associated with the 
region of the protein that is affected in the patient. Where mutations occur 
prior to the essential coiled-coil domain and the patient does not contain the 
common variant mutation, patients tend to present with a more severe 
phenotype consisting of additional abnormalities such as polydactyly and 
shortening of the long bones (Bachmann-Gagescu et al., 2015; Malicdan et 
al., 2015) and in the most severe cases, embryonic lethality (Alby et al., 
2015). Unlike the severe embryonic lethal phenotype seen in animal models 
lacking TALPID3, only two homozygous KIAA0586 mutations have been 
identified as producing a lethal phenotype (Figure 3.4) (Alby et al., 2015). 
Both the homozygous c.230C>G, p.Ser77* variant  and the homozygous 
c.1815G>A (splice) variant resulted in embryonic lethality (Alby et al., 2015). 
In both cases, the phenotypes were severe, with skeletal abnormalities 
including polydactyly, short ribs and micromelia. Additionally the foetuses 
presented with cleft palate and cerebral phenotypes. Testing confirmed 
nonsense-mediated decay of KIAA0586 in the foetus homozygous for the 
c.230C>G, p.Ser77* variant, confirming that no functional KIAA0586 protein 
was produced. There were three live births of individuals homozygous for 
the c.1815G>A (splice) variant, however all died soon after birth (Alby et al., 
2015), which suggests that no functional protein was produced and provides 




Figure 3.4 Schematic of lethal mutations in KIAA0586 in human ciliopathy patients. The mutation c.230C>G, p.Ser77* is found in a homozygous 
state and results in lethality. The mutation c.1815G>A is found in a homozygous state and results in lethality. The red line at c.230C>G, p.Ser77* 
indicates that the mutation is predicted to result in a premature stop codon. The grey line at c.1815G>A indicates that the mutation is predicted to 





Despite only a few cases of embryonic lethality being associated with 
mutations in human KIAA0586, the evidence from the talpid3 chicken 
mutant, the talpid3-/- mouse and the TALPID3 knockdown zebrafish suggests 
that all of the patients would present with severe phenotypes linked to 
Hedgehog signalling pathway defects such as polydactyly, skeletal defects, 
brain and neural abnormalities (Bangs et al., 2011; Ben et al., 2011; Davey et 
al., 2006). However, this is not observed, instead only a small number of 
cases fall into the category of severe non-lethal ciliopathy phenotypes 
(Figure 3.5) including polydactyly and skeletal defects (Bachmann-Gagescu 
et al., 2015; Malicdan et al., 2015). There are three patients with mutations 
in both KIAA0586 alleles that present with a more severe phenotype, 
including severe eye abnormalities, polydactyly and skeletal defects 
(Bachmann-Gagescu et al., 2015; Malicdan et al., 2015). Of the three 
patients, one is compound heterozygous for c.745-350_1288+1117del and 
c.130dupC, p.H44Pfs*8, the second patient is compound heterozygous for 
c.745-350_1288+1117del and c.990C>T, p.L330L and the third patient is 
homozygous for c.1697A>T, p.D566V. The two compound heterozygous 
patient mutations occur prior to the essential coiled-coil domain suggesting 
that the protein loses the essential region for function, which could explain 
the more severe phenotype. The third patient, although occurring after the 
essential coiled-coil domain still disrupts the conserved region which most 
likely explains the more severe phenotype. Additionally there are three 
single rare deleterious variants that are associated with more severe 
phenotypes, including severe eye abnormalities, polydactyly and skeletal 
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defects (Bachmann-Gagescu et al., 2015). The single rare deleterious 
mutations are found after the conserved essential coiled-coil domain, more 
towards the C-terminal and the predicted intrinsically disordered domain of 
the KIAA0586 protein. These mutations towards the C-terminal in patients 
with a more severe ciliopathy phenotype, support the studies suggesting 
that an important functional domain is found at the C-terminal of KIAA0586. 
These patients however also contain additional mutations in other ciliopathy 
genes including TCTN3, C2CD3 and AHI1 (Bachmann-Gagescu et al., 2015). 
Mutations in all three genes can caused Joubert Syndrome and mutations in 
TCTN3 and C3CD3 can also cause orofaciodigital syndrome (Bachmann-
Gagescu et al., 2015; Cortés et al., 2016; Parisi et al., 2006; Thomas et al., 
2012), suggesting that there could also be other factors that contribute to 
the severe ciliopathy phenotype observed in the patients with single rare 




Figure 3.5 Schematic of mutations in KIAA0586 that are linked to a severe non-lethal patient phenotype. The annotated mutations, identify those 
that are associated with a more severe patient phenotype. As well as typical characteristics of Joubert syndrome such as a Molar Tooth sign, 
developmental delay, hypotonia and abnormal eye movements at birth, these patients have a range of skeletal defects, polydactyly, more severe 
neural defects and more severe eye abnormalities. The mutation c.745-350_1288+1117del is found in a compound heterozygous state in one patient 
combined with c.130dupC and in a compound heterozygous state with another patient with c.990C>T. The mutation c.1697A>T was found in a 
homozygous state. Red lines indicate mutations that result in a premature stop codon. Grey lines indicate a splice variant mutation. The green lines 





Ciliopathy patients containing the remaining mutations in KIAA0586 present 
with relatively mild phenotypes, the majority of which are caused by 
compound heterozygous mutations consisting of the common variant 
mutation and a second mutation (Akawi et al., 2015; Bachmann-Gagescu et 
al., 2015; Malicdan et al., 2015; Roosing et al., 2015; Stephen et al., 2015). 
There is no apparent pattern between where the second mutations occur in 
relation to the essential coiled-coil domain and what the phenotype of the 
patient is, however the presence of the common variant mutation is 
predicted to account for the mild phenotype of most these patients by 
producing some functional protein (Pauli et al., 2018). Of the patients with 
mild phenotypes, there are three exceptions to the pattern that do not 
contain the common variant mutation but still present with a mild 
phenotype (Figure 3.6). Of these three patients, one is homozygous for 
c.2414-1G>C (splice) (Roosing et al., 2015), which occurs after the essential 
coiled-coil domain and may still produce some of the functional region of 
protein, thus explaining the relatively mild phenotype. The mutation 
c.74delA, p.L25Rfs*6 is homozygous (Roosing et al., 2015) and given the 
early point in the protein at which it occurs, it is possible that an alternative 
start codon is also able to produce protein in order to produce some 
functional protein in this patient to explain the mild phenotype. The 
c.1430_1434delAGCTAinsGAAG, p.E477Gfs*7 mutation occurs in 
combination with c.3303G>A, p.P1084fs*22 (Bachmann-Gagescu et al., 
2015); both of these mutations are predicted to result in a premature stop 
codon, suggesting loss of function of the protein. However, the mild 
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phenotype associated with this compound heterozygous mutation suggests 
that there may be functional protein; the second mutation occurs after the 
essential coiled coil domain, which could explain the presence of functional 
protein and therefore the mild phenotype. Although these mutations 
present as the exceptions to the trend of lack of severity in patient 
phenotypes, it is possible that this mutation is not consistent in all tissue 
types; different expression levels and transcription start codons in different 
tissue types could explain the patient’s lack of phenotypic severity, and is 
not uncommon in ciliopathy patients with overlapping ciliopathy 




Figure 3.6 Schematic of mutations in KIAA0586 that are found in patients with a mild phenotype. Patients classified as having a mild phenotype 
have been diagnosed with Joubert syndrome; most of these patients present with the Molar Tooth Sign, developmental delay, hypotonia, ataxia 
and often abnormal eye movements early on in life. With the exception of the mutations indicated by a black asterisk, all of these mutations are 
found in patients with compound heterozygous mutations combined with the common variant mutation, which is marked by the pink asterisk. Of 
the mutations that do not occur in combination with the common variant mutation, c.74delA, p.L25Rfs*6 is homozygous, c.2414-1G>C, splice is 
homozygous and c.1430_1434delAGCTAinsGAAG, p.E477Gfs*7 occurs in combination with c.3303G>A, p.P1084fs*22. Red horizontal lines indicate 





One explanation for the possible production of functional protein, for 
example in patients with the common variant mutation, is a potential 
downstream alternative start codon that exists in human KIAA0586. The 
alternative start codon, identified in Zenbu in FANTOM5, produces a shorter 
protein of 1463 amino acids (NM_001244193/NP_001231122) (Figure 3.7 A) 
that still contains the essential coiled-coil domain required for function and 
localisation to the centrosome (Lizio et al., 2015). CAGE data in FANTOM5 
demonstrates that this transcript is expressed in a range of human tissue 
and cell types, supporting this prediction (Figure 3.7 B). Although 
unconfirmed in patients, mutations that produce premature stop codons 
prior to this alternative start codon, such as the common variant mutation, 
might still produce functional protein from this alternative start codon. It is 
also possible that expression only occurs from this alternative start codon in 
some tissue types, which would explain why only some tissues and organs 
are affected in patients with mutations in KIAA0586. This is one possible 
explanation for some of the less severe phenotypes seen in ciliopathy 
patients with mutations in KIAA0586 and may explain why some of the 




Figure 3.7 The presence of predicted alternative start codon for human 
KIAA0586 was identified on Zenbu in Fantom5. (A) A blue arrow indicates 
the transcript that represents human KIAA0586 that produces a protein of 
1644 amino acids (NM_001244189). The orange arrow indicates an 
alternative downstream transcript that would produce a KIAA0586 protein 
of 1463 amino acids (NM_001244193). The red arrow marks the 
transcription start site associated with NM_00244193. (B) The dotted lines 
from the red arrow indicate FANTOM5 CAGE data that shows the expression 
of the transcript associated with NM_00244193 in a range of different 
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human cell lines and tissue types. This range of expression demonstrates 
that the alternative start codon is expressed and could be a valid explanation 
for the ability to produce functional KIAA0586 protein in human ciliopathy 




3.1.3 TALPID3/KIAA0586 localisation studies 
As well as questions surrounding how mutations in KIAA0586 can provide 
such a wide range of phenotypes in human patients, there are still questions 
that remain unanswered relating to the dynamic localisation and protein 
interacting network of TALPID3. Multiple antibodies against KIAA0586 exist 
that were raised against a range of different regions of the KIAA0586 
protein. Of these antibodies, one was raised against the C-terminal of 
chicken TALPID3 (Yin et al., 2009) and one was raised against the N-terminal 
of mouse KIAA0586 (Wu et al., 2014), while the remaining antibodies were 
raised against various regions of human KIAA0586 (Kobayashi et al., 2014; 
Stephen et al., 2015; Yadav et al., 2016). Despite all of these antibodies 
showing localisation of KIAA0586 to the centrosome, there has been some 
conflicting evidence with two studies showing localisation of KIAA0586 to 
both the mother and daughter centrioles (Kobayashi et al., 2014; Yin et al., 
2009), and one study showing that KIAA0586 localises more to the mother 
centriole than the daughter centriole (Wu et al., 2014). Protein tagging has 
also been used as a way to study the localisation of KIAA0586 and to identify 
proteins that interact with KIAA0586 (Davey et al., 2006; Kobayashi et al., 
2014). A C-terminal TALPID3-myc tag and an N-terminal TALPID3-HA tag in 
cultured chicken cells showed cytoplasmic localisation (Davey et al., 2006), 
suggesting that the overexpression of TALPID3 prevents correct localisation. 
A Flag-KIAA0586 tag in human cells proved more effective, demonstrating 
localisation to the centrosome (Kobayashi et al., 2014), however a tagged 
protein is not expressed from the endogenous locus and this study was 
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completed in wildtype RPE1 cells that already express KIAA0586 showing 
that the levels observed were higher than would be expected in normal 
healthy conditions (Kobayashi et al., 2014). Although overexpression studies 
can provide a wealth of information, they may not accurately reflect the 
expression pattern from the endogenous locus and can produce artefacts in 
other cellular processes, affect protein folding and disturb downstream 
regulation (Fetter et al., 2015; Gibson et al., 2013), therefore demonstrating 
the need for an alternative tool to monitor endogenous levels of TALPID3.  
Despite antibodies against KIAA0586 and KIAA0586-protein tags showing 
localisation to the centrosome, these methods both have limitations that 
prevent analysis of endogenous KIAA0586 protein levels in a dynamic state. 
The pattern of localisation of KIAA0586 to the centrosome, does not explain 
how mutations in KIAA0586 can lead to a satellite phenotype in talpid3 
mutant cells or in human RPE1 cells depleted of KIAA0586 (Kobayashi et al., 
2014; Stephen et al., 2015); in addition it does not explain the actin 
phenotype seen in talpid3 (Yin et al., 2009), which leads to the question of 
where in the cell is KIAA0586 interacting with proteins such as PCM1 to 
influence satellite dispersal as well as how and where does KIAA0586 control 
actin regulation and organisation. These unanswered questions highlight the 
need for a new approach to study the dynamic localisation of KIAA0586 at 
endogenous levels, to understand the dynamic localisation of KIAA0586 and 





To date, it has not been possible to uncover the actual structure (Acharya 
Lab, personal communication) or predicted structure of TALPID3, or to 
identify all of the functional domains, which may help to understand both 
TALPID3 function and structure, in part due to the predicted intrinsically 
disordered domain found at the C-terminal of TALPID3 and the lack of tools 
to study TALPID3 at an endogenous level. The recent discovery of ciliopathy 
patients with mutations in KIAA0586 has presented a variety of phenotypes 
ranging from mild to severe, which if modelled could help to identify 
hypomorphic mutations leading to an insight into additional regions in the 
protein that are necessary for function. The aim of this study was to 
determine if KIAA0586 ciliopathy mutations can be modelled in talpid3 
embryos, in an attempt to understand the phenotypes associated with each 
mutation and where the important functional domains are in the protein. In 
addition, the study aimed to overcome previous complications of studying 
the subcellular localisation of TALPID3, by introducing a fluorescent tag at 
the endogenous locus of TALPID3 in primary chicken cells, which would also 






3.2.1 Electroporation of human KIAA0586 can rescue 
Hedgehog-dependent expression patterns in the talpid3 neural 
tube 
The patterning of neural progenitors along the dorsoventral axis of the 
developing neural tube requires highly regulated signalling events, one of 
which is Sonic Hedgehog (Briscoe & Ericson, 1999). The initial source of Sonic 
Hedgehog signal for neural patterning comes from the notochord, which lies 
below the ventral midline of the neural plate. The specification of cell types 
within the ventral neural tube depends on levels of Sonic Hedgehog, with a 
gradient running high to low from ventral to dorsal (Goetz et al., 2009). Cells 
in the dorsal half of the neural tube generate neurons that relay sensory 
information, whereas cells in the ventral half of the neural tube generate 
motor neurons and ventral interneurons. The distinct groups of motor 
neurons and ventral interneurons arise at distinct positions in the ventral 
neural tube (Briscoe & Ericson, 1999). For example Nkx2.2, Islet1 and Nkx6.1 
are expressed in specific progenitor cells in the ventral neural tube whereas 
Pax7 expression is limited to dorsal progenitors (Figure 3.8 A). Due to 
abnormal Hedgehog signalling, the Hedgehog-dependent expression 
patterns in the talpid3 neural tube are lost during early development in the 
chick. Talpid3 mutants have a gain of function phenotype in the dorsal neural 
tubes that presents as a ventral expansion of the expression domains, such 
as Pax7 (Figure 3.8 B); a loss of function phenotype is seen in the ventral 
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neural tube of talpid3 mutants, which presents as a loss of expression 
domains such as Nkx2.2, Nkx6.1 and Islet1 (Figure 3.8 B). This loss of function 




Figure 3.8 Schematic showing expression domains in the wildtype neural 
tube compared to abnormal expression domains in the talpid3 neural tube. 
(A) Schematic of wildtype neural tube with normal Pax7, Nkx2.2, Islet1 and 
Nkx6.1 expression domains annotated. (B) Schematic of talpid3 neural tube 
with abnormal Pax7, Nkx2.2, Islet1 and Nkx6.1 expression domains of caused 




In order to determine if full length human KIAA0586 could rescue Hedgehog-
dependent neural tube patterning in talpid3, electroporation with a full 
length human KIAA0586 cDNA construct (pCAGGS-hsKIAA0586) was carried 
out in the neural tube of talpid3 and wildtype embryos and Hedgehog-
dependent expression patterns and cell types were examined. The construct 
being tested, was injected at approximately the base of the neural tube of 
Hamburger Hamilton stage 10-12 talpid3 flock embryos. The embryo was 
electroporated, immediately following successful injection of the DNA 
construct into the neural tube, by placing electrodes either side of the neural 
tube at the level of injection. Embryos were then allowed to develop for a 
further 48-60 hours to Hamburger Hamilton stage 22-24. The embryos were 
examined for signs of successful electroporation by the presence of eGFP 
expression in the neural tube. A section of the neural tube between the 
forelimb and hindlimb containing eGFP was harvested and sectioned, to 
analyse for rescue of expression.   
Control electroporations of pCAGGS-eGFP showed no change in expression 
patterns of Pax7, Islet1, Nkx2.2 or Nkx6.1 in wildtype embryos (Figure 3.9 A, 
C, E, G) or Pax7, Islet1 and Nkx2.2 in talpid3 embryos compared to the non-
electroporated side (Figure 3.9 B, D, F). These results demonstrate that the 
injection technique, the introduction of eGFP and the electroporation 
technique do not change the Hedgehog-dependent expression patterns in 




Figure 3.9 Control electroporation of pCAGGS-eGFP into the developing 
neural tube does not change Hedgehog-dependent expression patterns. 
Following electroporation with pCAGGS-eGFP, cells that took up the DNA are 
marked by eGFP, Dapi marks the nuclei in blue and the protein expression 
being examined is in red. (A) The expression pattern of Pax7 remains 
unchanged in the dorsal region of the electroporated side of the wildtype 
neural tube, when compared to the non-electroporated side. Domains are 
marked by white dashed lines. (B) The ventrally extended expression pattern 
of Pax7 remains unchanged in the electroporated side of the talpid3 neural 
tube when compared to the non-electroporated side. Domains are marked 
by a white dashed lines. (C) The expression pattern of Islet1 remains 
unchanged in wildtype at the lateral edge of the ventral neural tube in 
differentiating motor neurons of the electroporated side, when compared 
to the non-electroporated side. Domains are marked by white dashed lines. 
The dorsal domain of Islet1 is marked by white arrowheads. (D) The loss of 
expression of Islet1 remains unchanged in talpid3 at the lateral edge of the 
ventral neural tube in the electroporated side, when compared to the non-
electroporated side. A few cells expressing Islet1 are indicated by white 
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arrowheads. The dorsal domain of Islet1 is marked by white arrowheads. (E) 
The expression pattern of Nkx2.2 remains unchanged in the ventral neural 
tube of the electroporated side in wildtype when compared to the non-
electroporated side. Domains are marked by white dashed lines. (F) The loss 
of expression of Nkx2.2 remains unchanged in the ventral neural tube of the 
electroporated side in talpid3 when compared to the non-electroporated 
side. (G) The expression pattern of Nkx6.1 remains unchanged in the ventral 
neural tube of wildtype in the electroporated side, when compared to the 
non-electroporated side. Domains are marked by white dashed lines. 
Arrowheads mark the regions of expression at the lateral edges of the neural 




On electroporation of pCAGGS-ggKIAA0586 (chicken TALPID3 construct), a 
rescue of expression patterns of Pax7 and Islet1 was seen in talpid3 embryos. 
The abnormal ventral expansion of Pax7 expression was reduced to a smaller 
domain that remained in the dorsal half of the neural tube on the 
electroporated side in talpid3, more closely resembling the expression 
pattern in Pax7 in the wildtype (Figure 3.10 A, B). Islet1 expression was 
rescued at the site of electroporation in the talpid3 neural tube, showing a 
similar expression domain to that of the wildtype; the non-electroporated 
side of the neural tube did not express Islet1 (Figure 3.10 C, D). 
Electroporation failed to rescue expression of Nkx2.2 in the talpid3 neural 
tube (Figure 3.10 E, F). In conclusion, these results show that expression of 
chicken TALPID in talpid3 can rescue Hedgehog dependent neural tube 
patterning of Pax7 and Islet1, but under the conditions of this experiment 
was unable to rescue expression of Nkx2.2. These results demonstrate that 
chicken TALPID3 can rescue both gain of function and loss of function 
phenotypes seen in the talpid3 neural tube. Additionally, these results 
demonstrate that following electroporation of a functional construct in the 
neural tube, the conditions of this experiment are appropriate for rescuing 






Figure 3.10 Electroporation of full length chicken TALPID3 rescues expression in the talpid3 neural tube. Following electroporation with pCAGGS-
ggKIAA0586 and pCAGGs-eGFP, cells that took up the DNA are marked by eGFP, Dapi marks the nuclei in blue and the protein expression being 
examined is in red. (A) Expression of Pax7 is found in the dorsal region of the neural tube in wildtype and remains unchanged on the electroporated 
side. (B) Expression of Pax7 is extended ventrally in talpid3, but is reduced to a more dorsal region following rescue on the electroporated side of 
the neural tube. Expression domains of Pax7 are marked by a white dashed line on both sides of the neural tube. (C) Expression of Islet1 is found at 
the lateral side of the ventral neural tube in wildtype and remains unchanged on the electroporated side. (D) Islet1 expression is lost in talpid3, but 
is rescued on the electroporated side of the neural tube, marked by a white dashed line. (E) Expression of Nkx2.2 is found in a small region of the 
ventral neural tube in wildtype and remains unchanged on the electroporated side. (F) Nkx2.2 expression is lost in talpid3. No rescue of Nkx2.2 was 
observed following electroporation. All scale bars, 50 μm.
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On electroporation of pCAGGS-hsKIAA0586, a rescue of the gain of function 
expression pattern of Pax7 was seen; additionally a partial rescue of the loss 
of function expression pattern of Iselt1, Nkx2.2 and Nkx6.1 was seen. The 
partial rescue of Islet1 and Nkx2.2 both showed a non-cell autonomous 
effect (Figure 3.11). The abnormal ventral expansion of Pax7 expression was 
reduced to a smaller domain that remained in the dorsal half of the neural 
tube on the electroporated side in talpid3 (n=4), more closely resembling the 
expression pattern in wildtype (Figure 3.11 A, B). The electroporated side of 
the talpid3 neural tube contained additional Islet1-expressing cells towards 
the lateral edge of the neural tube (n=2)(Figure 3.11 C, D); these cells were 
not all marked by eGFP expression, suggesting a non-cell autonomous effect. 
There was a small clump of Nkx2.2-positive cells in the ventral region of the 
neural tube on the electroporated side in talpid3 (n=2) (Figure 3.11 E, F); 
similar to Islet1, the cells were not all marked by eGFP expression, suggesting 
a non-cell autonomous effect. There were also Nkx6.1-positive cells that 
spanned a larger domain in the ventral region on the electroporated side in 
the talpid3 neural tube (n=4) when compared to the non-electroporated side 
(Figure 3.11 G, H).  
In conclusion, these results show that expression of human KIAA0586 in 
talpid3 can rescue neural tube patterning of Pax7. Additionally, expression 
of human KIAA0586 in talpid3 can partially rescue expression of Nkx6.1 and 
can produce a non-cell autonomous effect in Islet1 and Nkx2.2. These results 
suggest that human KIAA0586 can function in the talpid3 chick to rescue the 
gain of function phenotype seen in the dorsal region of the neural tube, thus 
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supporting the use of the talpid3 chick for modelling human KIAA0586 
ciliopathy patient mutations in order to identify functional protein domains. 
The inability of human KIAA0586 to fully rescue the loss of function 
phenotype seen in the ventral neural tube of talpid3 suggests that KIAA0586 
may play a role in the cilia environment needed for responsiveness to 
Hedgehog signalling and that the protein domain responsible for this role 
differs between chicken and human. 
 
 
Figure 3.11 Electroporation of full length human KIAA0586 rescues 
expression in the talpid3 neural tube. Following electroporation with 
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pCAGGS-hsKIAA0586 and pCAGGs-eGFP, cells that took up the DNA are 
marked by eGFP, Dapi marks the nuclei in blue and the protein expression 
being examined is in red. (A) Expression of Pax7 is found in the dorsal region 
of the neural tube in wildtype and remains unchanged on the electroporated 
side. (B) Expression of Pax7 is extended ventrally in talpid3, but is reduced to 
a more dorsal region following rescue on the electroporated side of the 
neural tube. Expression domains of Pax7 are marked by a white dashed line 
on both sides of the neural tube. (C) Expression of Islet1 is found at the 
lateral side of the ventral neural tube in wildtype and remains unchanged on 
the electroporated side. (D) Islet1 expression is lost in talpid3. There are 
more cells expressing Islet1, marked by white arrowheads, on the 
electroporated side of the neural tube, suggesting rescue. (E) Expression of 
Nkx2.2 is found in a small region of the ventral neural tube in wildtype and 
remains unchanged on the electroporated side. (F) Nkx2.2 expression is lost 
in talpid3. A small group of Nkx2.2 positive cells, marked by white 
arrowheads are seen on the electroporated side of the neural tube 
suggesting non-cell autonomous rescue. (G) Expression of Nkx6.1 is found in 
the ventral region of the neural tube in wildtype and remains unchanged on 
the electroporated side. (H) Nkx6.1 expression is lost in talpid3. There are 
some cells expressing Nkx6.1, marked by white arrowheads, on the 






Having shown that human KIAA0586 can rescue the gain of function 
phenotype in the dorsal neural tube of talpid3, a ciliopathy patient mutation 
was modelled in talpid3 flock embryos to determine if hypomorphic 
mutations could be identified and whether from this modelling, additional 
functional domains could be identified in KIAA0586. In order to identify a 
mutation to model, KIAA0586 ciliopathy mutations were examined for 
evidence of having some function based on remaining domains in the 
protein and patient phenotype associated with the mutation. A known 
patient mutation, c.1697A>T, p.D566V, (Figure 3.12) was chosen to model in 
the neural tube of developing talpid3 flock embryos. The mutation is a 
homozygous mutation found in a patient presenting with a Molar Tooth 
Sign, polydactyly and neurological defects (Bachmann-Gagescu et al., 2015). 
Unlike many of the patients presenting with mild forms of Joubert 
syndrome, the polydactyly associated with this patient suggested that the 
single amino acid change caused a severe change to the protein. 
Additionally, this mutation arises after the potential alternative start codon 
and results in a single amino acid change instead of a premature stop codon 
which suggests that nonsense-mediated decay does not occur. The mutation 
is recessive and the parents of the affected individual have a normal 
phenotype, therefore no change would be expected when modelling in 
wildtype embryos. Additionally, because the patient is homozygous for this 
mutation, any functional conclusions drawn from modelling the mutation 
can be directly linked to the phenotype associated with the patient instead 
of determining which mutation is responsible for functional abnormalities, 
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which would be the case in patients with compound heterozygous 
mutations; therefore modelling of c.1697A>T, p.D566V was attempted in 




Figure 3.12 Schematic of human KIAA0586 protein with mutation c.1697A>T, p.D566V that was chosen to model in talpid3 flock embryos. Black 
vertical lines along the protein indicate exon boundaries. Purple boxes mark coiled-coil domains in the protein, the blue asterisk marking the 




On electroporation of pCAGGS-c.1697A>T,p.D566V into the neural tube of 
talpid3 flock embryos Pax7, Islet1, Nkx2.2 and Nkx6.1 remained unchanged 
in the wildtype neural tube (Figure 3.13 A-D) (n=3). No talpid3 embryos 
survived so analysis was not undertaken to determine if pCAGGS-






Figure 3.13 Electroporation of human ciliopathy mutation c.1697A>T, 
p.D566V does not alter expression in the neural tube of wildtype chicken 
embryos. Following electroporation with pCAGGS-c.1697A>T,p.D565V + 
pCAGGS-eGFP, cells that took up the DNA are marked by eGFP, Dapi marks 
the nuclei in blue and the protein expression being examined is in red. (A) 
Expression of Pax7 is found in the dorsal region of the neural tube and 
remains unchanged on the side electroporated with the mutant construct. 
(B) Expression of Islet1 is found in the lateral regions of the ventral neural 
tube and remains unchanged on the side electroporated with the mutant 
construct. (C) Expression of Nkx2.2 is found in the ventral neural tube and 
remains unchanged on the side electroporated with the mutant construct. 
(D) Expression of Nkx6.1 is found in the ventral third of the neural tube and 
remains unchanged on the side electroporated with the mutant construct. 
All scale bars, 50 μm. 
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3.2.2 Targeting the endogenous locus of TALPID3 with a 
fluorescent tag  
In order to overcome challenges presented by analysing the subcellular 
localisation with antibodies against TALPID3, CRISPR/Cas9 editing was 
designed and carried out with the aim of incorporating a fluorescent tag, 
through homology directed repair, at the endogenous locus of TALPID3 in 
chicken Primordial Germ Cells (PGCs). By making a chicken cell line that 
stably expressed fluorescently labelled TALPID3, I intended to provide a tool 
to examine the dynamic subcellular localisation of TALPID3 at endogenous 
levels throughout the cell cycle while also providing a tool that could be used 
in future targeted proteomic studies. In addition this tool could be used to 
model the human KIAA0586 ciliopathy mutations to determine if the 
KIAA0586 protein localisation is altered in response to the mutations, for 
example movement to the satellites, which could help to explain the 
previously described satellite phenotype associated with reduced levels or 
loss of KIAA0586 protein (Kobayashi et al., 2014; Stephen et al., 2015). 
TALPID3 is a centrosome protein therefore, due to the centrosome playing 
a key role in regulating the cell cycle (Doxsey et al., 2005), it is likely that the 
levels and localisation patterns of TALPID3 change during the cell cycle. 
CRISPR/Cas9 editing was designed to incorporate an eGFP protein tag 
(Lippincott-Schwartz & Patterson, 2003) at the N-terminal of TALPID3 
(Figure 3.14 A, B); the N-terminal of TALPID3 was chosen for targeting 
because rescue studies have shown that it is not needed for function (Yin et 
al., 2009). By targeting a region that was not necessary for function the aim 
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was to reduce the potential for disrupting the functional domains of TALPID3 
when a fluorescent protein tag was added. The homology repair template 
was designed with homology arms of 1.5 kilobase pairs in length that 
targeted the region surrounding the ATG start codon of TALPID3. A flexible 
linker was incorporated between the fluorescent eGFP protein tag and 
TALPID3 to prevent disruption to the normal folding of TALPID3 (Argos, 
1990; Chen et al., 2013). The glycine-rich flexible linker consisted of six 
amino acids, with serine dispersed between the glycine; glycine is small and 
serine is polar, providing a flexible and soluble linker that should allow 
appropriate movement, interaction and space between the eGFP tag and 
the TALPID3 protein (X. Chen et al., 2013). However, studies have shown that 
fluorescent protein tags at the N-terminal are more likely to disrupt normal 
localisation of the protein (Palmer & Freeman, 2004), therefore additional 
CRISPRs were designed to incorporate a fluorescent tag at the C-terminal of 
TALPID3 (Figure 3.14 C, D). The homology repair template for the C-terminal 
of TALPID3 was designed to include a Venus fluorescent protein tag, 
homology arms that were 500 base pairs in length and a flexible linker region 
that contained two extra glycine residues. Venus is a variant of yellow 
fluorescent protein (YFP) that is stable and has brighter fluorescence than 
eGFP (Nagai et al., 2001). Localisation studies of centrosome proteins can be 
challenging due to the low expression levels and size of the organelle being 
imaged, therefore Venus was chosen as the fluorescent protein tag for the 
C-terminal because it is brighter than eGFP and could be more easily imaged 
in the centrosome. The DNA templates for both the 5’ and 3’ end of TALPID3 
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were generated by Gibson Cloning, to allow joining of multiple fragments in 
a single reaction using overlapping ends. Pairs of guides were designed for 
both the N-terminal and the C-terminal targeting as this has been shown to 
produce fewer off-target effects (Ran et al., 2013). Following transfection of 
the CRISPRs and homology repair templates into chicken PGCs, the cells 
were examined for incorporation of the fluorescent tag at the endogenous 
locus of TALPID3. Despite several attempts, there was no successful 
incorporation of eGFP or Venus at the N-terminal or the C-terminal of 
TALPID3, respectively. PGCs are amenable to gene editing (Taylor et al., 
2017), therefore the lack of success was most likely due to the design of an 
inefficient homology directed repair template or the fluorescent protein tag 
being incompatible with TALPID3 protein function in the design that was 
used. In conclusion, attempts to fluorescently tag TALPID3 at the N-terminal 
and C-terminal proved unsuccessful, meaning that a different approach to 
study the dynamic localisation of TALPID3 is required; additionally, an 
alternative approach or tool will be required to analyse the protein 




Figure 3.14 Schematic of chicken TALPID3 targeting design with CRISPR/Cas9. (A) Schematic of the design to target the N-terminal region of chicken 
TALPID3, using CRISPRS to introduce a GFP tag. The 5’ arm and 3’ arm each represent regions of homology that are approximately 1.5 kilobase pairs 
in length. The blue arrowhead indicates the ATG start codon. (B) The schematic represents the DNA repair template used for homologous 
recombination at the N-terminal of TALPID3 during CRISPR targeting. The flexible linker, marked in orange, is a region of 6 amino acids that is rich 
in glycine with serine dispersed between the glycine. (C) Schematic of the design to target the C-terminal region of chicken TALPID3 using CRISPRs 
to introduce a Venus tag. The 5’ arm and 3’ arm each represent regions of homology that are approximately 500 base pairs in length. The blue 
arrowhead indicates the ATG start codon. (D) The schematic represents the DNA repair template used for homologous recombination at the C-
terminal of TALPID3 during CRISPR targeting. The flexible linker, marked in orange, represents a region of eight amino acids that is rich in glycine 
with serine dispersed between the glycine. 
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3.2.3 Super resolution imaging of KIAA0586 and candidate 
centrosome proteins shows distinct localisation patterns at the 
centrosome 
I subsequently undertook super resolution using a newly produced 
(unpublished) antibody against KIAA0586. The antibody was raised against 
human KIAA0586 and recognised 146 amino acids (1313-1458 amino acids) 
in a region after the predicted intrinsically disordered domain at the C-
terminal of the protein. In human RPE1 cells, low resolution imaging with 
the antibody showed localisation to the centrosome (Figure 3.15 A). 
Negative controls, omitting primary antibodies, showed no localisation 
patterns in the cells confirming that there was no nonspecific binding of the 
secondary antibody. Structured Illumination Microscopy (SIM) imaging 
showed that KIAA0586 localised to one end of both the mother and the 
daughter centrioles (Figure 3.15 B). Additionally the results showed that the 
region of KIAA0586 on each centriole co-localised with gamma tubulin and 
that there was more KIAA0586 localising to one centriole than the other 
(Figure 3.15 C). A previous report suggested that KIAA0586 localises more to 
the mother centriole than the daughter centriole (Wu et al., 2014), however 
without an additional marker to distinguish between the centrioles, these 
results do not confirm which centriole has more KIAA0586. 3D models, that 
provide a more reliable visual representation of where the proteins localise 
in relation to one another, can be produced in Imaris Software from the 
reconstructed images acquired on the SIM. 3D modelling of the centrosome 
showed a distinct region of KIAA0586 at one end of each centriole with a 
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region of co-localisation with gamma tubulin on each centriole (Figure 3.15 
D). In support of the primary antibody being specific, all imaging of 
centrosome proteins (TALPID3, ARMC3, MYCBPAP, RIBC2, VWA3A) in cells 
following immunofluorescence, was completed at the same time, under the 
same condititions; following super resolution imaging, each centrosomal 
protein showed a different pattern of localisation in the centrosome in 





Figure 3.15 KIAA0586 localises to the distal end of centrioles in the 
centrosome. (A) Immunofluorescence for KIAA0586 (red) using a newly 
produce antibody against KIAA0586, gamma tubulin (green) and Dapi (blue) 
in human RPE1 cells. (B) Super resolution imaging for KIAA0586 (red), 
gamma tubulin (green) and Dapi (blue) in human RPE1 cells shows KIAA0586 
co-localising with gamma tubulin at the centrioles. A white arrowhead marks 
each of the centrioles. (C) Single plane reconstruction at a higher 
magnification shows KIAA0586 at the ends of both centrioles, partially co-
localising with gamma tubulin, with more KIAA0586 on one centriole than 
the other. The centriole with more KIAA0586 is marked by a white 
arrowhead. (D) 3D modelling in Imaris shows the structural localisation of 
KIAA0586 at the centrioles. All scale bars as specified in figure. 
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Bioinformatic analysis was used to identify novel cilia and centrosome 
proteins with a motile cilia signature, from RNA-Sequencing data taken from 
a pool of 52 human tissues (The Genotype-Tissue Expression (GTEx) Project). 
The tissues were analysed for high expression of FOXJ1, a gene required for 
specification of motile cilia (Yu et al., 2008). Co-expression analysis was used 
to identify genes that had a similar pattern of expression to FOXJ1 and were 
expressed in tissues also expressing FOXJ1. The candidate genes were then 
tested, identifying ARMC3, MYCBPAP, RIBC2 and VWA3A as candidate 
centrosome proteins (Patir et al., 2019, in preparation). ARMC3 (Armadillo 
Repeat Containing 3) belongs to a family of proteins that function in signal 
transduction, development, cell adhesion, mobility and tumor initiation and 
metastasis (Li et al., 2006); mutations in ARMC3 have been shown to cause 
sperm motility defects (Pausch et al., 2016). MYCBPAP (AMAP-1, Cod106) is 
expressed during development in neuronal and sensory cells in the inner ear 
and brain as well as the testis (Reisinger et al., 2005; Yukitake et al., 2002). 
RIBC2 (RIB43A domain with coiled-coils 2) has been identified as a gene that 
is silenced in some cases of ulcerative colitis inflammatory bowel disease 
(Kang et al., 2016). Additionally, RIBC2 has been shown to be highly 
expressed in testis, localises to the ciliary axoneme and is involved in ciliary 
motility (Chung et al., 2014). VWA3A (Von Willebrand Factor A Domain 
Containing 3A) is a protein coding gene that when mutated can lead to 
Ovarian cancer; VWA3A has a high association with survival in patients with 
Ovarian cancer (Madden et al., 2014). 
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Super resolution imaging of the four candidate centrosome proteins showed 
distinct patterns of localisation to the centrioles that were different to 
KIAA0586. Imaging showed that ARMC3 had a small region of co-localisation 
with gamma tubulin at the centrioles, as well as localisation around the 
centrioles (Figure 3.16 A-D). MYCBPAP co-localised with gamma tubulin on 
both centrioles as well as localising to the end of both centrioles (Figure 3.16 
E-H). RIBC2 co-localised with gamma tubulin on both centrioles (Figure 3.16 
I-L). VWA3A did not co-localise with gamma tubulin, instead localising to a 
region adjacent to the centrioles (Figure 3.16 M-P). Low resolution imaging 
suggested that only MYCBPAP and RIBC2 localised to the centrioles, 
however super resolution imaging showed that ARMC3 also localised to the 
centrioles, demonstrating the value of super resolution imaging to 
determine if a protein localises to the centrosome. 3D modelling proved 
particularly useful when imaging VWA3A, by demonstrating that the regions 
that looked like co-localisation of VWA3A and gamma tubulin were in 
different planes and therefore not co-localising. Super resolution for 
ARMC3, MYCBPAP, RIBC2, VWA3A and KIAA0586 all showed slightly 
different localisation patterns at the centrioles, with different patterns of co-
localisation with gamma tubulin; these results support specificity of the 
antibodies, including the KIAA0586 antibody and highlight the power of 







Figure 3.16 Super resolution imaging of centrosome protein candidates 
identified in a bioinformatics cilia screen. Centrosome protein candidates, 
ARMC3, MYCBPAP, RIBC2 and VWA3A are in red, gamma tubulin is in green 
and Dapi is in blue. (A, E, I, M) Low resolution imaging of candidate proteins 
suggests that only MYCBPAP and RIBC2 co-localise with gamma tubulin at 
the centrosome. Centrosomes indicated by white arrowheads. (B, F, J, N) 
Super resolution imaging at a low magnification suggests that MYCBPAP, 
RIBC2 and VWA3A co-localise with gamma tubulin at the centrosome. (C, G, 
K, O) Single plane reconstruction at a higher magnification suggests that all 
four candidate centrosome proteins co-localise with gamma tubulin, based 
on regions of overlapping red and green. (D, H, L, P) 3D modelling in Imaris 
demonstrates that ARMC3, has a small region of co-localisation with gamma 
tubulin at the centrioles, MYCBPAP and RIBC2 both show a much broader 
region of co-localisation with gamma tubulin at the centrioles and VWA3A 
does not co-localise with gamma tubulin at the centriole. Instead, VWA3A 





The region of KIAA0586 recognised by the antibody had 51% sequence 
conservation between human and chicken KIAA0586 proteins. Using talpid3 
PGCs as negative controls the antibody showed distribution similar in 
wildtype and talpid3 PGCs, demonstrating that it was not specific in chicken 
cells (Figure 3.17 A and B). This result was not unexpected given the low 
sequence conservation between human and chicken KIAA0586 protein 
sequence at the recognition site of the antibody. 
 
 
Figure 3.17 Anti-KIAA0586 antibody is non-specific for TALPID3 in chicken 
PGCs. (A) Immunofluorescence for TALPID3 (red), gamma tubulin (green) 
and Dapi (blue) shows lack of localisation of TALPID3 to the centrosome in 
wildtype chicken PGCs. (B) Immunofluorescence for TALPID (red), gamma 
tubulin (green) and Dapi (blue) shows lack of localisation of TALPID3 to the 
centrosome in talpid3 chicken PGCs. Although localisation of TALPID3 in the 
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centrosome would not be expected for talpid3 PGCs as there is no TALPID3 
protein, the lack of localisation in the wildtype and similar non-specific red 
staining in both wildtype and talpid3 PGCs suggests that the antibody does 






This study has demonstrated for the first time that human KIAA0586 can 
rescue the gain of function Hedgehog-dependent expression patterns in the 
dorsal neural tube of talpid3 embryos, enabling the identification of 
hypomorphic mutations and increasing the understanding of functional 
domains in KIAA0586. Despite lack of success tagging the endogenous locus 
of chicken TALPID3 with a fluorescent protein tag, this study has used super 
resolution imaging to show that KIAA0586 localises to the distal ends of both 
centrioles with more KIAA0586 localising to one centriole than the other in 
human RPE1 cells. Super resolution imaging was also used to show 
localisation patterns of novel centrosome proteins, identified through a 
screen to identify the human motile cilia associated transcriptional 
signature; combined with the super resolution imaging of TALPID3, this data 
highlights the power of using super resolution imaging to observe different 
centrosome protein localisation patterns. 
Unlike the chicken TALPID3 construct, which was able to rescue both gain of 
function and loss of function phenotypes in the talpid3 neural tube, the 
human KIAA0586 construct was only able to fully rescue gain of function 
phenotypes. Rescue of the Hedgehog-dependent expression pattern in 
talpid3 occurs when a cell takes up the TALPID3/KIAA0586 construct, 
returning the cells ability to form a cilium and thus respond to the Sonic 
Hedgehog gradient extending from the notochord and floorplate. Due to the 
ventral to dorsal gradient of Hedgehog ligand extending from the floorplate 
and notochord, the cells in the dorsal neural tube are acting in the absence 
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of Hedgehog ligand. Therefore following rescue in the dorsal neural tube of 
talpid3, Patched1 (PTCH1) is localised to the cilium, inhibiting the presence 
of Smoothened (SMO) at the cilium and causing processing and truncation 
of Gli proteins to their shortened repressor forms. This leads to the rescue 
of the Pax7 gain of function phenotype, following electroporation with the 
chicken TALPID3 construct and the human KIAA0586 construct. Following 
rescue in the ventral neural tube with chicken TALPID3, Hedgehog ligand 
binds the transmembrane protein PTCH1, allowing translocation of SMO to 
the ciliary membrane, which in turn leads to the translocation of full length 
Gli protein (activator form) to the nucleus. This leads to a rescue of the Islet1 
loss of function phenotype in talpid3. However, electroporation of human 
KIAA0586 is unable to fully rescue this loss of function phenotype, instead 
only showing a small number of cells that express the correct ventral domain 
markers, which suggests a partial rescue. This result suggests that human 
KIAA0586 functions differently during the translocation of SMO to the ciliary 
membrane, which implies that there might be a difference in functionality 
of the domains between chicken and human KIAA0586. 
PTCH1 and SMO do not directly interact, instead there is evidence to suggest 
that PTCH1 controls a SMO-binding compound (Arensdorf  et al., 2016; Chen 
& Struhl, 1998). Therefore it is possible that TALPID3/KIAA0586 plays a role 
in activation of SMO, either by acting on PTCH1 or by acting on a PTCH1-
controlled SMO-binding compound. The region of KIAA0586 responsible for 
this could differ between the chicken and human proteins, which could 
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explain the inability of human KIAA0586 to rescue the loss of function 
phenotype in the ventral neural tube of talpid3.  
Smoothened knockouts (Smo-/-) show a similar phenotype to talpid3 in the 
neural tube. Cells fail to express markers of ventral neuroprogenitor 
populations such as Nkx2.2, Nkx6.1 and Olig2, demonstrating that 
specification of these populations have an absolute requirement for 
Hedgehog signalling (Wijgerde et al., 2002). Based on the knowledge that 
specification of these ventral neuroprogenitor populations requires 
Hedgehog signalling, the small number of cells expressing Islet1, Nkx2.2 and 
Nkx6.1 following electroporation with human KIAA0586 suggests that these 
cells are the result of a partial rescue.  A more recent study has shown that 
endogenous levels of PTCH1 are able to inhibit SMO activity by a non-cell 
autonomous mechanism in nearby cells (Roberts et al., 2016). This could 
explain the unexpected non-cell autonomous result seen in Islet1 and 
Nkx2.2 expression following electroporation with the human KIAA0586 
construct. Additionally this supports a partial rescue of the ventral 
expression domains following electroporation with human KIAA0586. 
Super resolution imaging was used to examine centrosome localisation of 
four candidate proteins with a motile cilia signature as well as localisation of 
TALPID3. Imaging of centrosome proteins following immunofluorescence 
can be a challenging way of looking at localisation due to the size of the 
centrosome. Super resolution imaging provides a more reliable tool to look 
at localisation of proteins in such a small structure when compared to 
confocal imaging. Using confocal microscopy, ARMC3, MYCBPAP, RIBC2, 
150 
 
VWA3A and TALPID3 look very similar with a region of co-localisation with 
gamma tubulin at the centrosome. However, super resolution imaging 
combined with 3D reconstruction of the images provided a more accurate 
visual representation of each of these proteins, demonstrating that each 
protein had a slightly different localisation pattern. 
The establishment of several consortium and databases has been used to 
identify an expanding list of cilia-associated genes/proteins and their 
function (Arnaiz et al., 2009; Nogales-Cadenas et al., 2009; Roepman et al., 
2012). Additionally, studies have also focused their investigations into the 
proteins and genes associated with motile cilia (Blackburn et al., 2017; 
Campbell et al., 2016; Choksi et al., 2014; El Zein et al., 2009; Ostrowski, 
2002); however, the majority of these studies have been conducted in model 
organisms, looking at a specific tissue. These experimental approaches 
capture ciliary components that may be shared with other structures and 
functions out with the cilium. The study used to identify ARMC3, MYCBPAP, 
RIBC2 and VWA3A used a transcriptomic approach from 52 different tissue 
types to identify the motile cilia signature. The primary analysis used in this 
study demonstrates that previous cilia databases do contain genes 
associated with biological functions, non-specific to cilia, thus highlighting 
the importance of this study to capture motile cilia genes conserved across 
tissues (Patir et al., 2019, in preparation). Hence study provides a resource 
that validates and describes putative human motile cilia genes conserved 
across motile ciliated tissues, the roles of which can be further examined 
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Figure 3.18 Annotation of the derived signature genes. Annotation of 
signature motile cilia genes based on their function (italics) or spatial 
localization in the context of cilia. Signature genes with no cilia/centrosomal 
evidence or with no specific function or localization identified in the 
cilia/centrosome have been excluded (Patir et al., 2019, in preparation). 
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3.3.1 Conclusions and future studies 
Having shown that human KIAA0586 can only partially rescue the loss of 
function mutation in the ventral neural tube of talpid3, a future study could 
look at the ability of the human KIAA0586 construct to rescue ciliogenesis in 
cells in the neural tube. This would provide information as to whether 
human KIAA0586 is able to rescue ciliogenesis but is unable to rescue loss of 
function mutations for example through the activity of SMO. Alternatively a 
western blot on tissue taken from the ventral neural tube could be used to 
look at the ratio of full length Gli activator proteins compared to the 
truncated Gli repressor proteins. A higher level of Gli repressor protein in 
the ventral neural tube would support the hypothesis that human KIAA0586 
plays a role not just in ciliogenesis but is also in the PTCH1-mediated control 
of SMO. 
Having demonstrated that talpid3 can be used to model human KIAA0586 
ciliopathy patient mutations, a future study could set up an allelic series of 
mutations to be electroporated into the neural tube and embryos examined 
for Hedgehog-dependent expression changes in both wildtype and talpid3. 
A series of mutations, consisting of those that arise after the potential 
alternative start codon, do not result in premature stop codons to eliminate 
mutations resulting in nonsense-mediated decay and have more severe or 
different phenotypes associated with the patients could be modelled in 
talpid3 to gain a better understanding of what functional domains are lost or 
compromised in these patients to cause their symptoms (Figure 3.19). By 
analysing rescue of Hedgehog-dependent expression patterns in the neural 
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tube of talpid3 embryos, hypomorphic mutations could be identified, which 
could help provide a unique insight into the potential functional domains at 
the C-terminal. Additionally the single heterozygous deleterious mutations 
that are found towards the C-terminal of KIAA0586 (Bachmann-Gagescu et 
al., 2015) could be modelled as part of the allelic series; as single 
heterozygous mutations, these mutations in particular c.3614G>A, 
p.W1205* which is found in the predicted intrinsically disordered domain, 
could provide an understanding of the domains required for function at the 




Figure 3.19 Human KIAA0586 ciliopathy patient mutations, marked by dark blue asterisk, that could be included in a future study aimed at 
modelling an allelic series in talpid3. The schematic represents the human KIAA0586 protein. The dark blue asterisks identify mutations that could 
be included in an allelic series to be modelled in the talpid3 flock. Black vertical lines along the protein indicate exon boundaries. Purple boxes mark 
coiled-coil domains in the protein, the light blue asterisk indicates the conserved coiled-coil domain that is essential for function and the yellow box 
indicates the predicted intrinsically disordered domain. Red horizontal lines indicate mutations that cause premature stop codons. Grey horizontal 
lines indicate splice variant mutations and green horizontal lines indicate single heterozygous deleterious mutations. The pink asterisk indicates the 




Chapter 4. Identifying centrosome proteins 
through proteomic approaches in human 
Jurkat cells and chicken Primordial Germ 
Cells 
                  
4.1 Introduction 
Previous centrosome proteomic studies have used non-ciliated human KE37 
cells to uncover novel proteins. The following chapter explores ways to apply 
centrosome proteome studies to alternative cell lines not usually used in the 
field of centrosome and cilia studies, thus identifying cell models for future 
centrosome studies and uncovering novel centrosome proteins. 
 
4.1.1 Isolation of Centrosomes 
A protocol for isolating centrosomes was first described in 1984 to study 
microtubule nucleation and stabilisation. Sucrose gradient sedimentation 
was used to isolate centrosomes from N115 Neuroblastoma cells and 
Chinese Hamster Ovary (CHO) cells (Mitchison & Kirschner, 1984). N115 
cells, a loosely adherent cell line, gave a good yield of centrosomes but were 
heterogeneous in size with one to ten centrioles per cell. For this reason, 
CHO cells, an adherent cell line, were used due to their homogenous 
centrosomes and well-characterised centriole cycle (Mitchison & Kirschner, 
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1984). The following adaptations were made to correct for the difference in 
adherence: washes were carried out on the plate, instead of via 
centrifugation; an extra lysis buffer wash was added; the plates were 
incubated on a shaker to loosen the cells; 50x PE buffer was added to the 
lysate containing centrosomes and a low spread spin was carried out to 
remove chromatin instead of the filtration step.  
This sucrose gradient sedimentation protocol was then adapted for the 
isolation of centrosomes from human KE37 cells to look in more detail at the 
components of the centrosome and the structural features that allow 
centrioles to associate within the centrosome (Bornens et al.,  1987). The 
main modifications to the protocol involved the lysis steps and the 
centrosome purification procedure (Bornens et al., 1987). Mitchison and 
Kirschner treated the cells with the microtubule and microfilament 
dissociation drugs, Nocodazol and Cytochalasin, prior to lysis to prevent 
association of microtubules with the centrosome during isolation (Mitchison 
& Kirschner, 1984); Bornens et al. used these dissociation drugs at lower 
concentrations to avoid splitting of centrosomes and disruption of the 
pericentriolar material. Antiproteases, including Aprotinin, Leupeptin, 
Pepstatin and PMSF were included in the lysis buffer to inhibit proteolysis of 
pericentriolar material. A low Mg2+ concentration prevented excessive 
swelling of nuclei and DNAse treatment was added to prevent 
contamination with residual chromatin (Bornens et al., 1987). The original 
protocol used a Ficoll cushion to concentrate the centrosomes prior to 
sucrose gradient centrifugation, but this step was excluded due to loss of 
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centrosomes. Exclusion of the Ficoll cushion and instead using direct 
sedimentation onto a sucrose gradient took the yield of centrosomes to 60% 
in comparison to 15-20% when the Ficoll cushion was used (Bornens et al., 
1987). In conclusion, the adaptations described were carried out to ensure 
a higher yield of intact centrosomes from cells in suspension, suggesting that 
this protocol could be used to produce a high yield of isolated centrosomes 
from a wide range of different cell types in suspension. 
Following the adaptations described above, the protocol to isolate 
centrosomes from KE37 cells has been successfully used to identify and 
study proteins in the human centrosome (Andersen et al., 2003; Bauer et al., 
2016; Jakobsen et al., 2011). KE37 cells, an immortalised T lymphoblast cell 
line, were chosen for centrosome isolation because they grow in suspension 
and they have a low cytoplasmic to nuclear ratio (Bornens et al., 1987). They 
are an immortalised T cell line taken from acute lymphoblastic leukaemia 
cells, suggesting that they do not provide a representative model of what 
normally happens in healthy human cells (Burger et al., 1999). Immortalised 
cell lines may not be the most relevant models for studying disease (Horvath 
et al., 2016; Masters & Stacey, 2007) demonstrating the need for more 
physiologically relevant cell lines. In addition, T-cells are non-ciliated cells 
that form an immune synapse instead of a cilia (Finetti et al., 2009). The key 
role of the centrosome in ciliogenesis, highlights a need for centrosome 
proteomic studies to be carried out in a ciliated cell line. Although adapted 
for KE37 cells, this protocol could be used to isolate centrosomes from 
alternative non-adherent cells lines, providing a more versatile approach to 
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identifying centrosome proteins from different types of cells as well as 
different model organisms. 
 
4.1.2 Centrosome Proteome Studies in KE37 Cells 
The established centrosome isolation protocol in KE37 cells, was first used 
in combination with Mass Spectrometry based proteomics to determine the 
complex protein composition within the centrosome (Andersen et al., 2003). 
At the time of this study, there were approximately 60 proteins known to be 
associated with the centrosome; by using mass spectrometry on isolated 
centrosomes, Andersen et al. identified 47 of the 60 known centrosome 
proteins as well as a further 90 uncharacterised proteins. 32 of the 90 
uncharacterised proteins were cloned and 19 of the 32 were confirmed as 
centrosomal by immunofluorescence (Andersen et al., 2003). In a second 
attempt to identify centrosome proteins from their mass spectrometry 
dataset, the group tracked relative abundance of peptides through five 
sucrose gradient fractions. This method of quantitation was based on 
relative amounts of the same peptide as opposed to absolute quantitation 
(Andersen et al., 2003).  
Despite a large coverage, several known proteins were not detected; this 
was attributed to low abundance of the proteins, loss during purification or 
because the components did not associate with the centrosome to a 
significant degree under the conditions of the experiment (Andersen et al., 
2003). This study also demonstrated that a high proportion of centrosome 
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proteins (75%) contained coiled-coil domains, an observation that has 
remained consistent in subsequent studies (Andersen et al., 2003; Bauer et 
al., 2016; Jakobsen et al., 2011). An additional study using centrosomes 
isolated from KE37 cells aimed to examine the dynamic composition and 
localisation of the centrosome proteome through a ‘Mass Spectrometry-
screen’ combined with an ‘HPA-screen’ (Jakobsen et al., 2011). This method 
allowed identification of centrosome proteins in centrosome isolates, 
followed by validation through localisation studies using antibodies from the 
Human Protein Atlas (HPA)  (Barbe et al., 2008). Jakobsen et al. also 
incorporated SILAC (stable isotope labelling with amino acids in cell culture) 
into their mass spectrometry screen, providing an accurate way of 
quantifying the abundance of proteins in the centrosome isolates (Jakobsen 
et al., 2011). Previously, abundance of peptides across five fractions 
(Andersen et al., 2003) had allowed for the relative amount of the same 
peptide to be determined, providing a means of distinguishing between 
centrosomal proteins and nonspecific proteins based on the difference in 
peptide elution profiles between the two categories. The new approach 
using SILAC labelling (Jakobsen et al., 2011) increased the accuracy of 
protein quantitation in comparison to the relative abundance method. A 
further quantitative proteomics approach using selected reaction 
monitoring (SRM) and EGFP-tagging of endogenous proteins allowed high 
specificity detection of defined proteins in a complex mixture and 
quantification at a specific subcellular location through fluorescent signal 
quantification (Bauer et al., 2016). The study highlighted the challenges of 
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studying proteomes where the proteins are expressed at low levels, such as 
in the centrosome. The selected reaction monitoring approach combined 
with EGFP-tagging, was designed to overcome the complication that comes 
with trying to quantify proteins that are expressed at low levels, thus better 
understanding centriole regulation and duplication under physiological 
conditions (Bauer et al., 2016). This approach was more successful for 
absolute quantitation of specific low-abundance proteins within the 
centrosome when compared to previous quantitative studies (Andersen et 
al., 2003; Jakobsen et al., 2011), however, there were limitations. The main 
limitations included the inability to monitor proteins through the cell cycle 
because of technical mass spectrometry constraints and complications 
during fluorescence quantification due to photo bleaching and the 
possibility that the fluorescent tag might interfere with protein function. 
Importantly this quantitative proteomics approach could not be used to 
identify novel centrosome proteins due to the need to target specific, 
previously identified proteins in the centrosome (Bauer et al., 2016). 
In summary, isolation of centrosomes combined with mass spectrometry 
has accelerated our understanding of the centrosome network, providing a 
tool for identifying novel centrosome proteins, studying protein interactions 
within the centrosome and quantifying centrosome protein abundance in 
human KE37 cells (Andersen et al., 2003; Bauer et al., 2016; Jakobsen et al., 
2011). The distinct protein datasets produced following different mass 
spectrometry approaches highlights the need to identify a mass 
spectrometry approach that addresses the type of data relevant for the 
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study, whether protein identification, relative abundance or absolute 
quantification.  
 
4.1.3 Cell lines for cilia and centrosome studies 
To address the concerns that cell models that are incapable of making cilia 
and are not relevant to healthy conditions are being studied, I wanted to 
develop an approach to study centrosome proteins in alternative cell lines. 
Additionally, it was important to identify a cell line that could be used to 
study the TALPID3 protein interacting network. Human RPE1 cells and 
human Jurkat cells were included alongside chicken Primordial Germ Cells 
(PGCs). The human RPE1 cell line is an immortalised, ciliated cell line that is 
commonly used for studying the centrosome and cilia (Spalluto et al., 2013). 
RPE1 cells have been well characterised in the centrosome and cilia field 
through protein localisation and gene editing studies (Bauer et al., 2016; 
Jakobsen et al., 2011; Kobayashi et al., 2014; Prosser & Morrison, 2015), 
therefore can act as a good benchmark for the Jurkat cells and chicken PGCs.  
Jurkat cells, a human T-lymphocyte cell line, have not previously been used 
to carry out proteomic studies in the centrosome. Like KE37 cells, they are 
classed as T cells and both lines are derived from acute lymphoblastic 
leukaemia cells, making them the malignant version of their healthy T cell 
counterparts (Burger et al., 1999). Despite some differences in receptor 
expression between Jurkat cells and KE37 cells (Burger et al., 1999), Jurkat 
cells were included in this study because they have similar origins and 
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characteristics to KE37 cells (Orkin & Zon, 2008; Rothenberg, 2007). Chicken 
PGCs are a primary cell line that can easily be derived and cultured (Lavoir 
et al., 2006; Macdonald et al., 2010), meaning they can be derived from the 
talpid3 flock. As a pluripotent cell line, PGCs are suitable for addressing 
concerns about completing studies in a cell line that are more likely to mimic 
healthy physiological conditions (Park & Han, 2000). Moreover the chicken 
is a good model for studying human cranio-facial ciliopathies as shown 
through the talpid2 and talpid3 mutant lines (Schock et al., 2016), supporting 
the need for a chicken cell line that is suitable for studying the centrosome 
proteome. In conclusion, the study described in this chapter was completed 
on human Jurkat cells and chicken PGCs, with human RPE1 cells included as 
a benchmark where relevant.  
 
4.1.4 Aims 
To date, proteomic analysis of the centrosome has been carried out in KE37 
cells, a non-ciliated, immortalised human cell line (Andersen et al., 2003; 
Bauer et al., 2016; Jakobsen et al., 2011). In order to investigate the use of 
centrosome isolation to determine the centrosome proteome in alternative 
cell lines, the study described in this chapter uses a non-quantitative 
discovery mass spectrometry approach on cell lines that have not been 
established in the centrosome and cilia field. The aim of this study was to 
identify alternative cell lines for centrosome studies and use a discovery 
mass spectrometry proteomic approach on centrosomes generated from 
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these cell lines to identify the differences in the centrosome proteome 
composition. The inclusion of chicken PGCs aimed to provide a cell model 
that mimicked healthy physiological conditions, while also providing a tool 







4.2.1 Frequency of ciliogenesis in RPE1 cells, Jurkat cells and 
PGCs. 
In order to undertake centrosome proteome studies in cells that are capable 
of forming primary cilia, I first established if human Jurkat cells and chicken 
PGCs are capable of forming cilia. I used non-adherent cells because this has 
been shown to generate higher yields of centrosomes following centrosome 
isolation (Bornens et al., 1987). Immunofluorescence was used to examine 
ciliary axoneme marker acetylated tubulin and ciliary membrane marker 
Arl13B in RPE1 cells, Jurkat cells and PGCs (Figure 4.1 A-F). Following serum 
starvation, acetylated tubulin and Arl13B marked cilia in all three cell lines, 
demonstrating that all three cell lines all capable of forming cilia, when given 
ciliogenesis-inducing conditions in cell culture. Despite demonstrating the 
capability of ciliogenesis in Jurkat cells and PGCs, ciliogenesis frequency in 
Jurkat cells was found to be low. Following serum starvation, 79% of RPE1 
cells (n = 200) were ciliated and 70% of PGCs (n=90) were ciliated, however, 
only 8.5% of Jurkat cells (n = 200) were ciliated (Figure 4.1 G). In conclusion, 
these results suggest that PGCs are a ciliated cell line and that Jurkat cells 




Figure 4.1 Frequency of ciliogenesis in RPE1 cells, Jurkat cells and PGCs. (A-
F) Immunostaining with Gamma tubulin (green) to mark the centrosome, 
Acetylated tubulin (red) to mark the ciliary axoneme or Arl13B (red) to mark 
the ciliary membrane and Dapi (blue) to mark the nucleus. White 
arrowheads indicate a cilium, showing that RPE1 cells, Jurkat cells and PGCs 
are capable of forming cilia, with both a ciliary axoneme and ciliary 
membrane. (G) Percent of ciliated cells for each cell line shows, 8.5% of 
Jurkat cells are ciliated, 70% of PGCs are ciliated and 79% of RPE1 cells are 




4.2.2 PGCs have centrosome protein localisation patterns that 
correlate with the ability to form cilia. Jurkat cells have altered 
centrosome protein localisation patterns associated with 
reduced ciliogenesis.  
In order to understand if reduced frequency of ciliogenesis in Jurkat cells was 
due to loss of basal body maturation, immunofluorescence was completed 
for centrosome proteins. Centrosomes modified to basal bodies have key 
markers such as Cep164, PCM1, CP110 and MACF1. Without these proteins 
localising to the distal end of the centrioles (Graser et al., 2007; May-Simera 
et al., 2016; Spektor et al., 2007) or in the Pericentriolar Material (Balczon et 
al., 1994), ciliogenesis does not occur. 
Cep164 is a distal appendage protein that localises specifically to the distal 
end of the mother centriole (Graser et al., 2007). In RPE1 cells and PGCs, 
Cep164 localised to only one of the centrioles as expected, however in Jurkat 
cells Cep164 consistently localised to both mother and daughter centrioles 
(Figure 4.2 A, E, I). CP110 localises to the distal ends of centrioles and is 
removed from the mother centriole prior to ciliogenesis (Spektor et al., 
2007). In RPE1 cells and PGCs, CP110 localised to the distal end of either one 
or both of the centrioles as expected (Figure 4.2 B, J). However, Jurkat cells 
consistently showed excess CP110 staining within both centrioles, as well as 
around the edges of the centrioles usually marked as pericentriolar material 
(Figure 4.2 F). PCM1 is a component of the centriolar satellites (Balczon et 
al., 1994). In all three cell lines, it was localised in a scattered pattern around 
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the centrioles. There was also co-localisation of PCM1 with gamma tubulin 
in the centrioles in Jurkat cells, unlike the RPE1 cells and PGCs (Figure 4.2 C, 
G, K). Microtubule Actin Cross-linking Factor 1 (MACF1) localises to the distal 
end of the basal body (May-Simera et al., 2016). This expected pattern of 
MACF1 localisation was seen in RPE1 cells and PGCs, however in the Jurkat 
cells, MACF1 localised to both centrioles (Figure 4.2 D, H, L).  
In order for ciliogenesis to occur, the centriole must migrate to the 
membrane where the distal appendages play a role in docking. The centriole 
becomes the modified basal body and distal appendages become transition 
fibres, following which the IFT (intraflagellar transport) system controls 
extension of the cilia from the basal body (Avasthi & Marshall, 2012; Dawe 
et al., 2007). The presence of Cep164 on both centrioles in Jurkat cells 
suggests that both centrioles contain modifications that are usually only 
associated with the mother centriole, and therefore the reduction in 
ciliogenesis could be due to the inability to distinguish between mother and 
daughter centriole. The accumulation of CP110 and PCM1 around the 
centrosome in Jurkat cells is similar to abnormal localisation patterns seen 
in some ciliopathies. For example, a similar localisation pattern presents in 
RPE1 cells with reduced levels of TALPID3; loss of TALPID3 results in 
accumulation of Cep290 and PCM1 around the centrosome (Kobayashi et 
al., 2014). PGCs are ciliated cells that have localisation patterns of Cep164, 
CP110, PCM1 and MACF1 that correlate with their ability to form cilia. In 
conclusion, these results suggest that RPE1 cells and PGCs have modification 
of centrioles that correlate with their ability to form cilia; Jurkat cells 
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Figure 4.2 RPE1 cells and PGCs have centrosome protein localisation patterns that correlate with the ability to form cilia. Jurkat cells have altered 
centrosome protein localisation patterns associated with ciliogenesis. (A - L) Immunostaining with antibodies against Gamma Tubulin (green) for 
the centrioles, Cep164, CP110, PCM1 or MACF1 (red) and Dapi (blue) for the nucleus. A white asterisk marks the mother centriole where protein 
markers distinguish between mother and daughter centriole. (M-O) Schematic to show observed localisation patterns of Cep164 (blue), CP110 
(purple), PCM1 (orange) and MACF1 (red) in RPE1 cells, Jurkat cells and PGCs respectively. The observed localisation patterns of Cep164, CP110, 
PCM1 and MACF1 in Jurkat cells was different to RPE1 cells and PGCs, suggesting that altered centrosome protein localisation in Jurkat cells may be 





4.2.3 Isolation and validation of centrosome proteins in Jurkat 
cell samples and PGC samples 
In order to complete centrosome studies in alternative cell lines, the 
protocol used to isolate centrosomes from non-adherent KE37 cells 
(Andersen et al., 2003; Jakobsen et al., 2011) was applied to the non-
adherent human Jurkat cells and chicken PGCs. RPE1 cells were excluded 
from the proteomic analysis as they are an adherent cell line and thus not 
suitable for centrosome isolation using this protocol. Centrosomes were 
isolated from Jurkat cells and PGCs using centrifugation through a 
discontinuous sucrose gradient (Figure 4.3). By using cell lines that are not 
typically used for centrosome and cilia studies, I aimed to uncover 
differences in centrosome protein composition. Having demonstrated that 
PGCs are a ciliated cell line with centrosome localisation patterns that 
correlate with their ability to form cilia, I intended to direct centrosome 
proteome network studies towards conditions that are more physiologically 
relevant to healthy conditions. Inclusion of PGCs would also provide a means 
to carry out proteomic studies aimed at uncovering the TALPID3 protein 





Figure 4.3 Schematic of protocol used to isolate centrosomes from human 




To confirm the presence of protein following the centrosome isolation 
protocol, the amount of protein was quantified in the Jurkat and PGC protein 
samples. There was 0.7 – 1.1 μg/μl of protein in the Jurkat centrosome 
protein samples, whereas the PGC centrosome protein sample only 
contained 0.53 μg/μl. The reduced amount of protein in the PGC protein 
sample compared to the Jurkat protein sample suggested that the protocol 
was not as efficient in PGCs as it was in Jurkat cells.  
To confirm enrichment of proteins associated with the centrosome, I  
undertook a Western Blot for gamma tubulin (Figure 4.4 A), a key 
component of the pericentriolar material as well as the core of the centrioles 
(Fuller et al., 1995). Relative quantification of the bands showed a 3.26 fold 
increase of gamma tubulin in the Jurkat centrosome sample compared to 
the Jurkat whole cell sample (Figure 4.4 B), suggesting that the centrosome 
isolation protocol was successful in the Jurkat cells. A loading control was 
not included in this Western blot and could not be repeated due to the low 
protein concentration in the sample. A loading control would have 
confirmed that the protein loading was the same across the gel; without this 
control it cannot be conclusively stated that the loading was the same across 
the gel and therefore the quantification may not be exact. Due to the low 
concentration of protein in the PGC centrosome sample, there was not 
enough protein to complete a Western Blot. A starting number of 
approximately 1 x 109 cells was needed for isolating centrosomes from 
Jurkat cells and PGCs. Due to the specific requirements and expenses 
associated with chicken PGC culture conditions (Whyte et al., 2015), it was 
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not possible to repeat the centrosome isolation in PGCs to produce more 
protein.  
In order to identify centrosome proteome differences in human Jurkat cells 
compared to chicken PGCs, discovery shotgun mass spectrometry was 
undertaken on the Jurkat centrosome protein samples and the PGC 
centrosome protein sample, despite the low protein content in the PGC 
centrosome sample. Protein lists generated from mass spectrometry were 
analysed in the Database for Annotation, Visualisation and Integrated 
Discovery (DAVID) for associated centrosome function through Gene 
Onotology (GO) terms associated with the proteins. In the Jurkat 
centrosome sample, GO term clusters associated with the cytoskeleton, 
microtubules and actin (Figure 4.4 C), which are families largely associated 
with the centrosome interactome (Amato et al., 2014). Unlike the Jurkat 
centrosome sample, GO term clusters associated with the PGC centrosome 
sample did not show signs of enrichment for families associated with the 
cytoskeleton, microtubules or actin (Figure 4.4 D). This analysis failed to 
show enrichment by GO term association for protein families associated 
with the centrosome interactome (Amato et al., 2014) in the PGC sample. 
The scores associated with the GO terms identified in the PGC sample were 
low, suggesting there was no specific enrichment within the samples (Figure 
4.4 D). In conclusion, the centrosome isolation protocol yielded a protein 
sample from the Jurkat cells that suggested enrichment of centrosome 
proteins by GO term association, but a low yield of protein in the PGCs that 




Figure 4.4 Validation of centrosome enrichment in Jurkat cells and GO term 
analysis in Jurkat and PGC centrosome protein samples. (A) Western Blot 
analysis for gamma tubulin, showing a brighter band in the Jurkat 
centrosome protein sample compared to the Jurkat whole cell protein 
sample and controls. Blue arrow marks gamma tubulin band at 48 kDa. (B) 
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Table to show relative quantification of bands in Western Blot. A 3.26 fold 
increase of band intensity in Jurkat centrosome sample compared to Jurkat 
whole cell sample supports enrichment for centrosome proteins. (C) Top 9 
clusters by GO Term, identified in DAVID Functional Cluster Analysis for 
Jurkat Centrosome Sample suggest proteins belong to families largely 
associated with the centrosome. (D) Top 9 clusters by GO Term, identified in 
DAVID Functional Cluster Analysis for PGC Centrosome Sample demonstrate 
lack of enrichment for protein families associated with the centrosome and 
low enrichment scores. 
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To determine the relative efficiency of the centrosome isolation protocol 
completed in the Jurkat cells and the PGCs, proteins from the Jurkat 
centrosome sample were compared to proteins identified in the KE37 
centrosome dataset (Andersen et al., 2003). In addition, proteins from both 
the Jurkat centrosome sample and the PGC centrosome sample were 
compared to all currently known centrosome and cilia proteins found in the 
CCDB protein dataset (1554) (Gupta et al., 2015). There were 88 proteins 
overlapping across the two datasets when Jurkat centrosome proteins were 
compared to the KE37 proteomic dataset (Andersen et al., 2003), by 
accession number (Figure 4.5 A). Comparison of the Jurkat centrosome 
protein sample and the PGC centrosome protein sample to CCDB showed an 
overlap of 142 proteins (Figure 4.5 B) (Appendix 2) and 139 proteins (Figure 
4.5 C) (Appendix 3) respectively. There were 76 CCDB proteins that were 
common to both the Jurkat proteins and the PGC proteins (Appendix 4). The 
76 overlapping centrosome proteins may be higher abundance proteins in 
comparison to the other centrosome proteins identified; this conclusion is 
supported by the lack of any these proteins in the list of low abundance 
centrosome proteins, which was published while this study was being 
completed (Bauer et al., 2016). 
The overlap of proteins from the Jurkat dataset with the Andersen dataset 
and CCDB supports enrichment of centrosome proteins. Of the 72 low 
abundance centrosome proteins (Bauer et al., 2016), only CCDC77, CETN2, 
NEDD1 and POC5 were identified in the Jurkat centrosome protein sample, 
suggesting that the centrosome proteins identified are high abundance 
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centrosome proteins. The non-overlapping protein identifications suggest 
that there are likely to be more centrosome interactome proteins that have 
not yet been identified. Based on the GO terms from the DAVID cluster 
analysis, there is evidence of some mitochondrion contamination, which 
could also account for some of the non-overlapping proteins.  
In conclusion, the Jurkat centrosome sample showed enrichment for 
centrosome proteins allowing protein candidates to be taken forward for 
further analysis. The overlap of PGC centrosome proteins with CCDB showed 
that there was centrosome enrichment in the PGCs, however there were no 
low abundance proteins (Bauer et al., 2016) identified in the PGC 
centrosome sample, suggesting that despite centrosome enrichment the 
protocol was not as efficient in PGCs as in Jurkat cells. The low protein yield 
and lack of evidence to suggest centrosome enrichment based on the GO 
term analysis resulted in the decision not to take any PGC proteins forward 






Figure 4.5 Comparison of Jurkat and PGC centrosome protein datasets to 
known centrosome and cilia proteins. (A) Comparison of the Jurkat 
centrosome sample to the Andersen centrosome dataset by accession 
number shows an overlap of 88 proteins, suggesting there are centrosome 
proteins in the Jurkat sample and that this method of centrosome isolation 
is also applicable to Jurkat cells. (B) Comparison of CCDB proteins to the 
Jurkat centrosome proteins shows an overlap of 142 proteins, confirming 
that there are centrosome proteins in the Jurkat sample. (C) Comparison of 
CCDB proteins to the PGC centrosome proteins shows an overlap of 139 
proteins, showing there are centrosome proteins in the PGC sample. 
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Both the Jurkat centrosome protein dataset and the PGC centrosome 
protein dataset were examined for the presence of TALPID3. TALPID3 was 
not identified in either dataset, leading to the conclusion that centrosome 
isolation in cell lines is not a feasible way to study the TALPID3 protein 
interacting network. It has since been suggested that TALPID3 is one of a 
number of proteins expressed at very low levels in the centrosome and 
therefore challenging to identify through mass spectrometry (Bauer et al., 
2016), which could explain the lack of TALPID3 identification in the Jurkat 
centrosome or the PGC centrosome dataset. In conclusion, studying the 
TALPID3 proteome through isolation of centrosomes in PGCs is not possible 
and identification of an alternative approach to study the TALPID3 proteome 
is necessary.  
 
4.2.4 Identification of novel centrosome protein candidates 
from the Jurkat centrosome dataset 
Having shown that the Jurkat centrosome sample was enriched for proteins 
associated with the centrosome, a set of parameters (Table 4.1) was applied 
to the proteins in order to investigate differences in centrosome protein 
composition and identify novel centrosome proteins. The parameters were 
designed to include proteins with characteristics similar to those associated 
with centrosome and cilia proteins. Microtubules and actin filaments make 
up the cytoskeleton network, which is responsible for intracellular 
architecture and cell polarity. The centrosome nucleates and anchors 
microtubules and can directly promote actin-filament assembly (Farina et 
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al., 2016). Additionally Rho GTPases play a role in actin cytoskeleton 
organisation, particularly during cell movement when the centrosome 
orientates towards the leading edge of the cell  (Sit & Manser, 2011; 
Wittmann & Waterman-Storer, 2001), therefore parameters for taking 
proteins forward included Rho GTPases, cytoskeletal, actin-related, cell 
migration or movement and polarity. Centrioles duplicate once during the 
cell cycle, and their role in forming primary cilia is linked to the cycling of 
cells (Nigg & Stearns, 2011), therefore association with the cell cycle was 
included in the parameters to take forward. Coiled-coil domains are a 
structural feature found in many centrosome proteins (Andersen et al., 
2003), therefore presence of one or more coiled-coil domains was also 
included in the parameters to take forward (Table 4.1). 
Proteins with properties or functions that are unlikely to be associated with 
the centrosome were excluded from further analysis. Proteins that have 
already been shown to localise to and function in distinct structures, such as 
ribosomes or mitochondria, are unlikely to overlap with the centrosome and 
were therefore excluded. ATPase family proteins are classified by a 
conserved module that promotes ATP hydrolysis and are usually involved in 
molecular remodelling events. Although the dynein heavy chain proteins, 
found in cilia, are part of the ATPase family (Snider et al., 2008), these 
proteins have already been well characterised; therefore, ATPase family 
proteins were excluded. Heat shock proteins are a ubiquitous family of 
proteins, produced in response to non-lethal stress such as heat, ethanol, 
nicotine, surgical stress and viral agents to name a few. These proteins play 
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a critical role in cellular homeostasis through cell death and disease 
processes (Whitley et al., 1999), therefore are unlikely to be produced in 
healthy conditions in the centrosome and were excluded. Apoptosis, or 
programmed cell death, is controlled by a specific series of signals, therefore 
production of apoptosis proteins will result in cell death (Papaliagkas et al., 
2007) and were not a group of proteins that would be associated with the 
centrosome in healthy cells. DNA-damage proteins are produced in response 
to the cell sensing a break in the DNA and interrupt the cell cycle (Polo & 
Jackson, 2011). Similar to apoptosis-related proteins, the DNA-damage 
proteins would be expressed in situations where the cell may be unhealthy 
due to DNA-damage, and were therefore excluded (Table 4.1). 
I applied these parameters to Jurkat centrosome protein dataset 1 and 
Jurkat centrosome protein dataset 2 (datasets described in Chapter 2, 
section 2.4.2) to produce a list of proteins for further analysis (Appendix 5 
and Appendix 6). Following application of parameters to the datasets, 
proteins that had previously been validated for specific functions or protein 
networks including but not limited to the centrosome proteome were 
excluded from further analysis as they were already well characterised. This 
resulted in the identification of two novel centrosome protein candidates 




Table 4.1 Parameters applied to the Jurkat centrosome protein mass 
spectrometry dataset to determine which proteins should be carried 
forward for further analysis. 
Carry Forward Exclude from further analysis 
Rho GTPase Association Mitochondrial 
Cytoskeletal Ribosomal 
Actin-related ATPase family 
Cell movement and/or migration Apoptosis-related 
Polarity DNA damage-related 
Cell Cycle Heat shock proteins 
Containing coiled-coil domain(s)  
 
 
CCDC77 (POC11 in Chlamydomonas) has previously been identified in a 
screen for centrosome proteins (Jakobsen et al., 2011) but at the time was 
not validated or further investigated. In contrast, CCDC127 is a novel protein 
that has not previously been identified in centrosome or cilia screens. Both 
CCDC77 and CCDC127 contain coiled-coil domains in their structure, a 
common feature shared in many centrosome proteins (Andersen et al., 
2003; Bauer et al., 2016; Jakobsen et al., 2011). 
Examination of the Human Protein Atlas (HPA) and the Allen Mouse Brain 
Atlas demonstrated localisation patterns of CCDC77 and CCDC127 in tissue 
sections that contained multi-ciliated cells, such as fallopian tube, brain 
tissue, lung tissue and the choroid plexus (Barbe et al., 2008; Lein et al., 
2007). CCDC77 showed higher levels of expression along the apical edge of 
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multi-ciliated tissues, consistent with a region containing a higher 
concentration of centrosomes (Figure 4.6 A). CCDC127 also showed higher 
expression levels along the apical edge of cells; in addition CCDC127 showed 
signs of expression in the motile cilia in the fallopian tube (Figure 4.6 B) 
(Barbe et al., 2008) and in the choroid plexus of the mouse brain (Figure 4.6 
C, D) (Lein et al., 2007). CCDC127 also showed high levels of expression along 
the edge of the cerebellum and the  hippocampus in the mouse brain (Figure 
4.6 E, F) (Lein et al., 2007). In conclusion, evidence from HPA and the Allen 
Mouse Brain Atlas, suggests that CCDC77 and CCDC127 are expressed in 
regions of tissue associated with centrosomes and cilia, therefore 




Figure 4.6 Immunohistochemistry from the Human Protein Atlas and RNA 
in situ hybridisation from the Allen Mouse Brain Atlas showing CCDC77 and 
CCDC127 in regions of tissue containing centrosomes and cilia. (A) 
Immunohistochemistry for an antibody against CCDC77 in the fallopian tube 
shows localisation to the apical edges of cells where a higher concentration 
of centrosomes is found, indicated by black arrowheads. (B) 
Immunohistochemistry for an antibody against CCDC127 in the fallopian 
tube shows localisation to the apical edges of the cells and in the motile cilia 
lining the fallopian tube, indicated by black arrowheads. (C) RNA in situ 
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hybridisation for CCDC77 shows expression in the choroid plexus in the 
mouse brain. (D) The expression levels for CCDC77 show the cells that have 
the highest probability of gene expression using a heat colour scale (from 
low/blue to high/red) in the choroid plexus. (E) RNA in situ hybridisation for 
CCDC127 shows expression in the choroid plexus and around the edge of the 
cerebellum in the mouse brain (F) The expression levels for CCDC127 show 
the cells that have the highest probability of gene expression using a heat 
colour scale (from low/blue to high/red) in the choroid plexus and 
cerebellum. Images from A and B are adapted from the Human Protein Atlas 
(Barbe et al., 2008). Images from C-F are adapted from the Allen Mouse Brain 
Atlas (Lein et al., 2007). 
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4.2.5 CCDC77 and CCDC127 localise to the centrosome in Jurkat 
cells and RPE1 cells 
To determine if CCDC77 and CCDC127 localise to the centrosome, 
immunofluorescence was used to examine protein localisation in Jurkat cells 
and RPE1 cells. In both cell lines, CCDC77 and CCDC127 co-localised with 
gamma tubulin in the centrosome. In Jurkat cells, CCDC77 localised to the 
centrosome, showing excess localisation patterns around the centrioles in 
addition to co-localising with gamma tubulin on both centrioles (Figure 4.7 
A). However, in RPE1 cells, CCDC77 predominantly co-localised with gamma 
tubulin on only one centriole (Figure 4.7 C). In Jurkat cells, CCDC127 co-
localised with gamma tubulin across both centrioles as well as additional 
localisation around the perimeter of the centrioles (Figure 4.7 B). However, 
in RPE1 cells, CCDC127 predominantly co-localised with a small region of 
gamma tubulin on one centriole (Figure 4.7 D). These results show that 
CCDC77 and CCDC127 localise to the centrosome in Jurkat cells and RPE1 
cells. The differences in the pattern of localisation seen between the cell 
lines was expected, consistent with altered centrosome protein localisation 
patterns seen previously when analysing Cep164, CP110, PCM1 and MACF1 





Figure 4.7 CCDC77 and CCDC127 localise to the centrosome in Jurkat cells 
and RPE1 cells. (A and C) Immunostaining with gamma tubulin (green), 
CCDC77 (red) and Dapi (blue) shows co-localisation of CCDC77 and gamma 
tubulin in the centrosome. White arrowhead marks the centriole where 
CCDC77 co-localises with gamma tubulin in RPE1 cells. Differences in 
localisation patterns of CCDC77 between Jurkat cells and RPE1 cells are 
observed. (B and D) Immunostaining with gamma tubulin (green), CCDC127 
(red) and Dapi (blue) shows co-localisation of CCDC127 and gamma tubulin 
in the centrosome. White arrowhead marks the centriole where CCDC127 
co-localises with gamma tubulin in RPE1 cells. Differences in localisation 
patterns of CCDC127 between Jurkat cells and RPE1 cells are observed. All 




To follow up localisation of CCDC77 and CCDC127 at the centrosome, super-
resolution imaging was completed in RPE1 cells to identify specific regions 
of localisation of CCDC77 and CCDC127 in the centrioles. Results from 
structural illumination microscopy confirmed localisation of CCDC77 to both 
centrioles, with multiple points of co-localisation with gamma tubulin 
(Figure 4.8 A-C). Structural illumination microscopy showed localisation of 
CCDC127 to only one centriole, with two regions of CCDC127 co-localisation 
with gamma tubulin within the centriole (Figure 4.8 D-F). Western blot 
analysis using these antibodies was attempted, however the antibodies did 
not work in western blot (Appendix 7) and therefore could not be confirmed 
by western blot in the Jurkat centrosome protein samples. In conclusion, 
localisation studies using confocal imaging and super-resolution imaging 
produced corresponding results, demonstrating that CCDC77 and CCDC127 





Figure 4.8 Super-resolution imaging of CCDC77 and CCDC127 shows 
localisation to the centrosome in human RPE1 cells. (A) 
Immunofluorescence for CCDC77 (red), Gamma Tubulin (green) and Dapi 
(blue) show CCDC77 co-localising with gamma tubulin at the centrioles. (B) 
Single plane reconstruction at a higher magnification shows CCDC77 co-
localising at several points in both centrioles. (C) 3D modelling in Imaris 
shows the structural localisation of CCDC77 at the centrioles. (D) 
Immunofluorescence for CCDC127 (red), Gamma Tubulin (green) and Dapi 
(blue) show CCDC127 co-localising with gamma tubulin in a small region at 
one of the centrioles. (E) Single plane reconstruction at a higher 
magnification shows CCDC127 localising at two points within one of the 
centrioles. (F) 3D modelling in Imaris shows the structural localisation of 
CCDC127 in one of the centrioles. All scale bars as annotated on figure. 
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4.2.6 RNA in situ hybridisation of CCDC77, CCDC127 and 
TALPID3 shows expression in the developing chick embryo 
Having shown that CCDC77 and CCDC127 localise to the centrosome in 
Jurkat cells and RPE1 cells, RNA in situ hybridisation was used to confirm that 
both genes are expressed in early embryonic development. RNA in situ 
hybridisation for CCDC77, CCDC127 and TALPID3 was completed in chick 
embryos at Hamburger Hamilton stage 25-26. TALPID3 was included in this 
analysis as a benchmark for expected patterns of expression by a 
ubiquitously expressed centrosome protein (Davey et al., 2006; Yin et al., 
2009). 
CCDC77 and CCDC127 showed a ubiquitous expression pattern, when 
analysed by whole mount in situ hybridisation (Figure 4.9 A, B). This pattern 
of expression is similar to the ubiquitous expression seen in whole mount in 
situ hybridisation for TALPID3 (Figure 4.9 C). In conclusion, these results 
support expression of CCDC77 and CCDC127 in early development and 
suggest that both genes have a ubiquitous expression pattern similar to 




Figure 4.9 Whole mount RNA in situ hybridisation of CCDC77, CCDC127 and TALPID3 shows expression in the developing chick embryo. (A, B, C) 
Whole mount RNA in situ hybridisation with probes for CCDC77, CCDC127 and TALPID3 show ubiquitous expression in Hamburger Hamilton stage 
25-26 chick embryos, demonstrating that CCDC77 and CCDC127 have similar ubiquitous expression patterns to centrosomal genes such as TALPID3. 




Despite an apparent ubiquitous expression pattern by whole mount in situ 
hybridisation, trapping can be difficult to distinguish from specific expression 
patterns, therefore embryos were sectioned to determine if CCDC77 and 
CCDC127 have tissue specific expression patterns during development. 
Sections of the developing head, the choroid plexus (CP) and trunk region at 
the level of the forelimb (FL) were analysed for expression. The choroid 
plexus is a multiciliated, secretory organ that develops from the roof plate 
of the telencephalon, diencephalon and hindbrain (Cohen & Davies, 1937; 
Dziegielewska et al., 2001). Genes required for multi-ciliogenesis, such as 
FOXJ1 (Yu et al., 2008), are expressed in the choroid plexus as well as the 
telencephalon and diencephalon in the chick (Cruz et al., 2010; Stephen et 
al., 2013). Evidence of CCDC77 and CCDC127 expression in multiciliated 
tissues on the Human Protein Atlas and in the choroid plexus on the Allen 
Mouse Brain Atlas prompted me to look for expression in the choroid plexus 
tissue in the developing chick to determine if either gene could be specific 
to early regulation of multi-ciliated organ development.  
Sections of Hamburger-Hamilton stage 25-26 embryos which had undergone 
RNA in situ hybridisation for CCDC77 revealed expression in the maxillary 
and mandibular regions of the first pharyngeal arch (PA1), the second 
pharyngeal arch (PA2) and extensively in the head mesenchyme (Figure 4.10 
A), which contributes to skeletal elements, connective tissue and 
musculature of the head. CCDC77 RNA expression was also present in the 
interneurons of the neural tube (NT), the mesenchyme around the neural 
tube, around the top of the crop and in the forelimb mesenchyme (Figure 
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4.10 G). The expression seen around the crop is most likely muscle and the 
forelimb mesenchyme, running ventrally and dorsally is most likely muscle; 
however, this is not conclusive without a muscle marker, such as MyoD. 
There was no CCDC77 expression observed in the heart, liver or epithelium. 
Tissue sections of Hamburger-Hamilton stage 25-26 embryos which had 
undergone RNA in situ hybridisation for CCDC127 revealed expression in the 
maxillary and mandibular regions of pharyngeal arch 1 (PA1) and in the head 
mesenchyme (Figure 4.10 B), which contributes to skeletal elements, 
connective tissue and musculature of the head. CCDC127 was also expressed 
in the mesenchyme on both sides of the neural tube (NT), the forelimb (FL) 
mesenchyme, and at low levels in the endothelia around the dorsal aorta 
(DA), the right and left anterior cardinal veins (RACV and LACV respectively), 
and the vessels of the forelimb (Figure 4.10 H). There was no CCDC127 
expression observed in the neural tube, dorsal root ganglion, somites, heart 
or liver. 
Tissue sections of Hamburger-Hamilton stage 25-26 embryos which had 
undergone RNA in situ hybridisation for TALPID3 revealed expression in the 
maxillary and mandibular regions of pharyngeal arch 1 (PA1) and in the head 
mesenchyme (Figure 4.10 C). TALPID3 was also expressed in the dorsal 
region of the neural tube (NT), the mesenchyme on both sides of the neural 
tube, the forelimb mesenchyme and around one side of the gizzard (Figure 
4.10 I). There was no TALPID3 expression observed in the heart, liver or 
blood vessels.  
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Of note, neither CCDC77 nor CCDC127 showed expression in the developing 
choroid plexus (CP) (Figure 4.10 D and E), suggesting that neither gene is 
specific to early regulation of multi-ciliated organ development in the chick. 
There was no expression of TALPID3 observed in the developing choroid 
plexus (Figure 4.10 F) as expected (Stephen et al., 2013). 
The expression patterns seen following RNA in situ hybridisation for CCDC77 
and CCDC127 confirm that they are expressed during embryonic 
development in the chick and show organ specific patterns of expression. 
The organ specific expression patterns of CCDC77 in the pharyngeal arches, 
and interneurons of the neural tube suggest that CCDC77 may play a role in 
early neural development. The extensive expression of both CCDC77 and 
CCDC127 in the mesenchyme could highlight the role centrosomes play in 
mesenchymal cell migration at this stage in development. Additionally head 
mesenchyme, stemming from cranial neural crest and head mesoderm cells 
populate the branchial arches and give rise to skeletal elements of the skull 
and face, connective tissue and musculature of the head; ciliopathies are 
known to result in craniofacial abnormalities and the expression of CCDC77 
and CCDC127 in the head mesenchyme could be as a result of the role of 
cilia in craniofacial development (Brugmann et al., 2010; Brugmann et al., 
2010; Xavier et al., 2016). 
Ciliopathy mutations are known to have varying levels of tissue penetrance, 
which suggests that not all centrosome proteins act equally in different 
tissues or at different stages of development (McIntyre et al., 2013); it is 
likely that both CCDC77 and CCDC127 follow this trend. Further RNA in situ 
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hybridisation at both earlier and later developmental stages could help to 
confirm this hypothesis; additionally RNA in situ at earlier developmental 
stages typically results in less trapping and therefore could be used to 
confirm that the results presented in figures 4.9 and 4.10 are not due to 
trapping. In conclusion, these results confirm that CCDC77 and CCDC127 are 
expressed during embryonic development in the chick; additionally the 
results show similar expression patterns of CCDC77 and CCDC127 to the 






Figure 4.10 RNA in situ hybridisation of CCDC77, CCDC127 and TALPID3 
shows expression in specific regions of the developing chick embryo. 
Sections that had undergone RNA in situ hybridisation for CCDC77, CCDC127 
and TALPID3 were examined for tissue specific expression patterns. (A, B, C) 
Sections through the head, showing expression of CCDC77, CCDC127 and 
TALPID3, respectively. Expression, marked by black arrowheads, was seen in 
the head mesenchyme and the pharyngeal arches (PA). (D, E, F) Sections 
through the choroid plexus (CP) show no expression of CCDC77, CCDC127 or 
TALPID3 respectively. (G) A section through the trunk at the level of the 
forelimb (FL) shows CCDC77 expression in the interneurons of the NT, the 
mesenchyme around the NT, around the top of the crop and in the forelimb 
(FL) mesenchyme. Expression marked by black arrowheads. (H) A section 
through the trunk at the level of the forelimb (FL) shows CCDC127 expression 
in the mesenchyme on both sides of the NT, the forelimb (FL) mesenchyme, 
and at low levels in the endothelia around the dorsal aorta (DA), the right 
and left anterior cardinal veins (RACV and LACV respectively) and the vessels 
of the forelimb. Expression marked by black arrowheads. (I) A section 
through the trunk at the level of the forelimb (FL) shows TALPID3 expression 
in the dorsal region of the neural tube (NT), in the mesenchyme on both 
sides of the NT, the forelimb (FL) mesenchyme and around one side of the 




4.2.7 Mutations in CCDC127 cause loss of CCDC127 localisation 
in RPE1 cells 
In order to understand the function of CCDC127 in the centrosome, 
CCDC127 was targeted with CRISPR/Cas9 editing to create functional 
mutations followed by ciliogenesis assays to determine if CCDC127 plays a 
role in ciliogenesis. Two independent editing events were identified in RPE1 
clonal cell lines, CCDC127 CRISPR Line 1 and CCDC127 CRISPR Line 2. 
CCDC127 CRISPR Line 1 had four altered nucleotides, CTTA (Figure 4.11 A) 
compared to GCTG in the unedited cell line (Figure 4.11 C), in the targeted 
region. CCDC127 CRISPR Line 2 had a deletion of two arginine nucleotides in 
the targeted region (Figure 4.11 B). These mutations are predicted to result 
in truncated proteins (Figure 4.11 D). 
To determine if the mutations affected localisation of CCDC127 in the 
centrosome, immunofluorescence was used to analyse localisation. Both 
CCDC127 CRISPR Line 1 and CCDC127 CRISPR Line 2 showed a loss of 
punctate localisation of CCDC127 in the centrosome (marked by gamma 
tubulin) when compared to the unedited RPE1 cells (Figure 4.11 D, E, F). 
These results suggest that the mutations in CCDC127 CRISPR Line 1 and 





Figure 4.11 Mutations in CCDC127 cause loss of CCDC127 localisation in the centrosome in RPE1 cells. (A) Sequence containing 
a mutation in the targeted region of CCDC127 in CCDC127 CRISPR Line 1. The purple box marks the mutated region containing 
four altered nucleotides. (B) Sequence containing a mutation in the targeted region of CCDC127 in CCDC127 CRISPR Line 2. The 
purple box marks the mutated region, containing a deletion of two arginine nucleotides. (C) Sequence of the targeted region of 
CCDC127 in unedited RPE1 cells. The purple box marks the unedited region containing correct wildtype sequence that has been 
altered in the edited cell lines. (D) Schematic of the CCDC127 protein in unedited RPE1 cells and the truncated CCDC127 protein 
in CCDC127 CRISPR Line 1 and CCDC127 CRISPR Line 2. (E-G) Immunostaining with gamma tubulin (green), CCDC127 (red) and 
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Dapi (blue) shows a loss of CCDC127 in the centrosome in CCDC127 CRISPR Line 1 and CCDC127 CRISPR Line 2. CCDC127 




4.2.8 Mutations in CCDC127 cause loss of ciliogenesis and 
altered centrosome protein localisation in RPE1 cells  
To determine if the mutations in CCDC127 CRISPR Line 1 and CCDC127 
CRISPR Line 2 affects ciliogenesis, edited RPE1 cells were examined using 
immunofluorescence. Both CCDC127 CRISPR Line 1 and CCDC127 CRISPR 
Line 2 showed a significant reduction in ciliogenesis compared to the 
unedited RPE1 cells (Figure 4.12 A, B, C, D). Only 28% of cells were ciliated in 
CCDC127 CRISPR Line 1 (*p=0.048) and 19% of cells were ciliated in CCDC127 
CRISPR Line 2 (**p=0.001) compared to 69% of cells being ciliated in the 
unedited RPE1 cells (Figure 4.12 D). To determine if the mutations in 
CCDC127 affected the ciliary membrane, Arl13b was examined. Despite the 
reduced number of ciliated cells, both edited cell lines showed similar 
localisation patterns of Arl13b in cilia to that seen in the unedited RPE1 cells 
(Figure 4.12 E, F, G). In conclusion, the mutations in CCDC127 cause a 
significant reduction of ciliogenesis in CCDC127 CRISPR Lines 1 and CCDC12 
CRISPR Line 2; however, the mutations do not appear to affect the 




Figure 4.12 Mutations in CCDC127 cause loss of ciliogenesis in RPE1 cells. Immunostaining for gamma tubulin (red), acetylated 
tubulin (green) and Dapi (blue), with white arrowheads indicating cilia. (A) Image of CCDC127 CRISPR Line 1 with cilia marked 
by a white arrowhead. (B) Image of CCDC127 CRISPR Line 2 shows no ciliated cells. (C) Unedited RPE1 cells are ciliated, with all 
cilia identified by a white arrowhead. (D) Bar chart represents percent of ciliated cells in each cell line. CCDC127 CRISPR Line 1 
and CCDC127 CRISPR Line 2 showed a significant reduction in ciliogenesis (*p = 0.048 and **p = 0.001 respectively) Unpaired 
two-tailed Student’s t-test was used, with standard error bars included. *p<0.05, **p<0.01. (E-G) Immunostaining for gamma 
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tubulin (red), Arl13b (green) to mark the ciliary membrane and Dapi (blue). Cilia are identified with white arrowheads in all cell 
lines showing that the ciliary membrane is able to form with expected patterns of Arl13b localisation, despite the mutations in 
CCDC127. Scale bars in A-C: 20 μm. Scale bars in E-G: 2 μm. 
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In order to determine if the reduction of ciliogenesis in CCDC127 CRISPR Line 
1 and CCDC127 CRISPR Line 2 was due to a loss of basal body maturation, 
localisation of Cep164, CP110 and PCM1 was examined. CCDC127 CRISPR 
Line 1 showed localisation patterns of both Cep164 and CP110 (Figure 4.13 
A, B) that were consistent with unedited RPE1 cells (Figure 4.13 G, H). 
Although PCM1 localised around the centrosome as expected, it consistently 
showed a more widespread distribution around the centrioles in CCDC127 
CRISPR Line 1 (Figure 4.13 C) when compared to unedited RPE1 cells (Figure 
4.13 I). In CCDC127 CRISPR Line 2, Cep164 localisation (Figure 4.13 D) was 
consistent with unedited RPE1 cells (Figure 4.13 G), however CP110 showed 
co-localisation with gamma tubulin on both centrioles (Figure 4.13 E), not 
just at the distal end as was seen in unedited RPE1 cells (Figure 4.13 H). 
PCM1 in CCDC127 CRISPR Line 2 looked similar to PCM1 in CCDC127 CRISPR 
Line 1, with localisation around the centrioles as well as a more widespread 
pattern of PCM1 around the centriole in the pericentriolar material (Figure 
4.13 F) compared to unedited RPE1 cells. In conclusion, these results show 
that Cep164 localisation in CCDC127 CRISPR Line 1 and CCDC127 CRISPR Line 
2 is like that of the unedited RPE1 cells suggesting that the distal appendages 
are modified as expected during basal body maturation. CP110 and PCM1 
however, have altered localisation patterns in the edited cell lines suggesting 
that the mutations in CCDC127 may have an effect on centrosome proteins 




Figure 4.13 Mutations in CCDC127 cause changes to localisation patterns 
of CP110 and PCM1. (A, D, G) Immunostaining with Cep164 (red), gamma 
tubulin (green) and Dapi (blue) in CCDC127 CRISPR Line 1, CCDC127 CRISPR 
Line 2 and unedited RPE1 cells respectively shows Cep164 at the distal end 
of the mother centriole. Mother centrioles indicated with white asterisk. (B, 
E, H) Immunostaining with CP110 (red), gamma tubulin (green) and Dapi 
(blue) in CCDC127 CRISPR Line 1, CCDC127 CRISPR Line 2 and unedited RPE1 
cells respectively. White arrowheads indicate CP110 at the distal end of each 
centriole in CCDC127 CRISPR Line 1 and unedited RPE1 cells. CCDC127 
CRISPR Line 2 shows co-localisation of CP110 with gamma tubulin across 
both centrioles. (C, F, I) Immunostaining with PCM1 (red), gamma tubulin 
(green) and Dapi (blue) in CCDC127 CRISPR Line 1, CCDC127 CRISPR Line 2 
and unedited RPE1 cells respectively shows more widespread distribution of 
PCM1 around centrioles in CCDC127 CRISPR Line 1 and CCDC127 CRISPR Line 




This study has demonstrated that alternative cell lines to the non-ciliated, 
immortalised KE37 cells can be used for proteomic studies in the 
centrosome, and that use of different cell lines can identify novel 
centrosome proteins such as CCDC127. Although isolation of centrosomes 
from PGCs combined with mass spectrometry proved an ineffective tool to 
investigate the TALPID3 protein network, this study has identified chicken 
PGCs as a ciliated cell line that has modifications of the centriole that 
correlate with the ability to form cilia. Therefore, chicken PGCs can be used 
as a potential future model for studying ciliopathies and studying the 
TALPID3 proteome using a different approach.   
Frequency of ciliogenesis is low in Jurkat cells; this is most likely due to a loss 
of maturation of the mother centriole, supported by the altered localisation 
patterns of Cep164, CP110, PCM1 and MACF1 in the centrosome. Chicken 
PGCs however, have modifications of the mother centriole that correlate 
with their ability to form cilia. The low protein yield and low centrosome 
enrichment in the PGCs was most likely due to the increased actin 
cytoskeletal structure preventing efficient isolation of centrosomes, and 
therefore inefficient protein extraction. However, despite these results, 
PGCs are a model that can be utilised for studying cilia and centrosomes in 
the future. Chickens have proven a suitable model for studying ciliopathies 
(Schock et al., 2016) and their ease of manipulation and potential for genetic 
modifications (Taylor et al., 2017) makes them an obvious choice for 
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modelling disease. The awareness that immortalised cell lines may not be 
the most relevant models for studying disease (Horvath et al., 2016; Masters 
& Stacey, 2007) has led to the need for new primary cell lines, providing a 
gap that PGCs can fill in the field of centrosome and cilia research. 
By applying a centrosome proteome screen to Jurkat cells in this study, 
CCDC77 and CCDC127 were identified as novel centrosome proteins. 
CCDC77 was previously identified in a centrosome proteomic screen 
(Andersen et al., 2003), however it was not validated and therefore only 
predicted to localise to the centrosome prior to this study. CCDC127 has not 
previously been identified in a centrosome or cilia screen, therefore this 
study is the first to present CCDC127 as a centrosome protein. While this 
study was ongoing CCDC77 was identified as a low abundance centrosome 
protein in a quantitative proteomic analysis of the centrosome (Bauer et al., 
2016) and was shown to localise to the centrosome in trypanosomes on the 
TrypTag database through a C-terminal tag with mNeonGreen (Dean et al., 
2017). Therefore CCDC77 studies were not taken any further and instead 
CRISPR/Cas9 gene editing in RPE1 cells was used to examine the role of 
CCDC127 in the centrosome. Mutations in CCDC127 led to a loss of 
ciliogenesis and minor alterations in localisation patterns of centrosome 
proteins. The mutations in CCDC127 resulted in an accumulation of PCM1 in 
the satellites; this phenotype is similar to changes in other satellite proteins 
linked to ciliopathy proteins such as OFD1, BBS4, Cep290 and TALPID3 
(Kobayashi et al., 2014; Lopes et al., 2011). Changes in CP110 in CCDC127 
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CRISPR Line 2 however, suggest that the protein interacting network of 
CCDC127 might be more complicated than just satellite association. 
 
4.3.1 Complex centrosome protein networks are involved in 
ciliogenesis 
A complex set of protein networks within the centrosome must work 
together in a time-dependent, localisation-specific manner for ciliogenesis 
to occur. For example, TALPID3 expression is necessary early on to ensure 
correct orientation and migration of the centriole to the apical surface 
(Stephen et al., 2013, 2015) as well as maturation of the mother centriole to 
form distal appendages. Proteins such as Cep164, Cep83 (CCDC41), Cep89 
(CCDC123), SCLT1, FBF1 are required for the formation of distal appendages 
(Tanos et al., 2013), without which docking at the membrane prior to 
ciliogenesis would not occur; MACF1 is associated with both distal and 
subdistal appendages (May-Simera et al., 2016). Pericentriolar proteins such 
as PCM1 and BBS4 localise to the satellites, which are required for transport 
complex assembly proteins as well as housing proteins that are transported 
to the centrosome (Bärenz et al., 2011). Meanwhile, proteins such as CP110 
and Cep97 work to suppress cilia assembly, and removal of CP110 results in 
the promotion of ciliogenesis (Spektor et al., 2007). Disruption to any one of 
these proteins or processes can alter the remaining proteins, due to the tight 
control and specific order of steps needed to produce a cilium. I have shown 
that the centrosome proteins Cep164, CP110, PCM1 and MACF1 do not 
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follow expected protein localisation patterns in Jurkat cells. It is likely that 
these are not the only centrosome proteins that are altered in Jurkat cells 
and that these protein changes are disrupting at least one of the processes 
involved in ciliogenesis such as centriole orientation, distal and subdistal 
appendage formation or docking to produce the reduced frequency of 
ciliogenesis observed. 
Large-scale proteomic approaches have been successful in further defining 
protein networks within the centrosome and what roles they play in 
centrosome and cilia biogenesis (Andersen et al., 2003; Bauer et al., 2016; 
Gupta et al., 2015; Jakobsen et al., 2011). A study showed that 112 out of 
335 polypeptides associated with centriole and cilia regulation generated a 
phenotype in at least two of the four functional assays in which they were 
tested (Gupta et al., 2015), demonstrating that genes involved in centriole 
amplification, ciliogenesis and/or satellite intensity overlap. The study 
suggested that components of networks that displayed a phenotype were 
more likely to overlap with other protein networks within the centrosome 
(Gupta et al., 2015). This complexity of the centrosome and cilia protein 
networks demonstrates that it is not as simple as individual proteins 
interacting with only a small subset of proteins within the network to give a 
well-defined phenotype, but instead much wider overlap of protein 




4.3.2 Centrosomes, ciliogenesis and human health 
The centrosome has been linked to many human diseases, from a broad 
range of ciliopathies to the less understood role abnormal centrosomes play 
in aneuploidy and cancer (Bettencourt-Dias et al., 2011; Godinho & Pellman, 
2014). Mutations in more than 40 genes have been found to associate with 
human ciliopathy patients; however, more than 1000 polypeptides have 
been found in the ciliary proteome to date (Waters & Beales, 2011). Given 
the large number of patients born with ciliopathy-associated phenotypes 
alongside the large number of cilia-associated proteins not currently linked 
to a ciliopathy, it is likely that new ciliopathy genes will be identified with 
future studies. CCDC77 and CCDC127 are both good ciliopathy candidates; 
in particular, the loss of ciliogenesis in the edited CCDC127 CRISPR cell lines 
supports CCDC127 as a ciliopathy candidate.  
A large deletion in chromosome 12 has been found in a series of patients 
diagnosed with Autism Spectrum Disorders (ASD); the deletion in the 
patients includes up to thirteen genes, of which CCDC77 is one. The main 
diagnosis of these patients is ASD, hypothesised to be due to loss of the gene 
ERC1; however, the majority of the patients also have additional ciliopathy-
like symptoms such as hypotonia, microcephaly and developmental delay 
(Silva et al., 2014). These phenotypes could be attributed in part to the loss 
of CCDC77. 
A transcriptome-wide analysis study showed that CCDC77 and CCDC127 
were among genes that were upregulated in foetuses with homozygous Kif7 
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mutations (Putoux et al., 2011). Kif7 is a cilia-associated protein that plays a 
critical role in mammalian Hedgehog signalling, acting downstream of SMO 
and upstream of the Gli proteins (Cheung et al., 2009; Liem et al., 2009). Kif7 
has been associated with ciliopathies, such as Joubert Syndrome, 
Acrocallosal Sydrome (ACLS) and Bardet-Biedl Syndrome (BBS) (Dafinger et 
al., 2011; Putoux et al., 2011; Walsh et al., 2013). Fibroblasts derived from 
individuals with mutations in KIF7 were able to produce cilia with normal 
components shown by ultrastructural analysis, however the cilia were 
significantly longer (Putoux et al., 2011). The association of an upregulation 
of CCDC127 with an increase in cilia length is opposite to the phenotype seen 
with a reduction or loss of CCDC127, which results in a loss of cilia as shown 
in the study presented in this chapter. Taken together these phenotypes 
suggest that CCDC127 could play a role in the regulation of cilia length, 
similar to the role of KIF7 (Putoux et al., 2011). However, it is more likely that 
CCDC127 plays a role at the initiation of ciliogenesis, which would explain 
how a loss of CCDC127 results in a loss of ciliogenesis. Consequently, this 
would suggest that the upregulation of CCDC127 in the KIF7 mutant is a 
downstream effect, most likely caused by the loss a of negative feedback 
cycle that is lost due to the unregulated growth of cilia. Given the predicted 
role of CCDC127 during initiation of ciliogenesis and the super resolution 
imaging that shows CCDC127 localising to only one of the centrioles, it is 
likely that CCDC127 localises to the mother centriole. It most likely localises 
at the distal end of the mother centriole, with the possibility of localising to 
the transition zone during ciliogenesis. 
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The upregulation of CCDC77 and CCDC127 in association with Kif7 mutations 
highlights the need to better understand the role of these proteins in the 
centrosome and thus determine their potential as ciliopathy candidate 
genes. Understanding the implications for human health requires an 
understanding of the highly complex subcellular protein interactions in the 
centrosome, alongside identification of novel centrosome proteins and 
protein interactions to fill the gaps in our understanding of the current 
known networks.  
 
4.3.3 Conclusions and future studies 
In conclusion, I have shown through identification of CCDC127 that there are 
still centrosome proteins that have not previously been discovered. 
Methods that use alternative cell lines to study the centrosome proteome 
should be used to maximise our understanding of the centrosome protein 
network and to increase our ability to identify new ciliopathy loci. CCDC127 
is a novel centrosome protein, that when disrupted causes a loss of 
ciliogenesis and abnormal localisation patterns of centrosome proteins. The 
changes observed in localisation patterns of PCM1 and CP110 in the 
CCDC127 edited RPE1 cell lines suggest that CCDC127 mutations may affect 
other ciliogenesis proteins.  
The study presented in this chapter does not investigate any direct 
interactions between CCDC127 and other centrosome proteins. To obtain a 
clearer picture of where CCDC127 fits into the protein interacting network 
213 
 
at the centrosome-cilium interface, future studies could use more targeted 
proteomic studies. Endogenously tagging CCDC127, followed by a 
quantitative mass spectrometry approach could be used to determine 
proteins that directly interact with CCDC127. Combined with super 
resolution imaging, this would determine what proteins CCDC127 interacts 
with and the precise subcellular localisation of CCDC127 within the 
centrosome. This data would provide a more comprehensive understanding 
of what role CCDC127 plays in the centrosome-cilium interface, thus helping 






Chapter 5. Utilising a quantitative proteomic 
approach to uncover altered protein 




Despite extensive research into TALPID3, there is still very little known about 
the TALPID3 protein interacting network and which protein networks are 
involved in producing the mutant phenotype observed. To examine the 
TALPID3 protein interacting network more comprehensively and determine 
what protein pathways are altered in talpid3, a quantitative proteomic 
approach was undertaken, comparing talpid3 chicken primordial germ cells 
to wildtype chicken primordial germ cells.  
 
5.1.1 Chicken Primordial Germ Cells 
In order to carry out a quantitative proteomic study comparing talpid3 to 
wildtype, it was important to identify a cell line or tissue that was suitable 
for studying TALPID3, through protein extraction and mass spectrometry. 
Primordial germ cells (PGCs) are the precursors of the germ cell lineage and 
are restricted to formation of the sperm and egg in adult organisms. In avian 
species, these cells are separated from the somatic cell lineages in the 
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epiblast of the laid egg (Tsunekawa et al., 2000). Germ cells, through their 
pluripotent nature, ensure that genetic and epigenetic information is carried 
forward to the next generation (Park & Han, 2000). They can easily be 
derived and cultured (Lavoir et al., 2006; Macdonald et al., 2010), meaning 
that they can be derived from talpid3 flock embryos for a proteomic 
comparison between talpid3 and wildtype conditions. I have already shown 
that chicken PGCs can be used as a cell model for studying the centrosome 
and cilia (Chapter 4), therefore supporting the suitability of using PGCs to 
study the centrosome protein TALPID3. 
Studies in human HeLa cells predict that about 10,000 proteins of the 20,000 
proteins in the human proteome are expressed in cells (Beck et al., 2011; 
Nagaraj et al., 2011), demonstrating that cell lines do not express all the 
proteins in the proteome. This is also true of gene expression in different 
tissue types in the chicken (Nie et al., 2010) suggesting that proteomic 
analysis in cells or tissue will not cover the entire proteome. However, 
extracting protein from cells instead of tissue produces a more homogenous 
protein set that can be repeated across individual cells lines more accurately 
(Kaur & Dufour, 2012). Talpid3 PGCs show characteristics consistent with the 
talpid3 mutant such as loss of cilia and slower migration patterns when 
colonising the gonad (Davey and McGrew labs, unpublished); therefore, 
despite not expressing the whole proteome the phenotype associated with 
the talpid3 PGCs suggests that they will provide a useful model for studying 
changes in protein expression patterns in talpid3 compared to wildtype.  
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In addition, mass spectrometry on protein isolated from chicken PGCs (see 
Chapter 4) demonstrated that the chicken proteome is complete enough to 
justify proteomic studies using mass spectrometry on chicken tissue. More 
than 29,000 proteins are included in the chicken proteome database in 
Uniprot (The Uniprot Consortium, 2018), which is the database used for 
protein identification of peptides following mass spectrometry. In 
conclusion, based on the nature of chicken PGCs, their ease of derivation 
and the evidence that mass spectrometry is applicable to chicken tissue, 
PGCs isolated from the talpid3 flock embryos were used to analyse the 
protein interacting networks affected in talpid3.  
 
5.1.2 TALPID3 protein interactions 
Studies to date have shown TALPID3 is involved in several different functions 
in the centrosome through various protein interactions and more broadly in 
the whole cell through links to the actin network. A study showed that 
TALPID3 interacts with CP110 and more weakly interacts with three other 
proteins in the CP110-containing protein complex, Cep97, Cep290 and Kif24 
(Kobayashi et al., 2014). Unlike TALPID3 which promotes ciliogenesis, CP110 
localises to the distal end of centrioles and works to suppress ciliogenesis 
until removed from the mother centriole (Spektor et al., 2007; Tsang et al., 
2008). Studies have suggested a model in which TALPID3 and Cep290 played 
overlapping roles in the appropriate localisation of Rab8a to the ciliary 
membrane (Kobayashi et al., 2014) and showed that loss of TALPID3 results 
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in abnormal accumulation of PCM1-positive granules at centrosomes 
(Kobayashi et al., 2014; Stephen et al., 2015). PCM1 is required for restricting 
the E3 ligase, Mindbomb1 (Mib1), to the satellites. Loss of PCM1 results in 
translocation of Mib1 to the centriole, where it interacts with and 
destabilises TALPID3 resulting in a loss of ciliogenesis (Wang et al., 2016). 
Another study showed that TALPID3 interacts with Cep120, a centrosome 
protein that is required for centriole duplication (Mahjoub et al., 2010; Wu 
et al., 2014); TALPID3 regulates the asymmetric localisation of Cep120 to the 
daughter centriole (Wu et al., 2014). Additionally TALPID3 has been shown 
to interact with Microtubule-Actin Cross Linking Factor 1 (MACF1), a 
ciliogenesis protein that is required in the early stages of ciliogenesis and 
required for maintenance of basal body positioning in differentiated tissue 
(May-Simera et al., 2016). In conclusion, these interactions with centrosome 
proteins involved in various centrosome functions including suppression of 
cilia assembly, centrosome duplication, restriction of proteins to the 
satellites and basal body positioning suggest that TALPID3 is essential for 
distinct roles and protein networks involved in centriole function.  
In addition to TALPID3 interactions with centrosome proteins, there is 
evidence to suggest that Actin and TALPID3 are associated and may depend 
on one another during basal body orientation, docking and ciliogenesis 
(May-Simera et al., 2016; Yin et al., 2009). In the developing neural tube of 
wildtype chick, there is a continuous band of actin at the apex of cells. In 
contrast, talpid3 neural tube shows a non-continuous band of actin at the 
apex of the cells, which can be rescued by electroporation of a full length 
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TALPID3 construct demonstrating that the talpid3 mutation is responsible for 
this defective actin phenotype (Yin et al., 2009). The more recent discovery 
of the interaction between TALPID3 and MACF1 supports the TALPID3-actin 
association. In conclusion, the actin phenotype observed in talpid3 suggests 
that the role and interacting network of TALPID3 may not be limited to the 
centrosome, therefore a proteomic study to uncover the wider protein 
interacting networks affected in talpid3 is crucial to understanding the role 
of TALPID3. 
 
5.1.3 Quantitative mass spectrometry approach 
In order to determine which proteins are altered in talpid3 compared to 
wildtype, a quantitative mass spectrometry approach was completed to 
compare relative amounts of protein in the two conditions. In order to 
determine the most appropriate mass spectrometry method to use, 
accuracy, proteome coverage, sample numbers and whether the method 
chosen would be applicable to PGCs had to be taken into consideration. To 
address the question of what proteins are altered in talpid3 PGCs relative to 
wildtype PGCs, a labelled mass spectrometry approach was undertaken. 
Although a label free approach would allow the inclusion of an unlimited 
number of samples and has a high quantitative proteomic coverage, the 
accuracy of the process is lower than labelled approaches and the overall 
protein identification output is lower (Table 5.1) (Bantscheff et al., 2007), 
therefore a labelled approach was used.  
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Of the labelled approaches, SILAC was excluded because it did not meet the 
specific culture conditions necessary for PGCs and only a low number of 
samples could be included (Bantscheff et al., 2007). PGCs require exact levels 
of culture medium supplements and any slight changes can disrupt the 
survival of the cells (Whyte et al., 2015), meaning that metabolic labelling of 
proteins within cell culture was  not viable for PGCs. Therefore, an isobaric 
labelling approach such as iTRAQ or TMT (Tandem Mass Tag) was considered 
the most appropriate method of labelling. Both iTRAQ and TMT have similar 
levels of accuracy, quantitative proteomic coverage, and protein 
identification output (Table 5.1) (Bantscheff et al., 2007). The difference 
between iTRAQ and TMT lies within the maximum number of samples that 
can be included. A TMT approach allowed inclusion of ten samples, meaning 
that protein from five independent talpid3 PGC cell lines and protein from 
five independent wildtype PGC cell lines could be included, therefore a TMT 
proteomic approach was undertaken.   
The main limitation with TMT labelling that had to be considered was the 
ratio compression (Ow et al., 2011; Savitski et al., 2013). Ratio compression 
occurs because all peptides are multiplied by a global normalisation factor, 
to centre the ratio distribution on 1, which corrects for inconsistencies with 
labelling efficiency and protein digestion efficiency (Karp et al., 2010). This 
normalisation can lead to smaller changes in protein levels seen in the data 
than would actually be present in physiological conditions (Karp et al., 2010; 
Ow et al., 2011; Savitski et al., 2013). Despite this potential limitation, I 
hypothesised that the changes that occur as a result of the talpid3 mutation, 
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such as altered Hedgehog pathway signalling and polarity defects, are 
significant enough that altered protein levels would still be detected despite 
ratio compression. 
 
Table 5.1 Characteristics of quantitative mass spectrometry methods taken 
















Label Free  
  



















To date, studies on proteins that interact with TALPID3 have focused on 
individual proteins within the centrosome (Kobayashi et al., 2014; May-
Simera et al., 2016; L. Wang et al., 2016; Wu et al., 2014) and have not 
attempted protein pathway analysis to understand the broader picture of 
the TALPID3 protein interacting network. In order to determine which 
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proteins are changed in the talpid3 mutant relative to the wildtype chick and 
how this translates to protein pathway changes in talpid3, a quantitative 
proteomic approach was undertaken. The aim of this study was to use a 
labelled TMT mass spectrometry approach on protein isolated from talpid3 
PGCs and wildtype PGCs, to identify proteins that are altered in talpid3. 
Additionally, protein pathway analysis on the quantitative dataset aimed to 
uncover protein pathways that are altered in talpid3 thus providing an 




5.2.1 Protein isolation from talpid3 flock PGCs for TMT mass 
spectrometry 
Having determined that a TMT quantitative mass spectrometry approach in 
PGCs was the most appropriate method of studying the changes in protein 
levels in talpid3, PGC cell lines were derived from talpid3 flock embryos. A 
previous attempt to isolate centrosomes from PGCs, for studying the 
TALPID3 protein network proved unsuccessful (see Chapter 4); therefore, 
protein extracted from whole cell lysate was used for this study. Instead of 
focusing on TALPID3 in the centrosome, protein was extracted from talpid3 
PGCs and compared to protein extracted from wildtype PGCs to look for 
differences in the proteomes. PGCs were isolated from the talpid3 mutants 
in the flock and also their wildtype counterparts to ensure the most direct 
comparison. Different breeds contain differences in protein expression 
levels (Zanetti et al., 2011) so for the most relevant quantitative protein 
comparison, wildtype from the talpid3 flock was used. 
Protein extracted from five independent talpid3 PGC cell lines and five 
independent wildtype PGC cell lines was used for the proteomic analysis. 
Including a larger sample size of five samples per condition increases the 
confidence and precision of the experimental analysis (Karp et al., 2005). In 
conclusion, five independent talpid3 protein samples and five independent 
wildtype protein samples from the talpid3 flock were included in the 
quantitative proteomic analysis. 
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5.2.2 Validation of the quantitative talpid3 flock PGC mass 
spectrometry dataset 
Following TMT mass spectrometry analysis on talpid3 and wildtype PGC 
protein samples, 7052 proteins were identified in all ten protein samples 
(five wildtype and five talpid3). All proteins lacking quantitative values were 
excluded from further analysis. All proteins lacking at least one unique 
identifying peptide were excluded from further analysis. Ensuring 
identification with at least one unique peptide, allows increased confidence 
in the protein identification within the dataset (Zhao & Lin, 2010). This left 
6606 proteins to carry forward for analysis. To validate the quantitative TMT 
mass spectrometry dataset, western blot analysis was used to confirm that 
proteins identified during mass spectrometry were in the protein samples 
and to confirm that the values associated with the proteins matched the 
quantitative values produced during mass spectrometry. Many proteins that 
were identified in the dataset did not have antibodies raised against the 
protein that were specific for the chicken protein and worked in western blot 
(Appendix 7); however, gamma tubulin, E-cadherin, Testin and gamma actin 
were identified in all ten PGC protein samples following mass spectrometry 
and were identified as suitable for western blot validation. Western blot 
analysis produced a band at 48 kDa for gamma tubulin in all protein samples 
(Figure 5.1 A), a band at 100 kDa for E-cadherin in all protein samples (Figure 
5.1 A), a band at 48 kDa for Testin in all protein samples (Figure 5.1 B) and a 
band at 41 kDa for gamma actin in all protein samples (Figure 5.1 B). These 
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results demonstrate that the proteins identified by mass spectrometry are 
components of the protein samples, thus validating the dataset.  
Western blot analysis for E-cadherin was used to validate the reporter 
intensity values produced in the TMT mass spectrometry dataset. E-cadherin 
had varying reporter signal intensities across the ten samples, with Wt1, 
Wt4, Wt5, Ta4 and Ta5 having higher reporter intensities than Wt2, Wt3, 
Ta1, Ta2 and Ta3 (Figure 5.1 C). The western blot band signal values (Figure 
5.1 C), although not exactly the same, followed the same trend, therefore 
confirming the reporter intensity values found in the TMT dataset for the 
PGC protein samples. In conclusion, the results of the western blots validate 
the proteins identified in talpid3 and wildtype PGCs using mass spectrometry 





Figure 5.1 Validation of quantitative talpid3 flock PGC mass spectrometry dataset through Western Blot. (A) Western blot for 
gamma tubulin shows a band at 48 kDa in all ten protein samples sent for mass spectrometry. Western blot for E-cadherin 
shows a band at 100 kDa in all ten protein samples sent for mass spectrometry. (B) Western blot for Testin shows a band at 48 
kDa in all ten protein samples sent for mass spectrometry. Western blot for gamma actin shows a band at 41 kDa in all ten 
protein samples sent for mass spectrometry. Together the results from both western blots validate the dataset by confirming 
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that the proteins identified during mass spectrometry are in the protein samples. (C) Table containing mass spectrometry 
reporter intensity values for E-cadherin for each protein sample sent for mass spectrometry and western blot band values for 
E-cadherin for each protein sample, quantified in Image Studio Lite. Although these values do not match exactly the trend in 
the report intensities matches the trend of the western blot band signal, with higher values for Wt1, Wt4, Wt5, Ta4 and Ta5 
and lower values for Wt2, Wt3, Ta1, Ta2 and Ta3. These results confirm that the quantitative data provided in the mass 




5.2.3 Dataset of proteins for Ingenuity Pathway Analysis 
Software 
Having validated the mass spectrometry dataset, I carried out analysis in 
Ingenuity Pathway Analysis software (IPA) to uncover altered protein 
pathways in talpid3. Before completing pathway analysis, the mass 
spectrometry dataset was filtered to include only proteins identified by two 
or more unique peptides. This filter ensures that the dataset is robust by 
guaranteeing the proteins in the dataset, annotated by peptide 
identification, are correct (Zhao & Lin, 2010). IPA identifies networks by gene 
name; therefore, any proteins in the dataset that were not identifiable by 
gene name were also excluded. This allowed a dataset containing 5192 
proteins with the relevant fold change values (talpid3/wildtype) to be 
imported into IPA.  
Within IPA, a fold change minimum limit of 1.2 was applied to the dataset of 
5192 proteins, prior to completing the pathway analysis. This limit ensured 
that only proteins that had a minimum change of 20% in the talpid3 PGCs 
when compared to the wildtype PGCs were included in the analysis; 
therefore, 163 proteins (Appendix 8) were included in pathway analysis in 
IPA (Figure 5.2). Included in the dataset of proteins are GLI2 and NRP2 
(Neuropilin2) (Figure 5.2). These proteins have previously been shown to be 
altered in talpid3 (Bangs et al., 2011; Ben et al., 2011; Davey et al., 2007; 
Davey et al., 2006; Li et al., 2017) and therefore support the quantitative 




Figure 5.2 Proteins identified with two or more unique peptides that have 
a minimum fold change of 1.2 in talpid3 compared to wildtype. The fold 
change represents the average talpid3 protein reporter intensities over the 
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average wildtype protein reporter intensities. Black arrows mark GLI2, which 
is upregulated in talpid3 compared to wildtype PGCs and NRP2, which is 
downregulated in talpid3 compared to wildtype PGCs. The proteins and fold 
change values plotted on this graph are listed by gene name in Appendix 8. 
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5.2.4 Protein pathway analysis in talpid3 PGCs 
Having validated the mass spectrometry dataset and identified a list of 163 
proteins to include, pathway analysis was completed in IPA. By looking at 
the overall protein networks that are changed in talpid3 PGCs, the aim was 
to understand what networks TALPID3 is involved in, instead of protein-
specific interactions of TALPID3. IPA produced a set of canonical signalling 
pathways that are predicted to be altered in talpid3 PGCs compared to 
wildtype PGCs (Figure 5.3). 
Of the canonical signalling pathways that were identified, two groups of 
pathways taken from the top 15 hits were focused on for further analysis. 
The groups included the pathways linked to cholesterol biosynthesis and 
pathways associated with Rho and Actin (Table 5.2). The proteins identified 
in the cholesterol biosynthesis pathways did not amount specifically to 
upregulation or downregulation of the pathway, but instead were annotated 
with no activity pattern available. However, the pathways associated with 
Actin and Rho were consistently downregulated with the Actin Cytoskeleton 
Signalling Pathway having the lowest z-score, which meant it was more 
highly downregulated than the RhoA Signalling pathway or the Regulation of 






Figure 5.3 Canonical pathways identified in Ingenuity Pathway Analysis software (IPA) that are altered in talpid3 PGCs compared to wildtype 
PGCs. The canonical pathways identified are based on the 163 proteins that have a fold change minimum of 1.2 when comparing talpid3 protein 
levels to wildtype protein levels. Orange refers to a positive z-score that correlates with upregulation of a pathway. Purple represents a negative z-
score that correlates with downregulation of a pathway. Grey represents a pathway that contains changed components that do not correlate 




Table 5.2 Canonical pathways, identified in the top 15 pathways in IPA that 
are associated with cholesterol biosynthesis or Rho and Actin signalling. 
Negative z-scores represent down regulation of a pathway. Where a z-score 
is annotated as unchanged, there was no activity pattern available on IPA. 
Canonical Pathway  P-value    
(-log) 
Z-score 
Superpathway of Cholesterol Biosynthesis 6.58 
 
Unchanged 
Cholesterol Biosynthesis I 4.91 
 
Unchanged 





Cholesterol Biosynthesis III (via Desmosterol) 4.91 
 
Unchanged 
RhoA Signalling  3.38 
 
-1 
Regulation of Actin-based motility by Rho 3.1 
 
-1.342 





5.2.5 Cholesterol Biosynthesis pathways are altered in talpid3 
PGCs 
Cholesterol biosynthesis pathways made up four of the top 15 hits of the 
canonical pathways changed in talpid3 PGCs compared to wildtype PGCs. 
This result was not completely unexpected as changes in morphology, 
structure or adhesion of cells is often associated with changes in cholesterol 
biosynthesis (Pace & Esfahani, 1987; Sun et al., 2007). Cholesterol is a 
principal component of cell membranes, with all subcellular membranes 
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containing cholesterol (Pace & Esfahani, 1987); cilia membranes have been 
shown to be rich in cholesterol (Chailley & Boisvieux-Ulrich, 1985; Cuevas et 
al., 1985). Additionally, cholesterol has been shown to be an efficient 
regulator of biophysical properties of the membrane, with decreased 
cholesterol resulting in actin cytoskeleton disorganisation (Sun et al., 2007). 
With the characteristics of talpid3 PGCs including loss of ciliogenesis and 
slower migration to colonise the gonads (Davey and McGrew labs, 
unpublished) as well as an overall talpid3 actin phenotype that could affect 
the cytoskeleton (Yin et al., 2009), a change in biosynthesis of cholesterol 
would be expected. 
The cholesterol pathways identified all share a common region and then 
branch after lanosterol production (Figure 5.4). Following branching after 
lanosterol production, the pathways differ only slightly and within each of 
the different branches, the same protein changes are seen, including sterol 
14-demethylase, methylsterol monooxygenase, 3beta-hydroxy-4alpha-
methylcholestencarboxylate 3-dehydrogenase (decarboxylating) and D24-
sterol reductase. The Superpathway of Cholesterol Biosynthesis contains 
three additional altered proteins at the top of the pathway (Figure 5.4), 
which are not part of the other identified cholesterol biosynthesis pathways. 
Despite making up four of the top 15 altered pathways, the cholesterol 
biosynthesis pathways were identified due to the same protein changes in 
each pathway and the overlap meant that it was the same region of each 
pathway that was changing. In conclusion, further analysis into the 
cholesterol biosynthesis pathways was not completed, as evidence from the 
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literature suggested this result is expected with changes in cell conditions 






Figure 5.4 Superpathway of Cholesterol Biosynthesis identified in IPA as 
altered in talpid3 PGCs compared to wildtype PGCs. Nodes that are shaded 
green indicate proteins that are downregulated. Nodes that are shaded grey 
indicate a protein that is contained in the dataset but that does not contain 
a change over the minimum 1.2 fold change limit. Nodes with no shading 
(white) indicate a protein that is integral to the network but not included in 
the dataset. Of the four cholesterol biosynthesis pathways identified in IPA, 
they all share the same region marked by the blue box. The superpathway 
contains the first region of the pathway shown in this figure. The other three 




5.2.6 Rho and Actin signalling pathways that control actin 
cytoskeleton dynamics are downregulated in talpid3 PGCs 
Actin and Rho pathways that are involved in actin signalling and cytoskeleton 
organisation were identified as downregulated in talpid3 in three of the top 
15 canonical pathways in IPA. In order to further explore the role of TALPID3 
in actin cytoskeleton signalling, these pathways were carried forward for 
further investigation. The downregulation predicted in IPA correlates with 
the actin phenotype previously described in talpid3 (Yin et al., 2009). Talpid3 
has been shown to have a punctate, non-continuous band of F-actin at the 
apex of cells in the neural tube, along with other characteristics such as 
increased actin at the ruffled membrane of cells (Yin et al., 2009). In order 
to determine if the change in actin cytoskeleton previously described and 
predicted by IPA could be observed, immunofluorescence was carried out 
on sections of talpid3 chick embryos and compared to sections of wildtype 
chick embryos, focussing on components of the RhoA Signalling pathway 
(Figure 5.5). The two remaining pathways, Regulation of Actin-based 
Motility by Rho pathway and the Actin Cytoskeleton Signalling pathway 
(Appendix 9), were not a focus of this investigation. The RhoA Signalling 
pathway is a less complex pathway to investigate than Actin Cytoskeleton 
Signalling; and unlike Regulation of Actin-based motility by Rho, it has a 
focus on F-actin instead of G-actin, hence the decision to take the RhoA 
Signalling pathway forward for further investigation. 
To examine proteins that are involved in actin cytoskeleton signalling, 
Alexafluor-conjugated phalloidin was used to visualise the previously 
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reported talpid3 F-actin phenotype; in addition, profilin, cofilin, twinfilin and 
RhoC were included. Profilin, cofilin and twinfilin were identified in the mass 
spectrometry dataset but were not included in the final pathway analysis, as 
they did not make the cut-off fold change of 1.2. Profilin and Cofilin are both 
involved in the RhoA Signalling pathway (Figure 5.5); profilin has a direct 
interaction with F-actin and thus controls actin polymerisation (Figure 5.5), 
similarly cofilin has a direct role in actin polymerisation and actin nucleation 
(Figure 5.5). Due to the control of actin polymerisation, talpid3 embryos were 
examined for evidence of altered localisation of profilin and cofilin. Twinfilin 
was identified in the mass spectrometry dataset and is similar to cofilin both 
in domains and through functioning to prevent actin filament assembly 
(Goode et al., 1998; Palmgren et al., 2002). The Rho proteins, including RhoC, 
promote reorganisation of the actin cytoskeleton and regulate cell shape, 
motility and attachment (Wheeler & Ridley, 2004). In addition, RhoC is 
required for initiation of centrosome duplication (Kanai et al., 2011). RhoC 
was only identified by one unique peptide so was not included in the 
pathway analysis, however the fold change between talpid3 and wildtype 
was 0.75 demonstrating a downregulation of RhoC in talpid3. In conclusion, 
profilin and cofilin were included due to their role in the RhoA Signalling 
pathway identified in IPA and Twinfilin was included due to the role it plays 
in actin organisation. RhoC was included because despite being identified by 
only one unique peptide, proteomic analysis showed that it was 






Figure 5.5 RhoA Signalling Pathway identified in IPA as downregulated in talpid3 PGCs compared to wildtype PGCs. Nodes 
that are shaded red indicate proteins that are upregulated. Nodes that are shaded green indicate proteins that are 
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downregulated. Nodes that are shaded grey indicate a protein contained in the dataset that does not contain a change over 
the minimum 1.2 fold change limit. Nodes with no shading (white) indicate a protein that is integral to the network but not 
included in the dataset. The blue box surrounds a region of the pathway that was targeted for further studies in this chapter, 
containing Profilin, F-actin and Cofilin, identified by orange boxes. 
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5.2.7 Localisation patterns of proteins involved in the regulation of 
Actin are altered in talpid3 
To investigate the pathway analysis results produced in IPA, immunofluorescence 
was carried out using phalloidin to stain the filamentous-actin (F-actin) in talpid3 
embryo sections and wildtype embryo sections. F-actin is shown to be downregulated 
in the RhoA Signalling pathway (Figure 5.5) and the Actin Cytoskeleton Signalling 
pathway (Appendix 9), which is consistent with changes in actin localisation patterns 
previously reported (Yin et al., 2009). Phalloidin staining showed that F-actin 
filaments were disorganised in the talpid3 embryos in comparison to the wildtype. 
Specifically F-actin in the myotome was disorganised when compared to the 
myotome in wildtype embryos (Figure 5.6 A-D). The wildtype myotome had a regular 
or ordered pattern of filaments that extended ventrally, unlike talpid3 myotome, 
which had a more rounded and clumped pattern of filaments that did not extend as 
ventrally as the wildtype myotome. Additionally talpid3 appeared to have greater 
expression of F-actin in the floor plate, which could be due to disorganisation of 
filaments around the neural tube (Figure 5.6 A-D). F-actin patterns at the apical edge 
of the neural tube were consistent with previous reports, demonstrating that F-actin 
fails to form a continuous band at the apical edge of the neural tube in talpid3 
embryos, unlike wildtype embryos (Figure 5.6 E, F). Quantitative analysis of 
fluorescent imaging is highly complex, with many factors such as background signal 
or noise, biological sample variation and photobleaching, contributing to inaccuracy 
and imprecision (Waters, 2009; Wolf et al., 2007), therefore the fluorescent signal 
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was not quantified, following immunofluorescence analysis in this study. In 
conclusion, the data from the quantitative mass spectrometry shows that actin 
regulatory pathways are down regulated in talpid3 PGCs, which is consistent with 
reports of loss of continuous F-actin at the apical edge of the neural tube in talpid3 





Figure 5.6 Actin is disorganised in talpid3 embryos compared to wildtype embryos. 
(A-D) Immunostaining for phalloidin (red) to mark the filamentous actin (F-actin) 
demonstrates actin disorganisation in talpid3 compared to wildtype. White arrows 
mark the myotome, where actin is highly disorganised in talpid3, unlike wildtype, 
which has organised actin fibres. White arrowheads indicate the floor plate where 
there appears to be more F-actin in talpid3 than wildtype, most likely due to 
disorganisation of actin fibres. (E, F) Immunostaining with phalloidin at the apical 
edge of the neural tube shows disruption of the F-actin in talpid3 as marked by white 
arrowheads, unlike wildtype, which has a continuous band of F-actin at the apical 
edge of cells. All scale bars as annotated on figure. 
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Having confirmed that actin organisation is disrupted in talpid3, localisation patterns 
of proteins that regulate assembly and disassembly of actin were examined to 
determine if they are altered in talpid3. I examined localisation patterns in two 
regions of polarised tissue that require actin during formation, the apical edge of the 
lumen of the dorsal aorta and the apical edge of the neural tube. Endothelial cells 
that form the lumen of the dorsal aorta are polarised and F-actin is required to form 
the apical pole of vascular lumen development (Strilic et al., 2009). Formation of the 
neural tube requires controlled changes in cell shape and polarised organisation of 
microtubules along the apicobasal axis, with actin playing a role at the apical side 
(Suzuki et al., 2012). Additionally I examined the localisation patterns in non-
polarised mesenchyme tissue (Ekblom, 1989), where differences in localisation of 
actin regulators would not be expected, due to the lack of polarisation and lack of 
organisation of the cells.  
Profilin is a small actin-binding protein that is involved in actin polymerisation 
(Carlsson et al., 1977; Krishnan & Moens, 2009). Although a quantitative change in 
profilin was not detected in the talpid3 PGC proteomic dataset, it is a component of 
the RhoA signalling pathway and acts directly on F-actin (Figure 5.5). I hypothesised 
that localisation patterns of Profilin might be altered in talpid3 compared to wildtype. 
Localisation patterns of profilin did not change between talpid3 and wildtype in the 
lumen of the dorsal aorta (Figure 5.7 A-D), the mesenchyme (Figure 5.7 E-H) or the 
neural tube (Figure 5.7 I-L). Profilin showed specific patterns of enhanced localisation 
in the nucleus, seen clearly in the lumen of the dorsal aorta (Figure 5.7 A-D), which 
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did not differ between wildtype and talpid3. In conclusion, localisation of profilin is 
not altered in talpid3. 
 
 
Figure 5.7 Profilin localisation does not change in talpid3 during development. (A-
D) Immunostaining for Profilin (green), Phalloidin (red) and Dapi (blue) in the lumen 
of the dorsal aorta showed that localisation patterns of Profilin remain unchanged in 
talpid3. White arrowheads mark regions in the nucleus that appear to have higher 
levels of expression of Profilin. (E-H) Immunostaining for Profilin, Phalloidin and Dapi 
in regions of non-polarised mesenchyme show that Profilin localisation remains 
unchanged in talpid3 when compared to wildtype. (I-L) Immunostaining for Profilin, 
Phalloidin and Dapi at the apical edge of the neural tube shows that Profilin 
localisation remains unchanged in talpid3 compared to wildtype. All scale bars as 
annotated on figure. 
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Cofilin, another protein that regulates actin, induces depolymerisation of actin 
filaments (Nishida et al., 1984). This promotes actin filament disassembly by severing 
and consequently promotes actin polymerisation by generating free actin monomers, 
generating rapid actin filament turnover (Bamburg et al., 1999; Lappalainen & 
Drubin, 1997; Ohashi, 2015). Similar to profilin, a quantitative change was not 
detected in cofilin in the talpid3 PGC proteomic dataset; however, it was shown to be 
involved in the RhoA Signalling pathway thus due to its role in actin polymerisation 
there might be a change in localisation patterns in talpid3 compared to wildtype. 
Immunostaining for cofilin in the lumen of the dorsal aorta showed regions of 
increased localisation at the apex of the cells in both wildtype and talpid3; this 
increased localisation was more pronounced in talpid3, with localisation patterns 
resembling a more rounded shaped compared to wildtype (Figure 5.8 A-D). However, 
localisation patterns of cofilin were not altered in talpid3 in the mesenchyme (Figure 
5.8 E-H) or at the apical edge of the neural tube (Figure 5.8 I-L). In conclusion, cofilin 
localisation appears more abundant and has a more rounded localisation pattern in 
the lumen of the dorsal aorta in talpid3, but is unchanged in the mesenchyme and 






Figure 5.8 Cofilin localisation is altered in the lumen of the dorsal aorta but remains unchanged in the mesenchyme and neural tube of 
talpid3. (A-D) Immunostaining for Cofilin (green), Phalloidin (red) and Dapi (blue) in the lumen of the dorsal aorta in wildtype and talpid3. 
White arrowheads mark regions of more abundant Cofilin localisation at the apex of cells in talpid3 and wildtype. The cofilin localisation at 
the apex of talpid3 cells has a rounder localisation pattern when compared to wildtype. (E-H) Immunostaining for Cofilin, Phalloidin and 
Dapi in regions of non-polarised mesenchyme show that Cofilin localisation remains unchanged in talpid3 when compared to wildtype. (I-
L) Immunostaining for Cofilin, Phalloidin and Dapi at the apical edge of the neural tube shows that Cofilin localisation remains unchanged 





Twinfilin is an actin monomer binding protein that inhibits nucleotide exchange on 
actin monomers and prevents assembly of the monomers into filaments. Loss of 
twinfilin results in uncontrolled polymerisation of actin filaments (Goode et al., 1998; 
Palmgren et al., 2002). Twinfilin was not included in the pathway analysis or identified 
in any of the canonical pathways identified, however due to its role in preventing 
filament assembly, I hypothesised that localisation might be altered in talpid3 
compared to wildtype. Twinfilin localises more abundantly to the apex of the cells in 
the lumen of the dorsal aorta of wildtype embryos (Figure 5.9 A, B); in talpid3 there 
appeared to be less twinfilin localisation at the apex of the cell. Where localisation 
was detected in talpid3, it appeared more disorganised than in wildtype (Figure 5.9 
C, D). There was no change in localisation pattern of twinfilin observed in the non-
polarised mesenchyme tissue in talpid3 compared to wildtype (Figure 5.9 E-H). The 
apical edge of the neural tube in talpid3 showed higher abundance of twinfilin than 
the apical edge of the neural tube in wildtype (Figure 5.9 I-L). In conclusion, polarised 
tissue in talpid3 shows altered localisation patterns of twinfilin when compared to 







Figure 5.9 Twinfilin localisation patterns are altered in polarised tissue in talpid3. (A-D) Immunostaining for Twinfilin (green), Phalloidin 
(red) and Dapi (blue) in the lumen of the dorsal aorta of wildtype and talpid3. White arrowheads indicate localisation of Twinfilin at the 
apex of cells, with wildtype showing abundant and organised localisation patterns of twinfilin. Talpid3 showed lower abundance of twinfilin, 
with less cells showing twinfilin localisation at the apex of cells. (E-H) Immunostaining for Twinfilin, Phalloidin and Dapi in regions of non-
polarised mesenchyme show that Twinfilin localisation remains unchanged in talpid3 when compared to wildtype. (I-L) Immunostaining for 
Twinfilin, Phalloidin and Dapi at the apical edge of the neural tube shows more abundant localisation of twinfilin, marked by white 





The Rho proteins consist of three isoforms, A, B and C, that belong to the 
Rho GTPase family, a distinct family within the superfamily of Ras-related 
small GTPases (Jaffe & Hall, 2005). The Rho proteins promote reorganisation 
of the actin cytoskeleton and regulate cell shape, motility and attachment 
(Wheeler & Ridley, 2004). Despite similar functions, the Rho proteins have 
distinct roles, with RhoC playing a role in initial stages of digit 
chondrogenesis and stress fibre generation (Hakem et al., 2005; Montero et 
al., 2007). The final component of actin regulation that was tested by 
immunofluorescence in talpid3 was RhoC. Although only identified by one 
unique peptide in the proteomic dataset, RhoC was shown to be 
downregulated in talpid3 PGCs; therefore, talpid3 was examined for changes 
in localisation patterns of RhoC. Localisation of RhoC was examined at the 
apex of cells in the lumen of the dorsal aorta (Figure 5.10 A-D) and at the 
apex of the neural tube (Figure 5.10 I-L); however RhoC remained 
unchanged in talpid3 when compared to wildtype. Similarly, localisation of 
RhoC in non-polarised mesenchyme tissue remains unchanged in talpid3 
(Figure 5.10 E-H). In conclusion, RhoC localisation patterns are not altered in 
talpid3. 
Taken together, the results of profilin, cofilin, twinfilin and RhoC suggest that 
some regulators of actin are altered in talpid3. Twinfilin and cofilin are 
involved in depolymerisation of actin filaments and prevention of actin 
filament assembly respectively, and appear to be altered in polarised tissue 
in talpid3, therefore could be contributing to the actin phenotype seen. 
Profilin and RhoC however, are responsible for the opposite regulation of 
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actin through actin polymerisation and re-organisation respectively, and 





Figure 5.10 RhoC localisation patterns remain unchanged in talpid3. (A-D) Immunostaining for RhoC (green), Phalloidin (red) 
and Dapi (blue) in the lumen of the dorsal aorta showed that localisation patterns of RhoC remain unchanged in talpid3. White 
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arrowheads mark the apex of cells in wildtype and talpid3 respectively. (E-H) Immunostaining for RhoC, Phalloidin and Dapi in 
regions of non-polarised mesenchyme show that RhoC localisation remains unchanged in talpid3 when compared to wildtype. 
(I-L) Immunostaining for RhoC, Phalloidin and Dapi at the apical edge of the neural tube shows that RhoC localisation remains 






This study has shown that labelled quantitative mass spectrometry in 
chicken PGCs, derived from the talpid3 flock, is a viable way to study protein 
pathways that are altered in talpid3. Completion of pathway analysis in 
talpid3 for the first time, has presented cholesterol biosynthesis pathways as 
being altered and actin and Rho signalling pathways as being down regulated 
in talpid3. This study has shown that proteins involved in actin regulatory 
pathways are altered in talpid3, leading to an overall down regulation of the 
RhoA Signalling pathway, the Regulation of Actin-based Motility by Rho 
pathway and the Actin Cytoskeleton Signalling pathway. These results are 
supported by changes in localisation patterns of F-actin in talpid3. 
Additionally regulators of F-actin such as twinfilin and cofilin show altered 
localisation patterns in talpid3 in polarised tissue. However, no changes were 
observed in localisation patterns of profilin and RhoC, suggesting that 
different regulators of actin are altered in talpid3 to produce the phenotype 
observed. 
During early embryonic development in the chick, a new pair of somites are 
formed every 90 minutes from the presomitic mesoderm. Sonic hedgehog 
signalling from the notochord precedes somite formation and contributes to 
regulating the pace of somitogenesis. The maturation of somites is 
dependent on a balance of Wnt signalling, Hedgehog and Noggin signalling 
and also signalling between the bone morphogenic proteins (BMPs) 
(Resende et al., 2010). Ventral somatic cells go on to form the mesenchymal 
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sclerotome and the dorsal somatic cells form epithelial dermomyotome. 
Precursors of the trunk skeletal muscle migrate underneath the 
dermomyotome to form the myotome (Andrade et al., 2007). This myotome 
is marked by F-actin which is a key component of muscle. The F-actin 
filaments in the myotome of talpid3 appear dysregulated, this could in part 
be due to a loss of Hedgehog signalling much earlier in development. The 
lack of cilia in talpid3 mutants means that cells cannot respond to Sonic 
hedgehog, therefore the initiation and regulation of somite formation in 
talpid3 is disrupted. The disruption in Hedgehog signalling has been shown 
to cause displacement of cells between myotome and dermomyotome, 
which results in an expression of MyoD in the dermomyotome in talpid3, 
instead of being limited to expression in the myotome as seen in wildtype 
(Davey et al., 2006). This dorsal expansion or shift of MyoD expression can 
be mimicked by overexpression of Sonic Hedgehog in wildtype somites, thus 
suggesting this is a gain of function phenotype (Davey et al., 2006). Similar 
to what is seen in the intermediate neural tube of talpid3 mutants with 
expansion of thePax7 expression domain, this gain of function phenotype is 
likely due to a loss of Gli repressor. The role of Hedgehog signalling in 
determining boundaries between myotome and dermomyotome suggests 
that TALPID3 plays an indirect role on the dysregulation of actin in the talpid3 
mutant. It is the loss of cilia in the talpid3 mutant cells that leads to an 
inability for cells to respond to Sonic Hedgehog, thus actin dysregulation in 
the myotome as shown in Figure 5.6 is likely to be a secondary effect of the 
loss of Hedgehog signalling. 
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During early development of the neural tube, progenitor cells at the apical 
surface of the neural tube undergo symmetric division to produce two 
daughter cells that continue as progenitor cells. During later stages of neural 
tube development, progenitors at the apical edge of the neural tube 
undergo asymmetric division to produce one cell that continues as a 
progenitor at the apical surface and one that will become a neuron (Wilcock 
et al., 2007). The apical edge of the neural tube is characterised by cadherin-
based adherens junctions with acto-myosin cable and proteins linked to 
tight junctions. Progenitors attach at this apical surface, meaning following 
asymmetric division the newly produced neurons must detach and move out 
of the proliferative progenitor zone and undergo neuronal differentiation; 
the detachment from the apical surface by differentiated neurons is known 
as delamination (Singh & Solecki, 2015; Wilcock et al., 2007). Detachment of 
the neuron occurs by apical abscission, which is triggered by constriction of 
the acto-myosin cable at the apical surface of the neural tube (Das & Storey, 
2014). The disruption of continuous actin seen at the apical edge of the 
neural tube in talpid3 could have negative implications on neurogenesis 
based on the acto-myosin cable’s role in apical abscission of newly formed 
neurons. The disruption of actin could lead to a failure of progenitor cells to 
attach at the apical surface leading to a loss of the progenitor pool at the 
apical edge of the neural tube. The final number of neurons in the brain is 
determined by the time at which progenitors start dividing and the number 
of divisions that occur (Homem et al., 2016). If the progenitor pool is 
depleted than this could lead to a loss of neurons and thus neuronal defects. 
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If the disruption of actin at the apical edge of the talpid3 neural tube does 
negatively affect neurogenesis, this could help to understand the neural 
defects seen in the talpid3 chicken mutant, as well as the human patients 
with mutations in KIAA0586. 
Taken together, the results of twinfilin, cofilin, profilin and RhoC suggest that 
only some regulators of actin are altered in talpid3. Twinfilin and cofilin are 
involved in depolymerisation of actin filaments and prevention of actin 
filament assembly respectively, and appear to be altered in polarised tissue 
in talpid3. Profilin and RhoC however, are responsible for the opposite 
regulation of actin through actin polymerisation and re-organisation 
respectively, and localisation remains unchanged in talpid3. The 
downregulation of pathways associated with actin that was identified in IPA, 
could be caused by changes in proteins that act as negative regulators of 
actin as shown by twinfilin and cofilin. Proteins that promote actin assembly, 
such as Profilin and RhoC, might not be involved in the downregulation of 
pathways associated with actin, as identified in IPA. Alternatively, the 
changes in localisation patterns of these proteins could be as a result of the 
altered actin organisation in talpid3, instead of causing the altered actin 
organisation. 
For cell motility to occur, a single polarised lamellipodia must form to direct 
cell migration (Krause & Gautreau, 2014). Cofilin defines the site of actin 
polymerisation to form a protrusion, and maintenance of active non-
phosphorylated ADF/Cofilin is necessary to maintain a polarised lamellipodia 
during cell migration, thus cofilin acts as a component of the ‘steering wheel’ 
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of the cell during migration (Dawe et al., 2003; Ghosh et al., 2004). Changes 
in cofilin localisation in polarised tissue in talpid3 were not consistent; 
changes were observed in the lumen of the dorsal aorta, but not in the 
lumen of the neural tube. This could reflect on different dynamics of cell 
movements between the two regions of polarised tissue. Additionally, 
talpid3 has been shown to have disrupted polarity (Stephen et al., 2015). 
Talpid3 embryos lose characteristic rostral-caudal polarisation of skin, 
examined through feather bud studies; talpid3 also loses polarity of 
stereocilia bundles in the hair cells of the inner ear, known as basilar papilla 
in the chicken (Stephen et al., 2015). The abnormal polarity findings in talpid3 
suggest that through its role in centriole migration and orientation, 
KIAA0586 (TALPID3) affects cell and tissue polarity (Stephen et al., 2015). 
The results of the study discussed in this chapter highlight a close link 
between components of actin regulation and TALPID3, suggesting that the 
abnormal cell and tissue polarity seen in talpid3 is most likely linked to the 
downregulation of actin signalling pathways. 
An actin phenotype in talpid3 has previously been reported (Yin et al., 2009); 
talpid3 was shown to have a discontinuous band of F-actin at the apical edge 
of the developing neural tube. In addition, talpid3 mutant limb cells were 
shown to have fewer stress fibres (and fewer focal adhesions) in comparison 
to the wildtype limb cells (Yin et al., 2009). RhoA is responsible for formation 
of stress fibres, and the analysis in this study has suggested a down 
regulation of the RhoA Signalling pathway in talpid3. It is possible that this 
down regulation could account for the loss of stress fibres seen in talpid3 
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mutant cells. Stress fibres are important as the major contractile force in 
animal cells (Tojkander et al., 2012). The loss of stress fibres in cultured 
talpid3 cells (Yin et al., 2009) could be contributing to the disorganisation 
during development due to cells decreased ability to migrate. Although 
stress fibres were not examined in talpid3 PGCs, the reduction of stress fibres 
could be causing the slower migration of PGCs when colonising the gonad in 
talpid3 (Davey and McGrew labs, unpublished). RhoA is also important in 
actin regulation for ciliogenesis; RhoA is required for the formation of a 
characteristic apical actin web in ciliated cells. This actin web is necessary for 
basal body docking and formation of the ciliary axoneme (Pan et al., 2007), 
again suggesting that the down regulation of the RhoA Signalling pathway 
and the down regulation of the Regulation of Actin-based Motility by Rho is 
crucial to causing the phenotype seen in talpid3. RhoC was identified as 
downregulated in the talpid3 PGC dataset; however, localisation studies did 
not show a change in patterns of RhoC in talpid3 when compared to wildtype. 
This result was unexpected due to the role of RhoC in generation of actin 
stress fibres (Hakem et al., 2005; Montero et al., 2007). However, the Rho 
proteins have distinct roles during development with RhoC playing a key role 
in digit morphogenesis during limb development (Montero et al., 2007); it is 
possible that altered localisation of RhoC might be seen in talpid3 at different 
stages or in different tissue. It is also possible that despite lower levels of 
RhoC, the localisation pattern does not change; however, without using 
quantitative fluorescent imaging it is not possible to draw that conclusion 
from the immunofluorescence data presented in this study. 
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Recent evidence shows that TALPID3 interacts with MACF1 (May-Simera et 
al., 2016); this interaction supports a role for TALPID3 associating with actin. 
MACF1, also known as ACF1 (actin cross-linking factor 7), is important for 
the coordination of microtubules and actin filaments in many cellular 
processes (Escobar-Aguirre et al., 2017; Karakesisoglou et al., 2000). It plays 
a critical role in ciliogenesis, with loss of MACF1 in the retina resulting in a 
failure of basal bodies to migrate apically and dock with the cell membrane, 
thus resulting in a loss of ciliogenesis (May-Simera et al., 2016). The 
conditional MACF1 knockout in the retina, produces a phenotype that is 
similar to that seen in talpid3 (Stephen et al., 2015; Yin et al., 2009). In both 
the conditional MACF1 knockout and talpid3 mutants, there is a loss of 
association of the basal body with ciliary vesicles. However, MACF1 mutant 
mouse embryonic fibroblasts, unlike talpid3 mutant cells, show an 
accumulation of actin stress fibres (May-Simera et al., 2016 Yin et al., 2009). 
This difference in actin stress fibre phenotypes between the conditional 
MACF1 knockout and talpid3 mutant, suggests that TALPID3 interacts with 
additional actin regulatory proteins to produce the actin phenotype 
observed. Previous investigation into microtubules in talpid3 showed that 
there was no obvious differences in microtubule organisation in talpid3 
chicken embryonic fibroblasts when compared to wildtype chicken 
embryonic fibroblasts. There was however a delay in microtubule regrowth 
in the talpid3 chicken embryonic fibroblasts following nocodazol treatment, 
a reagent used to depolymerise microtubules (Yin et al., 2009). Although 
TALPID3 does not appear to directly affect microtubule organisation, its 
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interaction with MACF1 could play a role in this delay of microtubule re-
growth. 
TALPID3 plays a role in and is necessary for several different functions within 
the centrosome. It is well established that loss of TALPID3 results in failure 
of centrosomes to orientate, migrate and dock therefore resulting in a loss 
of ciliogenesis (Stephen et al., 2013, 2015; Yin et al., 2009). The actin 
cytoskeleton at the apical region of the cell plays a role in orientation of the 
basal body prior to docking and ciliogenesis and enrichment of apical actin 
is thought to be required for ciliogenesis (Pan et al., 2007; Park et al., 2006). 
Cytoplasmic stress fibres appear to interfere with basal body migration while 
cortical actin can stabilise and organise basal body orientation and 
positioning (Avasthi & Marshall, 2012). Although talpid3 shows a loss of actin 
stress fibres, the combination of actin-related phenotypes found in talpid3 
along with the role actin plays in centrosome orientation and ciliogenesis is 
likely to be linked. This study has shown through pathway analysis that the 
mutation in TALPID3 is disrupting actin regulation and it is possible that the 
disruption of actin is playing a role in the misorientation of basal bodies and 
the polarity defects seen in talpid3.  
 
5.3.1 Conclusions and future studies 
In conclusion, the study presented in this chapter has shown that 
quantitative proteomic analysis in chicken PGCs can be used to identify and 
investigate altered protein interacting pathways in talpid3. Following 
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validation of the proteomic dataset, pathway analysis showed that the 
mutation in TALPID3 affects the cholesterol biosynthesis pathway and 
pathways involved in actin cytoskeleton organisation. Pathways controlling 
actin organisation are down regulated in talpid3, and the actin regulatory 
proteins cofilin and twinfilin have altered localisation patterns in talpid3. 
It is still unknown how TALPID3 controls down regulation of actin regulatory 
protein pathways, whether through a direct interaction with actin or 
whether it interacts with a protein upstream of actin. To identify additional 
proteins that are linked to the regulation of actin that could interact with 
TALPID3 directly or indirectly, the remaining proteins in the talpid3 PGC 
quantitative proteomic dataset that have links to actin (Figure 5.11) could 
be examined. Immunofluorescence to look at localisation patterns could be 
analysed to determine whether the proteins are altered in talpid3 in 
polarised and non-polarised tissue. If changes in localisation were observed, 
electroporation of constructs containing the proteins of interest, into the 
neural tube of talpid3, could be used to determine whether these proteins 
were able to rescue actin phenotypes seen in talpid3. If overexpression of a 
particular protein was able to rescue the phenotype caused by the mutation 
in TALPID3, it would confirm that the protein acted downstream of TALPID3 
in the pathway or mechanism that produces the actin phenotype in talpid3. 
Alternatively, an approach aimed at identifying direct TALPID3 protein 
interactors could be undertaken; a co-immunoprecipitation assay followed 
by mass spectrometry could be used to identify proteins that directly 
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interact with TALPID3. The dataset produced by this method could then be 
examined for proteins involved in the regulation of actin.  
 
 
Figure 5.11 Proteins identified in the TMT dataset, linked to actin 
signalling, that are upregulated or downregulated with a fold change 
minimum of 1.2 in talpid3 PGCs compared to wildtype PGC. Black arrows 
identify three proteins that have been investigated in relation to talpid3. 
RhoC and Actin were both investigated and presented in this study. Gli2 was 
investigated and presented in a previous study. 
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Future studies could use the data produced by IPA to explore different 
avenues, such as potential upstream regulators and molecular activators or 
inhibitors. IPA predicts upstream targets of the altered pathways identified 
and provides suggestions of drugs or molecules that can activate or inhibit 
the altered pathways. To demonstrate that the pathways identified in IPA 
are altered in talpid3, an upstream target of a pathway such as the RhoA 
Signalling pathway could be knocked out of wildtype PGCs and the resulting 
PGCs could be examined for phenotypes similar to talpid3 PGCs. 
Furthermore, drug or molecular activators identified in IPA could be tested 
on developing talpid3 embryos, which could be examined for signs of rescue 
of the phenotype being targeted. Further investigation into the protein 
pathways that are altered in talpid3 would increase our understanding of the 
phenotype and produce alternative avenues to explore and to uncover the 




Chapter 6. General Discussion 
 
Collectively, the results presented in this thesis provide the first evidence to 
support the talpid3 chicken mutant as a tool to model human KIAA0586 
ciliopathy patient mutations to understand C-terminal functional protein 
domains. The results identify CCDC77 and CCDC127 as novel centrosome 
proteins and demonstrate that loss of CCDC127 results in a significant 
decrease in ciliogenesis. Finally, the results demonstrate that chicken PGCs 
are a suitable model for studying the centrosome and present the first study 
aimed at analysing the talpid3 proteome through quantitative mass 
spectrometry of the mutant proteome compared to a wildtype proteome, 
finding a downregulation of pathways regulating the actin cytoskeleton.  
During the course of this thesis, I have explored many different tools to 
understand TALPID3; however despite these attempts, the dynamic 
localisation of TALPID3 in space and time and the protein networks it 
interacts with remain unknown.  TALPID3 is a low abundance protein that 
localises to a tiny organelle, it contains a predicted intrinsically disordered 
domain that has made structural modelling unsuccessful and localisation 
studies have not been extended to live cell imaging to determine the 
dynamic localisation of the endogenous TALPID3 protein due to a lack of 
viable tools. Attempts to overcome these challenges have provided insights 
into proteomic approaches that can be used to study TALPID3 despite its low 
abundance within the centrosome, however these attempts still have not 
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answered the fundamental questions of what proteins TALPID3 interacts 
with and what processes these interactions control. 
By combining what is currently known about the role of TALPID3 in the 
centrosome with the data presented in this thesis, I have identified two 
distinct roles for TALPID3 (Figure 6.1). The first role is a result of the 
relationship between TALPID3 and ciliogenesis. As previously shown, 
TALPID3 interacts with a group of centrosome proteins, to control processes 
such as centrosome orientation, migration and consequently ciliogenesis 
(Kobayashi et al., 2014; Wang et al., 2016; Wu et al., 2014); through 
interactions with Cep120 and C2CD3, TALPID3 has been shown to play a role 
in the maturation of the mother centriole and asymmetric localisation of 
proteins to the daughter centriole (Wang et al., 2018; Wu et al., 2014). As a 
result of the role of TALPID3 in ciliogenesis, the loss of TALPID3 causes a loss 
of the Hedgehog signal transduction pathway leading to phenotypes such as 
the loss of neural tube patterning during development, the loss of patterning 
during limb development and polydactyly and the lung abnormalities found 
in talpid3. The loss of ciliogenesis plays a role in loss of polarity in talpid3, 
contributing to phenotypes such as polycystic kidneys, skin defects and inner 
ear defects. The second role for TALPID3 is in the regulation of the actin 
cytoskeleton, suggesting that loss of TALPID3 results in downregulation of 
protein pathways that regulate the actin cytoskeleton. Although specific 
TALPID3 protein interactions that control the regulation of actin have not 
yet been identified, evidence from the discontinuous band of F-actin at the 
apical edge of the neural tube suggests that this dysregulation of actin, when 
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TALPID3 is lost, could lead to changes in neural progenitor proliferation and 
migration events. In turn this could cause a loss of neural progenitor pools 




Figure 6.1 Two distinct roles for TALPID3 during development. Lines 
represent direct links between proteins and processes. The group of 
proteins in red represent the protein interactions between TALPID3 and 
other centrosome proteins. These interactions are predicted to contribute 
to the role of TALPID3 in ciliogenesis. Loss of TALPID3 and consequently loss 
of the interactions between TALPID3 and the centrosome proteins in red, 
leads to a loss of cilia and therefore a loss of the Hedgehog signal 
transduction pathway and loss of polarity. TALPID3 also plays a role in the 
regulation of the actin cytoskeleton, shown in purple. Although direct 
protein interactions have not been identified for this role, evidence suggests 
that this role is important for neural progenitors at the apical edge of the 




The quantitative proteomics analysis presented in chapter 5 of this thesis, 
provides an extensive dataset regarding changes in protein expression levels 
in talpid3 compared to wildtype. However, the results and analysis 
presented in chapter 5 only focus on a small portion of this data. Moving 
away from the IPA data and the potential future studies that could be 
completed using the IPA analysis discussed in chapter 5, two proteins of 
interest were identified. Neuropilin1 (NRP1) and Neuropilin2 (NRP2) were 
both identified as altered in talpid3 compared to wildtype. The neuropilins 
(NRPs) are single transmembrane receptors that are well conserved in 
vertebrates. NRPs bind to Semaphorin 3 (SEMA 3) proteins and vascular 
endothelial growth factors (VEGF) and are known for their crucial role in 
neurogenesis and cardiovascular development (Schellenburg et al., 2017; 
Takashima et al., 2002). Knockout of NRP1 in mice leads to early embryonic 
death with a wide range of cardiovascular defects. A knockout of NRP2, 
although not embryonic lethal, results in abnormal guidance of nerves and 
fewer small vessels and capillaries (Schellenburg et al., 2017; Takashima et 
al., 2002). The quantitative data showed that NRP1 was upregulated in 
talpid3 compared to wildtype, but that NRP2 was downregulated in talpid3 
compared to wildtype. Although NRP1 and NRP2A have been studied in 
relation to the abnormalities in the limb vasculature (Davey et al., 2007), 
these proteins have not been examined in talpid3 in relation to the role they 
play in guidance of nerves during development. The NRP2 knockout mouse 
shows defects in axonal projections in the peripheral and central nervous 
system, demonstrating the role of NRP2 in axon guidance; the 
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downregulation of NRP2 could contribute to the neural defects seen in 
talpid3 and human KIAA0586 patients, therefore worth following up in 
future studies. 
It is likely that TALPID3 is involved in multiple distinct protein networks to 
control specific functions rather than forming one ‘TALPID3 protein 
network;’ if this hypothesis is correct then it will be necessary to identify 
specific TALPID3-interacting proteins in order to identify these smaller 
networks of proteins. One of the shortcomings of the method used to study 
the talpid3 proteome in chapter 5, is that pathway analysis is designed to 
predict an overall change to a large network of proteins based on the 
upregulation and downregulation of individual proteins within that network, 
which most likely explains the lack of small centrosome protein networks 
identified as being changed in talpid3. Despite providing valuable insight into 
the regulation of actin protein networks that TALPID3 is involved in, this 
study highlights the need for a way to carry out targeted proteomic studies 
on TALPID3. Given that TALPID3 is a low abundance protein within the 
centrosome, it is likely that some of the proteins it interacts with are also 
low abundance proteins within the centrosome, supporting the need for a 
targeted TALPID3 proteomic approach. 
One such targeted approach that has shown recent success in uncovering 
protein – protein interactions is the proximity-dependent biotinylation 
technique, BioID (Roux et al., 2012). Briefly, this approach relies on BirA* 
being fused to a protein of interest, or a bait protein, which is introduced 
into a cell where it biotinylates proteins within close proximity. Biotinylated 
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proteins can be identified following cell lysis, protein extraction, streptavidin 
pulldown and mass spectrometry (Kim et al., 2016; Roux et al., 2012). This 
would provide a more targeted method of identifying TALPID3 interacting 
proteins that could overcome the shortcomings of previous attempts. A 
modification of the BioID approach relies on splitting BirA* into two 
fragments that can be fused to two different bait proteins that are known to 
interact, therefore preventing biotinylated labelling of nearby proteins prior 
to the interaction of the two bait proteins (Schopp et al., 2017). This 
modification allows identification of additional proteins that are associated 
with a pair of interacting proteins and could be used to identify the multiple 
small protein networks that are predicted to involve TALPID3. Using the 
split-BioID approach, TALPID3 could be fused to one of the BirA* fragments 
in combination with another protein of interest. For example TALPID3 and 
PCM1 could be fused to the two BirA* fragments in an attempt to identify 
the network of proteins involved in the satellite phenotype that TALPID3 
controls. Additionally TALPID3 and Cep120 could be fused to the two BirA* 
fragments with the aim of identifying other proteins in that network, which 
could provide some answers as to what process the TALPID3-Cep120 
interaction controls. Alternatively TALPID3 and MACF1 could be fused to the 
two BirA* fragments to determine whether this interaction is likely to be 
controlling centrosome and cilia processes or whether it is likely to be 
involved in the ability of TALPID3 to regulate the actin cytoskeleton. By 
identifying additional proteins that are associated with individual TALPID3-
protein interactions and determining whether these proteins are the same 
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or different, some understanding could be gained as to whether these 
individual protein interactions overlap to form one network or whether 
TALPID3 is part of lots of smaller protein networks as predicted. In addition, 
the identification of these networks could provide insight into the processes 
controlled by TALPID3. 
The study presented in chapter 3, demonstrated that human KIAA0586 can 
be modelled in the talpid3 mutant with the aim of identifying functional 
domains through modelling the ciliopathy patient mutations. However, this 
assay is limited to analysis of Hedgehog-dependent expression in the neural 
tube and the availability of talpid3 embryos. An alternative approach for 
modelling an allelic series of human KIAA0586 mutations would be to use 
gene editing to introduce the mutations from an allelic series into TALPID3 
in chicken PGCs. Four lines of PGCs could be generated through gene editing, 
each modelling a different mutation, which could then be mixed together 
and introduced (approximately equal numbers of cells from each edited cell 
line) into a sterile surrogate host (McGrew lab, unpublished). The offspring 
generated would contain a range of mutations in TALPID3, including 
homozygous and compound heterozygous mutations, that could be 
analysed for severity of different phenotypes. The abnormal phenotypes 
associated with limb, vasculature, liver, kidney and skeletal development in 
the talpid3 mutant have been well characterised (Davey et al., 2007; Davey 
et al., 2006; Stephen et al., 2013, 2015; Stephen et al., 2014); this means that 
the time point during development, at which the embryos containing 
TALPID3 mutations should be examined for signs of specific abnormal 
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phenotypes, is already known. Evidence from human KIAA0586 ciliopathy 
patients suggests that some cilia are still formed (Alby et al., 2015; Malicdan 
et al., 2015); by using PGCs to model an allelic series of the human patients, 
the frequency of cilia in different tissue types in the chicken could also be 
analysed, which could provide insight into the different levels of tissue 
penetrance of the mutation, based on which tissues and cell types were still 
capable of forming cilia. The severity of the phenotype and reduction of cilia 
associated with each of the mutations, would allow conclusions to be drawn 
about the human mutations, but even more importantly would provide 
insight into and identification of additional functional domains at the C-






The full alignment of the TALPID3/KIAA0586 protein is shown below. The 
first sequence, Nematostella vectensis (Starlet sea anemone), is conserved, 
containing both the coiled-coil domain and an intrinsically disordered 
domain. The second sequence, Saccoglossus kowalevskii (Acorn worm), is 
not conserved. It contains a coiled-coil domain in a similar region, but does 
not appear to share sequence similarity and does not contain an intrinsically 
disordered domain. The bottom four sequences are Danio rerio (zebrafish), 
Gallus gallus (chicken), Homo sapiens (human) and Mus musculus (mouse) 
respectively and all contain the conserved coiled-coil domain and the 
intrinsically disordered domain. The conserved coiled-coil domain is marked 




















The following list of proteins contains 142 proteins that are found in both 






















































































































































The following list of proteins contains 139 proteins that are found in both 



















































































































































The following list of proteins contains 76 proteins that are found in the Jurkat 

















































































The following list of proteins contains 52 proteins from a combined Jurkat 
centrosome sample 1 and Jurkat centrosome sample 2 dataset that were 
identified as fitting the criteria for taking proteins forward for further 
















































The following list of proteins contains 29 proteins from Jurkat centrosome 
sample 2 alone that were identified as fitting the criteria for taking proteins 

































Western Blots display antibodies that were tested on protein extracted from 
human RPE1 cells and chicken PGCs. The expected size of each band is 
annotated with a red arrow to mark where the band was expected. 
Antibodies are often non-specific for chicken proteins, therefore it was 
important to test all the antibodies in control protein samples before 
carrying out Western Blots on protein samples sent for mass spectrometry 
to validate the dataset. Included are the test western blots for antibodies 
against CCDC77 and CCCDC127, which also did not work and therefore could 













The following list is comprised of the proteins (identified by gene name) that 
were filtered for two or more unique peptides and a minimum fold change 
of 1.2 when talpid3 PGC protein reporter intensities were compared to 
wildtype PGC protein reporter intensities, from the TMT mass spectrometry 
dataset. The left column represents the gene name and the right column in 
light blue contains the fold change value. This list of proteins was used for 
the pathway analysis in IPA. The genes and their respective fold change 
values are plotted on the graph seen in Figure 4.2.
















































































































































































The following pathways were generated in Ingenuity Pathway Analysis from 
the list of proteins found in Appendix 8. The pathways represent two of the 
three pathways identified in the top 15 canonical signalling pathways that 
involve Actin and Rho; the third pathway is found in Chapter 4. Nodes that 
are shaded red indicate proteins that are upregulated. Nodes that are 
shaded green indicate proteins that are downregulated. Nodes that are 
shaded grey indicate a protein contained in the dataset that does not 
contain a change over the minimum 1.2 fold change limit. Nodes with no 
shading (i.e. white) indicate a protein that is integral to the network but not 
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